P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
2.337e-10 | -22.18 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 32 | 16828 | 49 |
GPM6A,PREX2,NTM,MGAT4C,NKAIN3,FBXL7,SLC1A2,GPC5,LSAMP,RYR3,PAMR1,PTPRZ1,ADCY2,NTRK2,DST,SLC1A3,TNIK,SOX5,SLC4A4,NEBL,NRG3,GLIS3,ZBTB20,FMN2,BMPR1B,CTNND2,CSGALNACT1,MAML2,RORA,NFIA,GLI3,ITPR2 |
2.337e-10 | -22.18 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 32 | 16828 | 49 |
ADCY2,NTRK2,DST,SLC1A3,TNIK,SOX5,GPM6A,PREX2,NTM,MGAT4C,NKAIN3,FBXL7,SLC1A2,GPC5,LSAMP,RYR3,PTPRZ1,PAMR1,MAML2,RORA,NFIA,GLI3,ITPR2,SLC4A4,NEBL,NRG3,ZBTB20,GLIS3,FMN2,BMPR1B,CSGALNACT1,CTNND2 |
5.923e-10 | -21.25 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 24 | 16828 | 49 |
NHSL1,SOX5,SLC1A3,ADCY2,NTRK2,FBXL7,SLC1A2,NKAIN3,RYR3,GPC5,LSAMP,PREX2,GPM6A,NPAS3,ITPR2,MAML2,GLI3,FMN2,CTNND2,CSGALNACT1,BMPR1B,TPD52L1,NRG3,RFX4 |
5.923e-10 | -21.25 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 24 | 16828 | 49 |
SOX5,SLC1A3,NHSL1,NTRK2,ADCY2,RYR3,GPC5,LSAMP,FBXL7,SLC1A2,NKAIN3,NPAS3,GPM6A,PREX2,ITPR2,GLI3,MAML2,CSGALNACT1,CTNND2,BMPR1B,FMN2,NRG3,TPD52L1,RFX4 |
6.000e-10 | -21.23 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 46 | 16828 | 49 |
TPD52L1,NRG3,ZBTB20,RFX4,GLIS3,SLC4A4,FMN2,CTNND2,DPP10,RORA,GLI3,SORBS1,DTNA,RYR3,GPC5,MSI2,PARD3B,ABLIM1,NEBL,MACF1,CSGALNACT1,BMPR1B,NFIA,MAML2,PRKCA,ITPR2,GPM6A,PREX2,NTM,NPAS3,TRPM3,FBXL7,SLC1A2,NKAIN3,PTPRZ1,LSAMP,ADCY2,CDH20,NTRK2,DST,PITPNC1,NHSL1,SPARCL1,TNIK,SOX5,SLC1A3 |
6.230e-10 | -21.20 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 42 | 16828 | 49 |
ITPR2,GLI3,PRKCA,MAML2,RORA,NFIA,DPP10,CTNND2,CSGALNACT1,MACF1,FMN2,NEBL,SLC4A4,ZBTB20,GLIS3,RFX4,TPD52L1,NRG3,SLC1A3,ABLIM1,SOX5,TNIK,NHSL1,PITPNC1,DST,NTRK2,PARD3B,ADCY2,LSAMP,GPC5,PTPRZ1,PAMR1,RYR3,NKAIN3,SLC1A2,FBXL7,TRPM3,NPAS3,NTM,SORBS1,GPM6A,PREX2 |
1.166e-08 | -18.27 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 31 | 16828 | 49 |
DPP10,MACF1,CTNND2,CSGALNACT1,FMN2,NEBL,TPD52L1,NRG3,ITPR2,ATP1A2,PRKCA,GLI3,RORA,MAML2,GPC5,LSAMP,RYR3,NKAIN3,FBXL7,SLC1A2,DTNA,GPM6A,PREX2,SLC1A3,TNIK,SOX5,SPARCL1,DST,NTRK2,CDH20,ADCY2 |
4.380e-08 | -16.94 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 22 | 16828 | 49 |
CTNND2,FMN2,TPD52L1,NRG3,NEBL,ITPR2,GLI3,MAML2,PTPRZ1,RYR3,LSAMP,GPC5,SLC1A2,FBXL7,NKAIN3,PREX2,GPM6A,SOX5,SLC1A3,CDH20,NTRK2,ADCY2 |
4.380e-08 | -16.94 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 22 | 16828 | 49 |
GLI3,MAML2,ITPR2,NRG3,TPD52L1,NEBL,CTNND2,FMN2,CDH20,NTRK2,ADCY2,SOX5,SLC1A3,GPM6A,PREX2,PTPRZ1,RYR3,LSAMP,GPC5,SLC1A2,FBXL7,NKAIN3 |
5.128e-08 | -16.79 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 22 | 16828 | 49 |
SLC1A3,SOX5,ITPR2,NTRK2,CDH20,GLI3,MAML2,ADCY2,LSAMP,GPC5,PTPRZ1,CTNND2,RYR3,NKAIN3,FMN2,SLC1A2,FBXL7,NEBL,GPM6A,PREX2,TPD52L1,NRG3 |
1.057e-07 | -16.06 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 16 | 16828 | 49 |
SOX5,TNIK,ATP1A2,NTRK2,PRKCA,NFIA,ADCY2,BMPR1B,LSAMP,RYR3,NKAIN3,SLC1A2,FBXL7,NPAS3,PREX2,NRG3 |
1.057e-07 | -16.06 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 16 | 16828 | 49 |
LSAMP,BMPR1B,RYR3,NKAIN3,FBXL7,SLC1A2,NPAS3,NRG3,PREX2,TNIK,SOX5,ATP1A2,NTRK2,PRKCA,NFIA,ADCY2 |
1.132e-07 | -15.99 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 18 | 16828 | 49 |
SLC1A3,ITPR2,SOX5,RORA,MAML2,ADCY2,NTRK2,GLI3,FMN2,NKAIN3,FBXL7,GPC5,LSAMP,RYR3,CTNND2,NEBL,PREX2,NRG3 |
1.132e-07 | -15.99 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 18 | 16828 | 49 |
RYR3,CTNND2,GPC5,LSAMP,FBXL7,NKAIN3,FMN2,NRG3,PREX2,NEBL,ITPR2,SOX5,SLC1A3,GLI3,NTRK2,ADCY2,RORA,MAML2 |
1.173e-07 | -15.96 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 23 | 16828 | 49 |
ADCY2,CDH20,TNIK,SOX5,SLC1A3,GPM6A,PREX2,FBXL7,NKAIN3,RYR3,PTPRZ1,GPC5,LSAMP,MAML2,RORA,GLI3,PRKCA,ITPR2,TPD52L1,NRG3,ZBTB20,FMN2,CTNND2 |
1.451e-07 | -15.75 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 27 | 16828 | 49 |
GLI3,PRKCA,FMN2,MACF1,CTNND2,BMPR1B,NRG3,SLC4A4,DST,PITPNC1,TNIK,SLC1A3,ADCY2,MSI2,PARD3B,NTRK2,FBXL7,RYR3,PTPRZ1,PAMR1,GPC5,LSAMP,PREX2,NPAS3,TRPM3,DTNA,MGAT4C |
1.451e-07 | -15.75 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 27 | 16828 | 49 |
ADCY2,MSI2,PARD3B,NTRK2,PITPNC1,DST,TNIK,SLC1A3,PREX2,TRPM3,NPAS3,MGAT4C,DTNA,FBXL7,PAMR1,PTPRZ1,RYR3,LSAMP,GPC5,PRKCA,GLI3,NRG3,SLC4A4,FMN2,CTNND2,MACF1,BMPR1B |
1.593e-07 | -15.65 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 49 | 16828 | 49 |
ATP1A2,ITPR2,NFIA,MAML2,PRKCA,MACF1,CSGALNACT1,BMPR1B,NEBL,DST,PITPNC1,NHSL1,SPARCL1,TNIK,SOX5,SLC1A3,ADCY2,CDH20,NTRK2,FBXL7,SLC1A2,NKAIN3,PTPRZ1,LSAMP,PREX2,GPM6A,NTM,NPAS3,TRPM3,MGAT4C,RORA,GLI3,FMN2,CTNND2,DPP10,NRG3,TPD52L1,ZBTB20,RFX4,GLIS3,SLC4A4,ABLIM1,MSI2,PARD3B,RYR3,PAMR1,GPC5,SORBS1,DTNA |
1.607e-07 | -15.64 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 35 | 16828 | 49 |
ADCY2,PARD3B,CDH20,NTRK2,DST,SPARCL1,NHSL1,SOX5,SLC1A3,GPM6A,SORBS1,PREX2,TRPM3,NPAS3,SLC1A2,FBXL7,NKAIN3,PTPRZ1,PAMR1,RYR3,LSAMP,GPC5,NFIA,MAML2,RORA,GLI3,ITPR2,GLIS3,NRG3,TPD52L1,NEBL,FMN2,CTNND2,MACF1,DPP10 |
1.813e-07 | -15.52 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 13 | 16828 | 49 |
NTRK2,MAML2,ADCY2,SOX5,ATP1A2,PREX2,NRG3,GPC5,LSAMP,RYR3,NKAIN3,FBXL7,SLC1A2 |
1.955e-07 | -15.45 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 13 | 16828 | 49 |
MAML2,PARD3B,NTRK2,ABLIM1,ITPR2,NRG3,NEBL,NPAS3,PTPRZ1,CTNND2,RYR3,DPP10,GPC5 |
2.237e-07 | -15.31 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 24 | 16828 | 49 |
ITPR2,SOX5,SLC1A3,DST,PARD3B,PRKCA,GLI3,NTRK2,ADCY2,MAML2,RYR3,CTNND2,GPC5,LSAMP,FBXL7,SLC1A2,NKAIN3,FMN2,TRPM3,GPM6A,NRG3,PREX2,RFX4,NEBL |
2.486e-07 | -15.21 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 25 | 16828 | 49 |
NPAS3,PREX2,GPM6A,RYR3,PTPRZ1,GPC5,LSAMP,FBXL7,SLC1A2,NKAIN3,CDH20,ADCY2,TNIK,SOX5,SLC1A3,NRG3,TPD52L1,ZBTB20,CTNND2,FMN2,GLI3,PRKCA,RORA,MAML2,ITPR2 |
2.559e-07 | -15.18 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 38 | 16828 | 49 |
FMN2,MACF1,CTNND2,CSGALNACT1,NRG3,RFX4,ZBTB20,SLC4A4,NEBL,ATP1A2,ITPR2,MAML2,RORA,GLI3,PRKCA,FBXL7,SLC1A2,RYR3,PAMR1,PTPRZ1,GPC5,LSAMP,SORBS1,GPM6A,PREX2,NTM,TRPM3,DTNA,MGAT4C,DST,PITPNC1,NHSL1,TNIK,ABLIM1,SOX5,ADCY2,PARD3B,CDH20 |
2.603e-07 | -15.16 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 12 | 16828 | 49 |
NPAS3,NEBL,NRG3,DPP10,RYR3,CTNND2,PTPRZ1,NTRK2,PARD3B,MAML2,ITPR2,ABLIM1 |
2.608e-07 | -15.16 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 27 | 16828 | 49 |
PRKCA,GLI3,RORA,MAML2,ITPR2,ATP1A2,TPD52L1,NRG3,NEBL,MACF1,CSGALNACT1,CTNND2,FMN2,CDH20,ADCY2,TNIK,SOX5,DST,SPARCL1,PREX2,GPM6A,RYR3,GPC5,LSAMP,FBXL7,SLC1A2,NKAIN3 |
2.646e-07 | -15.15 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 12 | 16828 | 49 |
NPAS3,PARD3B,NTRK2,NRG3,NEBL,MAML2,CTNND2,PTPRZ1,ABLIM1,RYR3,ITPR2,DPP10 |
2.894e-07 | -15.06 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 11 | 16828 | 49 |
GPC5,LSAMP,RYR3,CTNND2,NKAIN3,FMN2,NRG3,GPM6A,TPD52L1,SOX5,ADCY2 |
3.120e-07 | -14.98 | nervous system development | biological process | GO:0007399 | 2185 | 20 | 18204 | 49 |
BMPR1B,CTNNA2,ATP1A2,NTRK2,NTM,LSAMP,GLI3,SOX5,CTNND2,RORA,TNIK,NRG3,SLC1A3,NFIA,SLC1A2,PREX2,RFX4,GPM6A,MSI2,PTPRZ1 |
3.797e-07 | -14.78 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 23 | 16828 | 49 |
RFX4,NRG3,SLC4A4,CTNND2,MACF1,DPP10,FMN2,PRKCA,NFIA,ATP1A2,NPAS3,DTNA,SORBS1,PREX2,PTPRZ1,RYR3,GPC5,SLC1A2,PARD3B,NTRK2,PITPNC1,DST,NHSL1 |
5.011e-07 | -14.51 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 23 | 16828 | 49 |
FMN2,NKAIN3,SLC1A2,FBXL7,LSAMP,GPC5,CTNND2,RYR3,NEBL,RFX4,GPM6A,NRG3,PREX2,DST,SLC1A3,SOX5,ITPR2,MAML2,ADCY2,NTRK2,PARD3B,PRKCA,GLI3 |
5.280e-07 | -14.45 | PRNP (prion protein (Kanno blood group)) | protein interactions | 5621 | 1118 | 14 | 19454 | 50 |
MSI2,GPM6A,MACF1,SORBS1,MAML2,NHSL1,SLC1A3,TRPM3,ATP1A2,SLC4A4,LSAMP,ABLIM1,PTPRZ1,SPARCL1 |
5.321e-07 | -14.45 | MAPT (microtubule associated protein tau) | protein interactions | 4137 | 948 | 13 | 19454 | 50 |
TNIK,SORBS1,GPM6A,ATP1A2,SLC1A2,SLC1A3,NEBL,PRKCA,CTNND2,ABLIM1,CTNNA2,LSAMP,NTM |
6.069e-07 | -14.31 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 18 | 16828 | 49 |
LSAMP,DPP10,GPC5,CTNND2,RYR3,DTNA,TRPM3,NEBL,GPM6A,NRG3,SLC1A3,SOX5,TNIK,ITPR2,NTRK2,PARD3B,PRKCA,MAML2 |
8.806e-07 | -13.94 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 19 | 16828 | 49 |
MGAT4C,NPAS3,NEBL,SLC4A4,ZBTB20,GPM6A,BMPR1B,CSGALNACT1,RYR3,MACF1,FMN2,PARD3B,GLI3,MAML2,RORA,SOX5,ITPR2,TNIK,DST |
8.947e-07 | -13.93 | larynx | COSMIC cancer mutations | larynx | 1948 | 19 | 16828 | 49 |
NPAS3,MGAT4C,ZBTB20,GPM6A,NEBL,SLC4A4,CSGALNACT1,MACF1,RYR3,BMPR1B,FMN2,GLI3,PARD3B,MAML2,RORA,SOX5,ITPR2,TNIK,DST |
1.354e-06 | -13.51 | generation of neurons | biological process | GO:0048699 | 1158 | 14 | 18204 | 49 |
CTNNA2,BMPR1B,SOX5,GLI3,NTM,NTRK2,CTNND2,SLC1A3,TNIK,RORA,NFIA,PREX2,GPM6A,PTPRZ1 |
1.606e-06 | -13.34 | cell morphogenesis | biological process | GO:0000902 | 687 | 11 | 18204 | 49 |
GPM6A,PTPRZ1,NFIA,PREX2,CTNND2,SLC1A3,TNIK,CTNNA2,BMPR1B,CDH20,GLI3 |
1.623e-06 | -13.33 | CTNNA1 (catenin alpha 1) | protein interactions | 1495 | 325 | 8 | 19454 | 50 |
MACF1,SORBS1,TNIK,CTNNA2,ABLIM1,DTNA,NEBL,NHSL1 |
2.063e-06 | -13.09 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 19 | 18204 | 49 |
PTPRZ1,GPM6A,NEBL,PREX2,ABLIM1,NFIA,RORA,NRG3,TNIK,SLC1A3,CTNND2,CSGALNACT1,NTRK2,GLI3,SOX5,PRKCA,BMPR1B,CDH20,CTNNA2 |
2.650e-06 | -12.84 | plasma membrane | cellular component | GO:0005886 | 5538 | 30 | 19108 | 49 |
DTNA,BMPR1B,SLC4A4,SLC1A3,NRG3,FMN2,DST,RYR3,GPC5,ADCY2,PARD3B,PRKCA,CTNND2,MACF1,TNIK,PTPRZ1,ITPR2,PREX2,CTNNA2,LSAMP,SORBS1,NKAIN3,ATP1A2,CDH20,TRPM3,NTRK2,GPM6A,NTM,SLC1A2,DPP10 |
3.759e-06 | -12.49 | neuron differentiation | biological process | GO:0030182 | 1081 | 13 | 18204 | 49 |
PREX2,NFIA,PTPRZ1,GPM6A,NTRK2,NTM,GLI3,BMPR1B,CTNNA2,RORA,TNIK,SLC1A3,CTNND2 |
4.655e-06 | -12.28 | cell periphery | cellular component | GO:0071944 | 6020 | 31 | 19108 | 49 |
TRPM3,NTRK2,GPM6A,SLC1A2,NTM,DPP10,ITPR2,PREX2,CTNNA2,SPARCL1,LSAMP,SORBS1,ATP1A2,NKAIN3,CDH20,ADCY2,PRKCA,PARD3B,CTNND2,MACF1,TNIK,PTPRZ1,DTNA,BMPR1B,SLC4A4,SLC1A3,NRG3,FMN2,RYR3,GPC5,DST |
4.959e-06 | -12.21 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 37 | 16828 | 49 |
PREX2,GPM6A,MGAT4C,SLC1A2,FBXL7,NKAIN3,PAMR1,PTPRZ1,RYR3,LSAMP,GPC5,ADCY2,PARD3B,CDH20,NTRK2,SPARCL1,NHSL1,ABLIM1,SOX5,TNIK,SLC1A3,GLIS3,RFX4,NRG3,TPD52L1,NEBL,FMN2,CSGALNACT1,CTNND2,MACF1,DPP10,BMPR1B,MAML2,RORA,GLI3,PRKCA,ITPR2 |
6.186e-06 | -11.99 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 47 | 16828 | 49 |
ABLIM1,PARD3B,RYR3,PAMR1,GPC5,SORBS1,DTNA,RORA,GLI3,FMN2,CTNND2,DPP10,TPD52L1,NRG3,GLIS3,RFX4,ZBTB20,SLC4A4,DST,PITPNC1,NHSL1,SPARCL1,TNIK,SOX5,SLC1A3,ADCY2,CDH20,NTRK2,FBXL7,SLC1A2,PTPRZ1,LSAMP,PREX2,GPM6A,NTM,NPAS3,TRPM3,MGAT4C,ATP1A2,ITPR2,NFIA,MAML2,PRKCA,MACF1,CSGALNACT1,BMPR1B,NEBL |
6.238e-06 | -11.98 | Salivary secretion | KEGG pathways | ko04970 | 90 | 5 | 7161 | 22 |
RYR3,PRKCA,ADCY2,ATP1A2,ITPR2 |
6.238e-06 | -11.98 | Salivary secretion | KEGG pathways | hsa04970 | 90 | 5 | 7161 | 22 |
RYR3,PRKCA,ADCY2,ATP1A2,ITPR2 |
6.276e-06 | -11.98 | cervix | COSMIC cancer mutations | cervix | 11793 | 47 | 16828 | 49 |
PRKCA,MAML2,NFIA,ITPR2,ATP1A2,NEBL,BMPR1B,CSGALNACT1,MACF1,NTRK2,CDH20,ADCY2,SLC1A3,SOX5,TNIK,SPARCL1,NHSL1,PITPNC1,DST,MGAT4C,TRPM3,NPAS3,NTM,GPM6A,PREX2,LSAMP,PTPRZ1,SLC1A2,FBXL7,GLI3,RORA,SLC4A4,ZBTB20,GLIS3,RFX4,TPD52L1,NRG3,DPP10,CTNND2,FMN2,PARD3B,ABLIM1,DTNA,SORBS1,GPC5,PAMR1,RYR3 |
6.705e-06 | -11.91 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 38 | 16828 | 49 |
ATP1A2,ITPR2,RORA,MAML2,GLI3,PRKCA,FMN2,BMPR1B,DPP10,MACF1,CSGALNACT1,CTNND2,SLC4A4,NEBL,TPD52L1,NRG3,RFX4,GLIS3,NHSL1,DST,SLC1A3,TNIK,ABLIM1,SOX5,ADCY2,NTRK2,CDH20,NKAIN3,FBXL7,SLC1A2,GPC5,LSAMP,RYR3,PAMR1,PTPRZ1,GPM6A,PREX2,TRPM3 |
7.103e-06 | -11.85 | neurogenesis | biological process | GO:0022008 | 1334 | 14 | 18204 | 49 |
BMPR1B,CTNNA2,NTM,NTRK2,SOX5,GLI3,CTNND2,TNIK,RORA,SLC1A3,NFIA,PREX2,GPM6A,PTPRZ1 |
8.073e-06 | -11.73 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 9 | 16828 | 49 |
NRG3,GPM6A,MAML2,PRKCA,TRPM3,RYR3,CTNND2,GPC5,LSAMP |
8.142e-06 | -11.72 | Pancreatic secretion | KEGG pathways | hsa04972 | 95 | 5 | 7161 | 22 |
ITPR2,SLC4A4,ADCY2,ATP1A2,PRKCA |
8.142e-06 | -11.72 | Pancreatic secretion | KEGG pathways | ko04972 | 95 | 5 | 7161 | 22 |
ADCY2,ATP1A2,PRKCA,ITPR2,SLC4A4 |
8.577e-06 | -11.67 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 27 | 16828 | 49 |
PREX2,GPM6A,SORBS1,NTM,TRPM3,FBXL7,RYR3,PTPRZ1,ADCY2,PARD3B,CDH20,NTRK2,NHSL1,TNIK,SOX5,NRG3,ZBTB20,RFX4,SLC4A4,FMN2,MACF1,CTNND2,CSGALNACT1,DPP10,NFIA,GLI3,ITPR2 |
8.905e-06 | -11.63 | mouth | COSMIC cancer mutations | mouth | 9004 | 41 | 16828 | 49 |
FBXL7,SLC1A2,RYR3,PAMR1,PTPRZ1,GPC5,LSAMP,PREX2,GPM6A,SORBS1,NTM,NPAS3,TRPM3,DTNA,MGAT4C,DST,PITPNC1,NHSL1,TNIK,ABLIM1,SOX5,SLC1A3,ADCY2,CDH20,PARD3B,NTRK2,FMN2,MACF1,CSGALNACT1,CTNND2,NRG3,RFX4,ZBTB20,SLC4A4,NEBL,ATP1A2,ITPR2,RORA,MAML2,PRKCA,GLI3 |
9.207e-06 | -11.60 | beta-catenin binding | molecular function | GO:0008013 | 107 | 5 | 18094 | 48 |
RORA,CTNND2,CDH20,CTNNA2,GLI3 |
9.320e-06 | -11.58 | plasma_cell_myeloma | COSMIC cancer mutations | plasma_cell_myeloma | 1263 | 14 | 16828 | 49 |
NEBL,NTM,GPM6A,NRG3,CTNND2,PAMR1,RYR3,MACF1,FMN2,NTRK2,GLI3,ADCY2,ABLIM1,TNIK |
9.320e-06 | -11.58 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | 1263 | 14 | 16828 | 49 |
FMN2,PAMR1,CTNND2,RYR3,MACF1,NEBL,NTM,GPM6A,NRG3,ABLIM1,TNIK,ADCY2,NTRK2,GLI3 |
1.053e-05 | -11.46 | cell junction organization | biological process | GO:0034330 | 532 | 9 | 18204 | 49 |
DST,GPM6A,CTNND2,NRG3,NFIA,CDH20,SPARCL1,SORBS1,PRKCA |
1.167e-05 | -11.36 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 34 | 16828 | 49 |
FBXL7,RYR3,PTPRZ1,GPC5,GPM6A,PREX2,SORBS1,NPAS3,TRPM3,MGAT4C,DST,PITPNC1,SPARCL1,TNIK,SOX5,ABLIM1,ADCY2,PARD3B,FMN2,MACF1,CSGALNACT1,CTNND2,BMPR1B,DPP10,NRG3,GLIS3,ZBTB20,SLC4A4,NEBL,ATP1A2,ITPR2,MAML2,PRKCA,GLI3 |
1.167e-05 | -11.36 | system development | biological process | GO:0048731 | 3533 | 23 | 18204 | 49 |
CSGALNACT1,CTNND2,TNIK,RORA,NRG3,SLC1A3,BMPR1B,CTNNA2,ATP1A2,NTRK2,NTM,PRKCA,LSAMP,GLI3,SOX5,RFX4,NEBL,GPM6A,MSI2,PTPRZ1,NFIA,PREX2,SLC1A2 |
1.215e-05 | -11.32 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 24 | 16828 | 49 |
ADCY2,DST,NHSL1,SPARCL1,TNIK,ABLIM1,SOX5,GPM6A,PREX2,TRPM3,RYR3,PAMR1,PTPRZ1,GPC5,MAML2,ATP1A2,NRG3,ZBTB20,SLC4A4,NEBL,FMN2,MACF1,CTNND2,DPP10 |
1.227e-05 | -11.31 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 24 | 16828 | 49 |
FMN2,CTNND2,MACF1,DPP10,ZBTB20,NRG3,NEBL,SLC4A4,ATP1A2,MAML2,PAMR1,PTPRZ1,RYR3,GPC5,PREX2,GPM6A,TRPM3,DST,SPARCL1,NHSL1,ABLIM1,SOX5,TNIK,ADCY2 |
1.359e-05 | -11.21 | neuron development | biological process | GO:0048666 | 859 | 11 | 18204 | 49 |
GLI3,NTM,PREX2,NTRK2,CTNNA2,BMPR1B,SLC1A3,PTPRZ1,TNIK,GPM6A,CTNND2 |
1.906e-05 | -10.87 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 8 | 18094 | 48 |
SLC1A3,RYR3,SLC4A4,SLC1A2,GPM6A,ATP1A2,TRPM3,ITPR2 |
1.986e-05 | -10.83 | Glutamatergic synapse | KEGG pathways | ko04724 | 114 | 5 | 7161 | 22 |
SLC1A3,ITPR2,ADCY2,SLC1A2,PRKCA |
1.986e-05 | -10.83 | Glutamatergic synapse | KEGG pathways | hsa04724 | 114 | 5 | 7161 | 22 |
PRKCA,ADCY2,SLC1A2,ITPR2,SLC1A3 |
2.023e-05 | -10.81 | positive regulation of chondrocyte differentiation | biological process | GO:0032332 | 20 | 3 | 18204 | 49 |
SOX5,GLI3,BMPR1B |
2.057e-05 | -10.79 | cell junction | cellular component | GO:0030054 | 2224 | 17 | 19108 | 49 |
NTRK2,CTNND2,PARD3B,PTPRZ1,TNIK,SLC1A2,GPM6A,DTNA,CTNNA2,SPARCL1,NFIA,DST,CDH20,NRG3,ATP1A2,SLC1A3,SORBS1 |
2.224e-05 | -10.71 | SR_plectin_7 | pfam domains | PF21097 | 3 | 2 | 17795 | 49 |
MACF1,DST |
2.276e-05 | -10.69 | multicellular organism development | biological process | GO:0007275 | 3957 | 24 | 18204 | 49 |
RFX4,PREX2,SLC1A2,NFIA,RORA,NRG3,SLC1A3,CSGALNACT1,ATP1A2,NTM,LSAMP,GLI3,CDH20,MSI2,PTPRZ1,NEBL,GPM6A,TNIK,CTNND2,NTRK2,PRKCA,SOX5,BMPR1B,CTNNA2 |
2.353e-05 | -10.66 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 31 | 16828 | 49 |
SLC4A4,NEBL,NRG3,DPP10,MACF1,CTNND2,FMN2,GLI3,MAML2,ITPR2,ATP1A2,DTNA,MGAT4C,NPAS3,TRPM3,GPM6A,SORBS1,NTM,GPC5,LSAMP,RYR3,PTPRZ1,PAMR1,NKAIN3,FBXL7,NTRK2,CDH20,PARD3B,ADCY2,SLC1A3,SOX5 |
2.353e-05 | -10.66 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 31 | 16828 | 49 |
DPP10,MACF1,CTNND2,FMN2,SLC4A4,NEBL,NRG3,ITPR2,ATP1A2,GLI3,MAML2,GPC5,LSAMP,RYR3,PAMR1,PTPRZ1,NKAIN3,FBXL7,DTNA,MGAT4C,NPAS3,TRPM3,SORBS1,GPM6A,NTM,SLC1A3,SOX5,NTRK2,PARD3B,CDH20,ADCY2 |
2.407e-05 | -10.63 | humerus | COSMIC cancer mutations | humerus | 546 | 9 | 16828 | 49 |
GPC5,SOX5,NKAIN3,FMN2,PARD3B,NEBL,TPD52L1,ADCY2,GPM6A |
2.465e-05 | -10.61 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 7 | 16828 | 49 |
GPM6A,TPD52L1,ADCY2,GPC5,SOX5,NKAIN3,FMN2 |
3.254e-05 | -10.33 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 25 | 16828 | 49 |
NFIA,MAML2,GLI3,ATP1A2,RFX4,GLIS3,NEBL,SLC4A4,FMN2,CTNND2,MACF1,DPP10,ADCY2,PARD3B,NTRK2,PITPNC1,NHSL1,TNIK,GPM6A,PREX2,NPAS3,SLC1A2,FBXL7,PTPRZ1,RYR3 |
3.402e-05 | -10.29 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 17 | 16828 | 49 |
TRPM3,GPM6A,PREX2,NRG3,NEBL,MACF1,CSGALNACT1,PTPRZ1,GPC5,LSAMP,DPP10,FMN2,MSI2,RORA,ITPR2,ABLIM1,DST |
3.484e-05 | -10.26 | OCLN (occludin) | protein interactions | 100506658 | 495 | 8 | 19454 | 50 |
DST,ABLIM1,PRKCA,DTNA,FMN2,MACF1,NTRK2,TNIK |
3.641e-05 | -10.22 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 14 | 16828 | 49 |
NFIA,NTRK2,PRKCA,ATP1A2,NHSL1,PITPNC1,DST,SLC4A4,RFX4,PREX2,FMN2,SLC1A2,DPP10,CTNND2 |
3.641e-05 | -10.22 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 14 | 16828 | 49 |
NFIA,PRKCA,NTRK2,DST,PITPNC1,NHSL1,ATP1A2,PREX2,RFX4,SLC4A4,SLC1A2,FMN2,CTNND2,DPP10 |
4.197e-05 | -10.08 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 8 | 18204 | 49 |
CTNNA2,GPM6A,BMPR1B,CTNND2,PTPRZ1,GLI3,TNIK,PREX2 |
4.271e-05 | -10.06 | PCN-like_spectrin-like_rpt | interpro domains | IPR049538 | 4 | 2 | 18521 | 50 |
DST,MACF1 |
4.271e-05 | -10.06 | Desmoplakin_Spectrin-like | interpro domains | IPR041573 | 4 | 2 | 18521 | 50 |
MACF1,DST |
4.441e-05 | -10.02 | Spectrin_2 | pfam domains | PF18373 | 4 | 2 | 17795 | 49 |
MACF1,DST |
4.441e-05 | -10.02 | Spectrin_4 | pfam domains | PF21020 | 4 | 2 | 17795 | 49 |
MACF1,DST |
4.441e-05 | -10.02 | Spectrin_3 | pfam domains | PF21019 | 4 | 2 | 17795 | 49 |
MACF1,DST |
4.512e-05 | -10.01 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 8 | 18204 | 49 |
PREX2,TNIK,GLI3,PTPRZ1,CTNND2,BMPR1B,GPM6A,CTNNA2 |
4.590e-05 | -9.99 | Neurotransmitter uptake and Metabolism In Glial Cells | REACTOME pathways | R-HSA-112313 | 4 | 2 | 10285 | 29 |
SLC1A3,SLC1A2 |
4.590e-05 | -9.99 | Astrocytic Glutamate-Glutamine Uptake And Metabolism | REACTOME pathways | R-HSA-210455 | 4 | 2 | 10285 | 29 |
SLC1A3,SLC1A2 |
4.687e-05 | -9.97 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 42 | 16828 | 49 |
FBXL7,NKAIN3,PAMR1,PTPRZ1,RYR3,GPC5,NTM,SORBS1,GPM6A,PREX2,TRPM3,NPAS3,MGAT4C,DTNA,PITPNC1,DST,SPARCL1,SOX5,ABLIM1,TNIK,MSI2,CDH20,PARD3B,NTRK2,FMN2,CTNND2,CSGALNACT1,MACF1,BMPR1B,DPP10,RFX4,NRG3,TPD52L1,NEBL,SLC4A4,ATP1A2,ITPR2,NFIA,RORA,MAML2,GLI3,PRKCA |
4.765e-05 | -9.95 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 42 | 16828 | 49 |
PITPNC1,DST,SPARCL1,ABLIM1,SOX5,TNIK,MSI2,CDH20,PARD3B,NTRK2,FBXL7,NKAIN3,PAMR1,PTPRZ1,RYR3,GPC5,NTM,PREX2,SORBS1,GPM6A,TRPM3,NPAS3,MGAT4C,DTNA,ATP1A2,ITPR2,NFIA,RORA,MAML2,GLI3,PRKCA,FMN2,CSGALNACT1,CTNND2,MACF1,BMPR1B,DPP10,RFX4,TPD52L1,NRG3,NEBL,SLC4A4 |
4.847e-05 | -9.93 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 8 | 18204 | 49 |
PREX2,TNIK,GLI3,PTPRZ1,CTNND2,BMPR1B,GPM6A,CTNNA2 |
4.917e-05 | -9.92 | - | gene3d domains | 1.20.58.1060 | 4 | 2 | 14470 | 42 |
MACF1,DST |
5.135e-05 | -9.88 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 43 | 16828 | 49 |
NFIA,PRKCA,ATP1A2,ITPR2,NEBL,BMPR1B,MACF1,CSGALNACT1,ADCY2,NTRK2,CDH20,DST,PITPNC1,SLC1A3,TNIK,SOX5,GPM6A,PREX2,NTM,MGAT4C,NPAS3,TRPM3,NKAIN3,FBXL7,SLC1A2,LSAMP,PTPRZ1,RORA,GLI3,SLC4A4,NRG3,RFX4,ZBTB20,GLIS3,FMN2,CTNND2,PARD3B,ABLIM1,SORBS1,DTNA,GPC5,RYR3,PAMR1 |
5.135e-05 | -9.88 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 43 | 16828 | 49 |
NTRK2,CDH20,ADCY2,SLC1A3,SOX5,TNIK,PITPNC1,DST,MGAT4C,TRPM3,NPAS3,NTM,GPM6A,PREX2,LSAMP,PTPRZ1,NKAIN3,SLC1A2,FBXL7,PRKCA,NFIA,ITPR2,ATP1A2,NEBL,BMPR1B,CSGALNACT1,MACF1,PARD3B,ABLIM1,DTNA,SORBS1,GPC5,PAMR1,RYR3,GLI3,RORA,SLC4A4,RFX4,GLIS3,ZBTB20,NRG3,CTNND2,FMN2 |
5.275e-05 | -9.85 | central nervous system development | biological process | GO:0007417 | 995 | 11 | 18204 | 49 |
RFX4,PTPRZ1,MSI2,SLC1A2,NRG3,RORA,CTNNA2,BMPR1B,GLI3,NTRK2,ATP1A2 |
5.352e-05 | -9.84 | EZR (ezrin) | protein interactions | 7430 | 526 | 8 | 19454 | 50 |
TNIK,SORBS1,MACF1,NEBL,DTNA,ABLIM1,PRKCA,DST |
6.426e-05 | -9.65 | face | COSMIC cancer mutations | face | 2139 | 17 | 16828 | 49 |
TRPM3,NEBL,NRG3,GPM6A,PREX2,DPP10,LSAMP,GPC5,CSGALNACT1,PTPRZ1,MACF1,FMN2,RORA,MSI2,ABLIM1,ITPR2,DST |
6.676e-05 | -9.61 | Thyroid hormone synthesis | KEGG pathways | hsa04918 | 74 | 4 | 7161 | 22 |
PRKCA,ATP1A2,ADCY2,ITPR2 |
6.676e-05 | -9.61 | Thyroid hormone synthesis | KEGG pathways | ko04918 | 74 | 4 | 7161 | 22 |
ATP1A2,ADCY2,PRKCA,ITPR2 |
6.856e-05 | -9.59 | high-affinity L-glutamate transmembrane transporter activity | molecular function | GO:0005314 | 5 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
6.856e-05 | -9.59 | glutamate:sodium symporter activity | molecular function | GO:0015501 | 5 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
6.943e-05 | -9.58 | stress fiber | cellular component | GO:0001725 | 86 | 4 | 19108 | 49 |
ABLIM1,NEBL,DST,SORBS1 |
6.943e-05 | -9.58 | contractile actin filament bundle | cellular component | GO:0097517 | 86 | 4 | 19108 | 49 |
SORBS1,ABLIM1,DST,NEBL |
7.038e-05 | -9.56 | Gastric acid secretion | KEGG pathways | ko04971 | 75 | 4 | 7161 | 22 |
ITPR2,PRKCA,ADCY2,ATP1A2 |
7.038e-05 | -9.56 | Gastric acid secretion | KEGG pathways | hsa04971 | 75 | 4 | 7161 | 22 |
ITPR2,ADCY2,ATP1A2,PRKCA |
7.061e-05 | -9.56 | D-aspartate transmembrane transport | biological process | GO:0070777 | 5 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
7.061e-05 | -9.56 | D-aspartate import across plasma membrane | biological process | GO:0070779 | 5 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
7.070e-05 | -9.56 | neurotransmitter uptake | biological process | GO:0001504 | 30 | 3 | 18204 | 49 |
SLC1A3,SLC1A2,ATP1A2 |
7.145e-05 | -9.55 | nodular | COSMIC cancer mutations | nodular | 1515 | 14 | 16828 | 49 |
CDH20,NTRK2,ABLIM1,ATP1A2,SPARCL1,NPAS3,PREX2,GLIS3,SLC4A4,NEBL,MACF1,PTPRZ1,CTNND2,FMN2 |
7.937e-05 | -9.44 | prostate | COSMIC cancer mutations | prostate | 13883 | 49 | 16828 | 49 |
PARD3B,MSI2,ABLIM1,DTNA,SORBS1,GPC5,PAMR1,RYR3,GLI3,RORA,SLC4A4,ZBTB20,GLIS3,RFX4,NRG3,TPD52L1,DPP10,CTNND2,FMN2,NTRK2,CDH20,ADCY2,SLC1A3,SOX5,TNIK,SPARCL1,NHSL1,PITPNC1,DST,MGAT4C,TRPM3,NPAS3,NTM,PREX2,GPM6A,LSAMP,PTPRZ1,NKAIN3,SLC1A2,FBXL7,PRKCA,MAML2,NFIA,ITPR2,ATP1A2,NEBL,BMPR1B,CSGALNACT1,MACF1 |
8.255e-05 | -9.40 | NTM (neurotrimin) | protein interactions | 50863 | 33 | 3 | 19454 | 50 |
LSAMP,NTM,GPM6A |
8.364e-05 | -9.39 | transport across blood-brain barrier | biological process | GO:0150104 | 86 | 4 | 18204 | 49 |
ATP1A2,SLC1A2,SLC1A3,SLC4A4 |
8.364e-05 | -9.39 | vascular transport | biological process | GO:0010232 | 86 | 4 | 18204 | 49 |
SLC4A4,SLC1A3,SLC1A2,ATP1A2 |
8.604e-05 | -9.36 | positive regulation of cartilage development | biological process | GO:0061036 | 32 | 3 | 18204 | 49 |
BMPR1B,GLI3,SOX5 |
8.887e-05 | -9.33 | anatomical structure development | biological process | GO:0048856 | 5207 | 27 | 18204 | 49 |
CTNND2,TNIK,CTNNA2,BMPR1B,SOX5,PRKCA,FMN2,NTRK2,GPM6A,NEBL,PTPRZ1,MSI2,ABLIM1,CSGALNACT1,SLC1A3,NRG3,RORA,CDH20,LSAMP,GLI3,NTM,ATP1A2,RFX4,NFIA,SPARCL1,SLC1A2,PREX2 |
9.033e-05 | -9.31 | actomyosin | cellular component | GO:0042641 | 92 | 4 | 19108 | 49 |
NEBL,DST,ABLIM1,SORBS1 |
9.307e-05 | -9.28 | telencephalon development | biological process | GO:0021537 | 276 | 6 | 18204 | 49 |
RFX4,NRG3,SLC1A2,NTRK2,ATP1A2,GLI3 |
9.314e-05 | -9.28 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 24 | 16828 | 49 |
ATP1A2,GLI3,NFIA,MAML2,CTNND2,MACF1,DPP10,FMN2,RFX4,GLIS3,NEBL,SLC4A4,TNIK,PITPNC1,PARD3B,NTRK2,ADCY2,PTPRZ1,RYR3,SLC1A2,FBXL7,NPAS3,GPM6A,PREX2 |
9.354e-05 | -9.28 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 24 | 16828 | 49 |
RFX4,GLIS3,SLC4A4,NEBL,MACF1,CTNND2,DPP10,FMN2,GLI3,NFIA,MAML2,ATP1A2,NPAS3,GPM6A,PREX2,RYR3,PTPRZ1,FBXL7,SLC1A2,PARD3B,NTRK2,ADCY2,TNIK,PITPNC1 |
9.946e-05 | -9.22 | cartilage development | biological process | GO:0051216 | 173 | 5 | 18204 | 49 |
SOX5,GLI3,BMPR1B,CSGALNACT1,NFIA |
1.057e-04 | -9.15 | mammary gland formation | biological process | GO:0060592 | 6 | 2 | 18204 | 49 |
NRG3,GLI3 |
1.057e-04 | -9.15 | L-aspartate import across plasma membrane | biological process | GO:0140009 | 6 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
1.057e-04 | -9.15 | D-amino acid transport | biological process | GO:0042940 | 6 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
1.064e-04 | -9.15 | Ins145_P3_rcpt | interpro domains | IPR014821 | 6 | 2 | 18521 | 50 |
ITPR2,RYR3 |
1.064e-04 | -9.15 | Desmoplakin_SH3 | interpro domains | IPR041615 | 6 | 2 | 18521 | 50 |
MACF1,DST |
1.064e-04 | -9.15 | RIH_dom | interpro domains | IPR000699 | 6 | 2 | 18521 | 50 |
RYR3,ITPR2 |
1.064e-04 | -9.15 | GAR_dom | interpro domains | IPR003108 | 6 | 2 | 18521 | 50 |
DST,MACF1 |
1.064e-04 | -9.15 | RyR/IP3R_RIH_dom_sf | interpro domains | IPR035910 | 6 | 2 | 18521 | 50 |
ITPR2,RYR3 |
1.064e-04 | -9.15 | GAR_dom_sf | interpro domains | IPR036534 | 6 | 2 | 18521 | 50 |
MACF1,DST |
1.064e-04 | -9.15 | Ryanodine_IP3_receptor | interpro domains | IPR015925 | 6 | 2 | 18521 | 50 |
ITPR2,RYR3 |
1.064e-04 | -9.15 | RIH_assoc-dom | interpro domains | IPR013662 | 6 | 2 | 18521 | 50 |
RYR3,ITPR2 |
1.064e-04 | -9.15 | GLI-like | interpro domains | IPR043359 | 6 | 2 | 18521 | 50 |
GLIS3,GLI3 |
1.066e-04 | -9.15 | actin filament bundle | cellular component | GO:0032432 | 96 | 4 | 19108 | 49 |
SORBS1,DST,NEBL,ABLIM1 |
1.106e-04 | -9.11 | RIH_assoc | pfam domains | PF08454 | 6 | 2 | 17795 | 49 |
RYR3,ITPR2 |
1.106e-04 | -9.11 | SH3_10 | pfam domains | PF17902 | 6 | 2 | 17795 | 49 |
DST,MACF1 |
1.106e-04 | -9.11 | Plectin | pfam domains | PF00681 | 6 | 2 | 17795 | 49 |
MACF1,DST |
1.106e-04 | -9.11 | GAS2 | pfam domains | PF02187 | 6 | 2 | 17795 | 49 |
DST,MACF1 |
1.106e-04 | -9.11 | Ins145_P3_rec | pfam domains | PF08709 | 6 | 2 | 17795 | 49 |
ITPR2,RYR3 |
1.106e-04 | -9.11 | RYDR_ITPR | pfam domains | PF01365 | 6 | 2 | 17795 | 49 |
ITPR2,RYR3 |
1.110e-04 | -9.11 | cell junction assembly | biological process | GO:0034329 | 285 | 6 | 18204 | 49 |
NRG3,PRKCA,CDH20,SORBS1,DST,GPM6A |
1.137e-04 | -9.08 | DAG and IP3 signaling | REACTOME pathways | R-HSA-1489509 | 34 | 3 | 10285 | 29 |
ADCY2,PRKCA,ITPR2 |
1.149e-04 | -9.07 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 16 | 19108 | 49 |
ADCY2,PRKCA,CTNND2,NTRK2,MACF1,GPM6A,SLC1A2,GLI3,CTNNA2,DTNA,BMPR1B,SLC1A3,ATP1A2,ABLIM1,FMN2,DST |
1.173e-04 | -9.05 | adherens junction | cellular component | GO:0005912 | 188 | 5 | 19108 | 49 |
SORBS1,PARD3B,CTNND2,CTNNA2,CDH20 |
1.219e-04 | -9.01 | tibia | COSMIC cancer mutations | tibia | 836 | 10 | 16828 | 49 |
TRPM3,PREX2,GPM6A,LSAMP,MACF1,TNIK,CTNND2,ABLIM1,NKAIN3,DST |
1.225e-04 | -9.01 | IP3 receptor type 1 binding core, RIH domain | gene3d domains | 1.25.10.30 | 6 | 2 | 14470 | 42 |
ITPR2,RYR3 |
1.225e-04 | -9.01 | Plakin repeat | gene3d domains | 3.90.1290.10 | 6 | 2 | 14470 | 42 |
MACF1,DST |
1.225e-04 | -9.01 | Gas2-like domain | gene3d domains | 3.30.920.20 | 6 | 2 | 14470 | 42 |
MACF1,DST |
1.352e-04 | -8.91 | PLC-gamma1 signalling | REACTOME pathways | R-HSA-167021 | 36 | 3 | 10285 | 29 |
ITPR2,PRKCA,ADCY2 |
1.352e-04 | -8.91 | EGFR interacts with phospholipase C-gamma | REACTOME pathways | R-HSA-212718 | 36 | 3 | 10285 | 29 |
ITPR2,PRKCA,ADCY2 |
1.367e-04 | -8.90 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 12 | 16828 | 49 |
TNIK,ITPR2,SOX5,RORA,ADCY2,PRKCA,NKAIN3,GPC5,DPP10,LSAMP,CTNND2,NRG3 |
1.370e-04 | -8.90 | actin binding | molecular function | GO:0003779 | 434 | 7 | 18094 | 48 |
ABLIM1,NEBL,SORBS1,FMN2,DST,MACF1,CTNNA2 |
1.374e-04 | -8.89 | C11orf52 (chromosome 11 open reading frame 52) | protein interactions | 91894 | 310 | 6 | 19454 | 50 |
FMN2,TNIK,DTNA,ABLIM1,MACF1,DST |
1.437e-04 | -8.85 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 8 | 18094 | 48 |
ITPR2,TRPM3,RYR3,SLC1A3,ATP1A2,GPM6A,SLC1A2,SLC4A4 |
1.469e-04 | -8.83 | HUNK (hormonally up-regulated Neu-associated kinase) | protein interactions | 30811 | 104 | 4 | 19454 | 50 |
DST,ABLIM1,SORBS1,SPARCL1 |
1.487e-04 | -8.81 | Plakin_repeat_sf | interpro domains | IPR035915 | 7 | 2 | 18521 | 50 |
DST,MACF1 |
1.487e-04 | -8.81 | Na-dicarboxylate_symporter_CS | interpro domains | IPR018107 | 7 | 2 | 18521 | 50 |
SLC1A2,SLC1A3 |
1.487e-04 | -8.81 | Na:dicarbo_symporter_sf | interpro domains | IPR036458 | 7 | 2 | 18521 | 50 |
SLC1A2,SLC1A3 |
1.487e-04 | -8.81 | Plectin_repeat | interpro domains | IPR001101 | 7 | 2 | 18521 | 50 |
MACF1,DST |
1.487e-04 | -8.81 | Na-dicarboxylate_symporter | interpro domains | IPR001991 | 7 | 2 | 18521 | 50 |
SLC1A2,SLC1A3 |
1.490e-04 | -8.81 | FLOT1 (flotillin 1) | protein interactions | 10211 | 453 | 7 | 19454 | 50 |
SOX5,SORBS1,MACF1,FMN2,DTNA,ABLIM1,DST |
1.546e-04 | -8.77 | SDF | pfam domains | PF00375 | 7 | 2 | 17795 | 49 |
SLC1A2,SLC1A3 |
1.563e-04 | -8.76 | GAR | prosite domains | PS51460 | 6 | 2 | 12186 | 40 |
MACF1,DST |
1.565e-04 | -8.76 | cellular response to alkaloid | biological process | GO:0071312 | 39 | 3 | 18204 | 49 |
SLC1A3,SLC1A2,RYR3 |
1.625e-04 | -8.72 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 34 | 16828 | 49 |
SLC1A2,FBXL7,PTPRZ1,RYR3,LSAMP,NTM,PREX2,TRPM3,NPAS3,PITPNC1,DST,NHSL1,SOX5,ADCY2,CDH20,PARD3B,NTRK2,FMN2,CTNND2,CSGALNACT1,MACF1,DPP10,ZBTB20,RFX4,NRG3,NEBL,SLC4A4,ATP1A2,ITPR2,NFIA,RORA,MAML2,PRKCA,GLI3 |
1.625e-04 | -8.72 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 34 | 16828 | 49 |
GLI3,PRKCA,RORA,MAML2,NFIA,ITPR2,ATP1A2,SLC4A4,NEBL,NRG3,RFX4,ZBTB20,DPP10,MACF1,CTNND2,CSGALNACT1,FMN2,NTRK2,CDH20,PARD3B,ADCY2,SOX5,NHSL1,DST,PITPNC1,NPAS3,TRPM3,PREX2,NTM,LSAMP,RYR3,PTPRZ1,FBXL7,SLC1A2 |
1.687e-04 | -8.69 | developmental process | biological process | GO:0032502 | 5716 | 28 | 18204 | 49 |
RFX4,PREX2,SLC1A2,SPARCL1,NFIA,RORA,NRG3,SLC1A3,CSGALNACT1,ATP1A2,NTM,GLI3,LSAMP,CDH20,MSI2,PTPRZ1,NEBL,GPM6A,ABLIM1,NHSL1,TNIK,CTNND2,NTRK2,FMN2,PRKCA,SOX5,BMPR1B,CTNNA2 |
1.707e-04 | -8.68 | cell adhesion | biological process | GO:0007155 | 942 | 10 | 18204 | 49 |
CTNND2,DST,SPARCL1,SORBS1,PARD3B,CDH20,CTNNA2,NTM,LSAMP,PRKCA |
1.711e-04 | -8.67 | Sodium:dicarboxylate symporter | gene3d domains | 1.10.3860.10 | 7 | 2 | 14470 | 42 |
SLC1A2,SLC1A3 |
1.712e-04 | -8.67 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 7 | 18204 | 49 |
CTNNA2,BMPR1B,GLI3,PREX2,CTNND2,SLC1A3,PTPRZ1 |
1.762e-04 | -8.64 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 34 | 16828 | 49 |
SLC1A2,FBXL7,NKAIN3,PAMR1,RYR3,LSAMP,GPC5,GPM6A,PREX2,NHSL1,SOX5,ABLIM1,SLC1A3,ADCY2,CDH20,NTRK2,FMN2,CSGALNACT1,CTNND2,MACF1,DPP10,BMPR1B,GLIS3,RFX4,TPD52L1,NRG3,NEBL,SLC4A4,ATP1A2,ITPR2,MAML2,RORA,GLI3,PRKCA |
1.814e-04 | -8.62 | neural precursor cell proliferation | biological process | GO:0061351 | 105 | 4 | 18204 | 49 |
SOX5,GLI3,RORA,NFIA |
1.874e-04 | -8.58 | GAS2 | smart domains | SM00243 | 6 | 2 | 9717 | 35 |
DST,MACF1 |
1.874e-04 | -8.58 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 4 | 16828 | 49 |
CTNND2,LSAMP,GPM6A,NKAIN3 |
1.979e-04 | -8.53 | Plakin | interpro domains | IPR043197 | 8 | 2 | 18521 | 50 |
MACF1,DST |
2.035e-04 | -8.50 | cell projection | cellular component | GO:0042995 | 2398 | 16 | 19108 | 49 |
GPM6A,SLC1A2,ADCY2,PRKCA,CTNND2,MACF1,NTRK2,SLC1A3,ATP1A2,ABLIM1,FMN2,DST,CTNNA2,GLI3,DTNA,BMPR1B |
2.183e-04 | -8.43 | NA_DICARBOXYL_SYMP_2 | prosite domains | PS00714 | 7 | 2 | 12186 | 40 |
SLC1A3,SLC1A2 |
2.183e-04 | -8.43 | NA_DICARBOXYL_SYMP_1 | prosite domains | PS00713 | 7 | 2 | 12186 | 40 |
SLC1A3,SLC1A2 |
2.273e-04 | -8.39 | cellular response to organic cyclic compound | biological process | GO:0071407 | 464 | 7 | 18204 | 49 |
RYR3,ADCY2,SLC1A3,ITPR2,ATP1A2,RORA,SLC1A2 |
2.276e-04 | -8.39 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 8 | 18094 | 48 |
SLC4A4,SLC1A2,GPM6A,ATP1A2,SLC1A3,RYR3,TRPM3,ITPR2 |
2.304e-04 | -8.38 | NEGR1 (neuronal growth regulator 1) | protein interactions | 257194 | 9 | 2 | 19454 | 50 |
LSAMP,NTM |
2.304e-04 | -8.38 | LSAMP (limbic system associated membrane protein) | protein interactions | 4045 | 9 | 2 | 19454 | 50 |
NTM,LSAMP |
2.402e-04 | -8.33 | acidic amino acid transport | biological process | GO:0015800 | 45 | 3 | 18204 | 49 |
NTRK2,SLC1A2,SLC1A3 |
2.531e-04 | -8.28 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 12 | 16828 | 49 |
GLIS3,PREX2,NEBL,NPAS3,PTPRZ1,CTNND2,MACF1,CDH20,NTRK2,SPARCL1,ATP1A2,ABLIM1 |
2.594e-04 | -8.26 | calcium channel activity | molecular function | GO:0005262 | 117 | 4 | 18094 | 48 |
ITPR2,RYR3,TRPM3,GPM6A |
2.601e-04 | -8.25 | EDTRNSPORT | prints domains | PR00173 | 7 | 2 | 5227 | 19 |
SLC1A2,SLC1A3 |
2.617e-04 | -8.25 | PLEC | smart domains | SM00250 | 7 | 2 | 9717 | 35 |
MACF1,DST |
2.864e-04 | -8.16 | SFN (stratifin) | protein interactions | 2810 | 671 | 8 | 19454 | 50 |
DST,ABLIM1,NFIA,FMN2,MACF1,SORBS1,TNIK,PARD3B |
2.955e-04 | -8.13 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 46 | 16828 | 49 |
RORA,GLI3,TPD52L1,NRG3,GLIS3,RFX4,ZBTB20,FMN2,CTNND2,DPP10,PARD3B,ABLIM1,SORBS1,RYR3,PAMR1,GPC5,NFIA,MAML2,PRKCA,ATP1A2,ITPR2,NEBL,MACF1,CSGALNACT1,BMPR1B,ADCY2,CDH20,NTRK2,DST,PITPNC1,NHSL1,SPARCL1,TNIK,SOX5,SLC1A3,GPM6A,PREX2,NTM,NPAS3,TRPM3,MGAT4C,FBXL7,SLC1A2,NKAIN3,PTPRZ1,LSAMP |
3.007e-04 | -8.11 | PLC beta mediated events | REACTOME pathways | R-HSA-112043 | 47 | 3 | 10285 | 29 |
PRKCA,ADCY2,ITPR2 |
3.150e-04 | -8.06 | neuronal action potential propagation | biological process | GO:0019227 | 10 | 2 | 18204 | 49 |
NTRK2,ATP1A2 |
3.150e-04 | -8.06 | action potential propagation | biological process | GO:0098870 | 10 | 2 | 18204 | 49 |
ATP1A2,NTRK2 |
3.150e-04 | -8.06 | cellular response to cocaine | biological process | GO:0071314 | 10 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
3.162e-04 | -8.06 | EPB41L4A (erythrocyte membrane protein band 4.1 like 4A) | protein interactions | 64097 | 127 | 4 | 19454 | 50 |
ABLIM1,MACF1,DST,DTNA |
3.170e-04 | -8.06 | MIR_dom_sf | interpro domains | IPR036300 | 10 | 2 | 18521 | 50 |
ITPR2,RYR3 |
3.170e-04 | -8.06 | MIR_motif | interpro domains | IPR016093 | 10 | 2 | 18521 | 50 |
RYR3,ITPR2 |
3.201e-04 | -8.05 | G-protein mediated events | REACTOME pathways | R-HSA-112040 | 48 | 3 | 10285 | 29 |
ADCY2,PRKCA,ITPR2 |
3.234e-04 | -8.04 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 31 | 16828 | 49 |
GPC5,RYR3,PAMR1,FBXL7,SLC1A2,MGAT4C,NPAS3,TRPM3,PREX2,SORBS1,GPM6A,NTM,SLC1A3,SOX5,ABLIM1,NHSL1,DST,PITPNC1,PARD3B,CDH20,ADCY2,MACF1,CTNND2,FMN2,SLC4A4,NRG3,RFX4,ZBTB20,GLI3,RORA,MAML2 |
3.244e-04 | -8.03 | bone | COSMIC cancer mutations | bone | 8157 | 36 | 16828 | 49 |
PARD3B,NTRK2,ADCY2,ABLIM1,SOX5,TNIK,SLC1A3,DST,SPARCL1,TRPM3,NPAS3,DTNA,GPM6A,SORBS1,PREX2,PTPRZ1,PAMR1,RYR3,LSAMP,GPC5,NKAIN3,GLI3,RORA,MAML2,ITPR2,ATP1A2,ZBTB20,GLIS3,NRG3,TPD52L1,NEBL,SLC4A4,CSGALNACT1,CTNND2,MACF1,FMN2 |
3.296e-04 | -8.02 | MIR | pfam domains | PF02815 | 10 | 2 | 17795 | 49 |
ITPR2,RYR3 |
3.346e-04 | -8.00 | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | 114 | 4 | 16828 | 49 |
RYR3,SOX5,PREX2,SLC1A2 |
3.387e-04 | -7.99 | actin cytoskeleton | cellular component | GO:0015629 | 520 | 7 | 19108 | 49 |
ABLIM1,FMN2,MACF1,NEBL,DST,SORBS1,CTNNA2 |
3.508e-04 | -7.96 | ADCY5 (adenylate cyclase 5) | protein interactions | 111 | 11 | 2 | 19454 | 50 |
PRKCA,ADCY2 |
3.844e-04 | -7.86 | L-glutamate import across plasma membrane | biological process | GO:0098712 | 11 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
3.844e-04 | -7.86 | L-aspartate transmembrane transport | biological process | GO:0070778 | 11 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
3.889e-04 | -7.85 | connective tissue development | biological process | GO:0061448 | 232 | 5 | 18204 | 49 |
GLI3,SOX5,NFIA,BMPR1B,CSGALNACT1 |
3.906e-04 | -7.85 | regulation of chondrocyte differentiation | biological process | GO:0032330 | 53 | 3 | 18204 | 49 |
SOX5,GLI3,BMPR1B |
3.988e-04 | -7.83 | NTRK2 (neurotrophic receptor tyrosine kinase 2) | protein interactions | 4915 | 135 | 4 | 19454 | 50 |
DTNA,DST,NTRK2,ABLIM1 |
4.043e-04 | -7.81 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 19 | 16828 | 49 |
NTRK2,GLI3,PRKCA,MAML2,ADCY2,MSI2,SPARCL1,ATP1A2,DST,TRPM3,NPAS3,NEBL,SLC4A4,NTM,NRG3,DPP10,BMPR1B,MACF1,FMN2 |
4.043e-04 | -7.81 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 19 | 16828 | 49 |
MAML2,MSI2,ADCY2,NTRK2,GLI3,PRKCA,SPARCL1,ATP1A2,DST,NEBL,SLC4A4,NTM,NRG3,TRPM3,NPAS3,FMN2,DPP10,BMPR1B,MACF1 |
4.282e-04 | -7.76 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 49 | 16828 | 49 |
FBXL7,SLC1A2,NKAIN3,PTPRZ1,LSAMP,GPM6A,PREX2,NTM,NPAS3,TRPM3,MGAT4C,DST,PITPNC1,NHSL1,SPARCL1,TNIK,SOX5,SLC1A3,ADCY2,CDH20,NTRK2,MACF1,CSGALNACT1,BMPR1B,NEBL,ATP1A2,ITPR2,NFIA,MAML2,PRKCA,RYR3,PAMR1,GPC5,SORBS1,DTNA,ABLIM1,MSI2,PARD3B,FMN2,CTNND2,DPP10,NRG3,TPD52L1,GLIS3,RFX4,ZBTB20,SLC4A4,RORA,GLI3 |
4.301e-04 | -7.75 | LYN (LYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 4067 | 713 | 8 | 19454 | 50 |
TNIK,SLC1A3,MACF1,MSI2,FMN2,DTNA,ABLIM1,DST |
4.439e-04 | -7.72 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 10 | 16828 | 49 |
PRKCA,NRG3,ADCY2,RORA,ITPR2,CTNND2,SOX5,GPC5,LSAMP,NKAIN3 |
4.466e-04 | -7.71 | neuron projection | cellular component | GO:0043005 | 1331 | 11 | 19108 | 49 |
CTNND2,ADCY2,NTRK2,GPM6A,SLC1A2,CTNNA2,DTNA,BMPR1B,ATP1A2,SLC1A3,DST |
4.593e-04 | -7.69 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 43 | 16828 | 49 |
NEBL,SLC4A4,RFX4,GLIS3,NRG3,FMN2,BMPR1B,DPP10,CSGALNACT1,CTNND2,MACF1,MAML2,RORA,NFIA,PRKCA,GLI3,ATP1A2,ITPR2,NTM,PREX2,DTNA,TRPM3,NPAS3,NKAIN3,SLC1A2,FBXL7,LSAMP,GPC5,PAMR1,PTPRZ1,RYR3,MSI2,ADCY2,NTRK2,CDH20,PARD3B,SPARCL1,NHSL1,DST,SLC1A3,SOX5,ABLIM1,TNIK |
4.598e-04 | -7.68 | calcium ion transmembrane transporter activity | molecular function | GO:0015085 | 136 | 4 | 18094 | 48 |
ITPR2,RYR3,TRPM3,GPM6A |
4.650e-04 | -7.67 | MIR | prosite domains | PS50919 | 10 | 2 | 12186 | 40 |
RYR3,ITPR2 |
4.796e-04 | -7.64 | neuron projection development | biological process | GO:0031175 | 693 | 8 | 18204 | 49 |
GPM6A,CTNNA2,CTNND2,BMPR1B,GLI3,PTPRZ1,PREX2,TNIK |
4.895e-04 | -7.62 | trunk | COSMIC cancer mutations | trunk | 3554 | 21 | 16828 | 49 |
MGAT4C,NPAS3,NEBL,PREX2,NRG3,GLIS3,DPP10,LSAMP,MACF1,RYR3,PTPRZ1,CTNND2,NTRK2,CDH20,MAML2,SLC1A3,SOX5,ABLIM1,ATP1A2,SPARCL1,DST |
5.053e-04 | -7.59 | Ion homeostasis | REACTOME pathways | R-HSA-5578775 | 56 | 3 | 10285 | 29 |
RYR3,ITPR2,ATP1A2 |
5.090e-04 | -7.58 | Calml3 (calmodulin-like 3) | protein interactions | 70405 | 144 | 4 | 19454 | 50 |
DST,MACF1,ABLIM1,ZBTB20 |
5.199e-04 | -7.56 | CTNNB1 (catenin beta 1) | protein interactions | 1499 | 926 | 9 | 19454 | 50 |
PARD3B,SORBS1,PTPRZ1,DTNA,NHSL1,DST,CTNNA2,CTNND2,PRKCA |
5.266e-04 | -7.55 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 8 | 18094 | 48 |
RYR3,SLC1A3,GPM6A,ATP1A2,SLC4A4,SLC1A2,TRPM3,ITPR2 |
5.507e-04 | -7.50 | cell development | biological process | GO:0048468 | 2236 | 15 | 18204 | 49 |
PTPRZ1,MSI2,NEBL,GPM6A,PREX2,SLC1A3,TNIK,RORA,CTNND2,GLI3,NTRK2,NTM,FMN2,CTNNA2,BMPR1B |
5.545e-04 | -7.50 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 13 | 16828 | 49 |
PTPRZ1,CTNND2,MACF1,DPP10,FMN2,DTNA,PREX2,SORBS1,ABLIM1,PARD3B,CDH20,GLI3,RORA |
5.545e-04 | -7.50 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 13 | 16828 | 49 |
DTNA,SORBS1,PREX2,DPP10,MACF1,CTNND2,PTPRZ1,FMN2,CDH20,PARD3B,GLI3,RORA,ABLIM1 |
5.570e-04 | -7.49 | MIR | smart domains | SM00472 | 10 | 2 | 9717 | 35 |
ITPR2,RYR3 |
6.104e-04 | -7.40 | VCL (vinculin) | protein interactions | 7414 | 268 | 5 | 19454 | 50 |
NEBL,DST,MACF1,PRKCA,SORBS1 |
6.145e-04 | -7.39 | L-glutamate transmembrane transporter activity | molecular function | GO:0005313 | 14 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
6.327e-04 | -7.37 | sodium ion export across plasma membrane | biological process | GO:0036376 | 14 | 2 | 18204 | 49 |
SLC4A4,ATP1A2 |
6.388e-04 | -7.36 | CDH1 (cadherin 1) | protein interactions | 999 | 757 | 8 | 19454 | 50 |
CTNNA2,DST,ABLIM1,CTNND2,NHSL1,NEBL,MACF1,SORBS1 |
6.401e-04 | -7.35 | brain development | biological process | GO:0007420 | 724 | 8 | 18204 | 49 |
ATP1A2,NTRK2,SLC1A2,GLI3,CTNNA2,RORA,NRG3,RFX4 |
6.409e-04 | -7.35 | EF-hand-dom_pair | interpro domains | IPR011992 | 258 | 5 | 18521 | 50 |
SPARCL1,DST,MACF1,DTNA,RYR3 |
6.412e-04 | -7.35 | cell adhesion molecule binding | molecular function | GO:0050839 | 560 | 7 | 18094 | 48 |
CDH20,PRKCA,PTPRZ1,DST,CTNNA2,MACF1,CTNND2 |
6.542e-04 | -7.33 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 47 | 16828 | 49 |
NRG3,ZBTB20,GLIS3,RFX4,SLC4A4,FMN2,CTNND2,DPP10,RORA,GLI3,SORBS1,DTNA,RYR3,PAMR1,GPC5,MSI2,PARD3B,ABLIM1,NEBL,MACF1,CSGALNACT1,BMPR1B,NFIA,MAML2,PRKCA,ATP1A2,ITPR2,PREX2,GPM6A,NTM,NPAS3,TRPM3,MGAT4C,FBXL7,SLC1A2,NKAIN3,PTPRZ1,LSAMP,ADCY2,CDH20,NTRK2,DST,PITPNC1,NHSL1,TNIK,SOX5,SLC1A3 |
6.642e-04 | -7.32 | ACTB (actin beta) | protein interactions | 60 | 958 | 9 | 19454 | 50 |
DST,PRKCA,ABLIM1,DTNA,FMN2,NHSL1,NEBL,MACF1,SORBS1 |
6.803e-04 | -7.29 | dendrite morphogenesis | biological process | GO:0048813 | 64 | 3 | 18204 | 49 |
CTNND2,CTNNA2,PREX2 |
6.850e-04 | -7.29 | scalp | COSMIC cancer mutations | scalp | 2110 | 15 | 16828 | 49 |
NFIA,RORA,DST,ATP1A2,SOX5,SORBS1,PREX2,NTM,SLC4A4,NEBL,FMN2,MACF1,PTPRZ1,GPC5,LSAMP |
7.031e-04 | -7.26 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 29 | 16828 | 49 |
PREX2,TRPM3,NPAS3,DTNA,NKAIN3,PTPRZ1,PAMR1,RYR3,ADCY2,NTRK2,DST,SPARCL1,ABLIM1,SOX5,SLC1A3,GLIS3,ZBTB20,TPD52L1,NRG3,NEBL,SLC4A4,CSGALNACT1,CTNND2,MACF1,MAML2,RORA,GLI3,ATP1A2,ITPR2 |
7.136e-04 | -7.25 | multicellular organismal process | biological process | GO:0032501 | 6177 | 28 | 18204 | 49 |
TNIK,CTNND2,PRKCA,SOX5,NTRK2,CTNNA2,DTNA,BMPR1B,PTPRZ1,MSI2,NEBL,GPM6A,ABLIM1,SLC1A3,RORA,NRG3,RYR3,CSGALNACT1,LSAMP,GLI3,ATP1A2,NTM,SLC4A4,CDH20,RFX4,PREX2,SLC1A2,NFIA |
7.405e-04 | -7.21 | monoatomic ion transmembrane transporter activity | molecular function | GO:0015075 | 752 | 8 | 18094 | 48 |
ITPR2,TRPM3,ATP1A2,GPM6A,SLC1A2,SLC4A4,RYR3,SLC1A3 |
7.411e-04 | -7.21 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 29 | 16828 | 49 |
NFIA,GLI3,ATP1A2,ITPR2,GLIS3,RFX4,ZBTB20,NRG3,NEBL,SLC4A4,FMN2,MACF1,DPP10,ADCY2,CDH20,PARD3B,NTRK2,DST,SPARCL1,ABLIM1,SLC1A3,GPM6A,SORBS1,PREX2,TRPM3,MGAT4C,DTNA,PTPRZ1,GPC5 |
7.424e-04 | -7.21 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 30 | 16828 | 49 |
TRPM3,PREX2,NTM,GPC5,RYR3,PTPRZ1,PAMR1,NTRK2,ADCY2,TNIK,SOX5,ABLIM1,DST,PITPNC1,SLC4A4,NRG3,RFX4,ZBTB20,DPP10,BMPR1B,MACF1,CTNND2,FMN2,GLI3,PRKCA,MAML2,RORA,NFIA,ITPR2,ATP1A2 |
7.424e-04 | -7.21 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 30 | 16828 | 49 |
MACF1,CTNND2,BMPR1B,DPP10,FMN2,NRG3,ZBTB20,RFX4,SLC4A4,ITPR2,ATP1A2,PRKCA,GLI3,NFIA,MAML2,RORA,RYR3,PTPRZ1,PAMR1,GPC5,TRPM3,PREX2,NTM,TNIK,ABLIM1,SOX5,DST,PITPNC1,NTRK2,ADCY2 |
7.457e-04 | -7.20 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 29 | 16828 | 49 |
GLI3,NFIA,ITPR2,ATP1A2,NEBL,SLC4A4,ZBTB20,RFX4,GLIS3,NRG3,DPP10,MACF1,FMN2,NTRK2,CDH20,PARD3B,ADCY2,SLC1A3,ABLIM1,SPARCL1,DST,MGAT4C,DTNA,TRPM3,SORBS1,GPM6A,PREX2,GPC5,PTPRZ1 |
7.502e-04 | -7.20 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 5 | 16828 | 49 |
GPC5,NPAS3,NFIA,ADCY2,NRG3 |
7.502e-04 | -7.20 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 5 | 16828 | 49 |
NPAS3,GPC5,ADCY2,NRG3,NFIA |
7.526e-04 | -7.19 | cellular response to endogenous stimulus | biological process | GO:0071495 | 1135 | 10 | 18204 | 49 |
SOX5,SLC1A2,NTRK2,ITPR2,ATP1A2,NFIA,SORBS1,BMPR1B,SLC1A3,RYR3 |
7.564e-04 | -7.19 | forebrain development | biological process | GO:0030900 | 408 | 6 | 18204 | 49 |
RFX4,NRG3,SLC1A2,ATP1A2,NTRK2,GLI3 |
7.686e-04 | -7.17 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 18 | 16828 | 49 |
SOX5,DST,NTRK2,CDH20,GLI3,PRKCA,ADCY2,GPC5,BMPR1B,MACF1,RYR3,PTPRZ1,CTNND2,NPAS3,TRPM3,NEBL,GPM6A,ZBTB20 |
7.941e-04 | -7.14 | plasma membrane protein complex | cellular component | GO:0098797 | 600 | 7 | 19108 | 49 |
CDH20,DPP10,BMPR1B,ATP1A2,CTNNA2,SORBS1,PRKCA |
8.065e-04 | -7.12 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 41 | 16828 | 49 |
NFIA,RORA,MAML2,PRKCA,GLI3,ATP1A2,ITPR2,GLIS3,RFX4,NRG3,NEBL,SLC4A4,FMN2,CTNND2,CSGALNACT1,MACF1,DPP10,MSI2,ADCY2,PARD3B,CDH20,NTRK2,DST,SPARCL1,NHSL1,ABLIM1,SOX5,TNIK,SLC1A3,NTM,PREX2,TRPM3,NPAS3,SLC1A2,FBXL7,NKAIN3,PTPRZ1,PAMR1,RYR3,LSAMP,GPC5 |
8.065e-04 | -7.12 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 41 | 16828 | 49 |
SLC4A4,NEBL,NRG3,GLIS3,RFX4,DPP10,MACF1,CTNND2,CSGALNACT1,FMN2,PRKCA,GLI3,RORA,MAML2,NFIA,ITPR2,ATP1A2,NPAS3,TRPM3,PREX2,NTM,GPC5,LSAMP,RYR3,PAMR1,PTPRZ1,NKAIN3,FBXL7,SLC1A2,NTRK2,PARD3B,CDH20,MSI2,ADCY2,SLC1A3,TNIK,SOX5,ABLIM1,NHSL1,SPARCL1,DST |
8.077e-04 | -7.12 | sodium ion transmembrane transporter activity | molecular function | GO:0015081 | 158 | 4 | 18094 | 48 |
SLC1A3,ATP1A2,SLC1A2,SLC4A4 |
8.086e-04 | -7.12 | human chr3q13.31 | chromosome location | human chr3q13.31 | 22 | 2 | 26134 | 50 |
ZBTB20,LSAMP |
8.145e-04 | -7.11 | retina development in camera-type eye | biological process | GO:0060041 | 156 | 4 | 18204 | 49 |
GPM6A,NFIA,BMPR1B,NTRK2 |
8.309e-04 | -7.09 | PARD3 (par-3 family cell polarity regulator) | protein interactions | 56288 | 287 | 5 | 19454 | 50 |
DTNA,PARD3B,DST,SORBS1,NTRK2 |
8.443e-04 | -7.08 | plasma membrane bounded cell projection organization | biological process | GO:0120036 | 1152 | 10 | 18204 | 49 |
GPM6A,RFX4,CTNND2,PTPRZ1,TNIK,CTNNA2,BMPR1B,GLI3,ABLIM1,PREX2 |
8.793e-04 | -7.04 | YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma) | protein interactions | 7532 | 1211 | 10 | 19454 | 50 |
NHSL1,FMN2,DST,PRKCA,TPD52L1,ABLIM1,PARD3B,MACF1,SORBS1,PITPNC1 |
8.898e-04 | -7.02 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 33 | 16828 | 49 |
ATP1A2,ITPR2,RORA,MAML2,GLI3,FMN2,MACF1,CSGALNACT1,CTNND2,TPD52L1,NRG3,ZBTB20,GLIS3,SLC4A4,NEBL,DST,SPARCL1,TNIK,SOX5,ABLIM1,SLC1A3,ADCY2,PARD3B,NTRK2,NKAIN3,RYR3,PTPRZ1,PAMR1,PREX2,SORBS1,NPAS3,TRPM3,DTNA |
9.010e-04 | -7.01 | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | 1485 | 12 | 16828 | 49 |
SORBS1,NRG3,PREX2,NPAS3,DTNA,FMN2,MACF1,RYR3,PTPRZ1,GPC5,PARD3B,DST |
9.140e-04 | -7.00 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 17 | 16828 | 49 |
NPAS3,TRPM3,SORBS1,PREX2,GLIS3,MACF1,RYR3,CTNND2,PTPRZ1,FMN2,GLI3,PARD3B,RORA,MAML2,NFIA,ADCY2,SPARCL1 |
9.140e-04 | -7.00 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 17 | 16828 | 49 |
GLI3,PARD3B,NFIA,ADCY2,RORA,MAML2,SPARCL1,TRPM3,NPAS3,GLIS3,SORBS1,PREX2,CTNND2,PTPRZ1,MACF1,RYR3,FMN2 |
9.825e-04 | -6.93 | signaling | biological process | GO:0023052 | 4968 | 24 | 18204 | 49 |
SORBS1,ADCY2,CTNND2,TNIK,DTNA,BMPR1B,PRKCA,FMN2,NTRK2,MACF1,NFIA,SPARCL1,SLC1A2,PREX2,DST,PITPNC1,RYR3,SLC1A3,NRG3,RORA,GLI3,MAML2,ATP1A2,ITPR2 |
9.890e-04 | -6.92 | head development | biological process | GO:0060322 | 774 | 8 | 18204 | 49 |
GLI3,SLC1A2,NTRK2,ATP1A2,CTNNA2,NRG3,RORA,RFX4 |
9.985e-04 | -6.91 | regulation of cartilage development | biological process | GO:0061035 | 73 | 3 | 18204 | 49 |
GLI3,SOX5,BMPR1B |
1.022e-03 | -6.89 | Htt (huntingtin) | protein interactions | 15194 | 77 | 3 | 19454 | 50 |
LSAMP,NTM,GPM6A |
1.026e-03 | -6.88 | acidic amino acid transmembrane transporter activity | molecular function | GO:0015172 | 18 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
1.026e-03 | -6.88 | intracellularly gated calcium channel activity | molecular function | GO:0015278 | 18 | 2 | 18094 | 48 |
ITPR2,RYR3 |
1.042e-03 | -6.87 | cellular component organization | biological process | GO:0016043 | 5636 | 26 | 18204 | 49 |
NFIA,SPARCL1,PREX2,SLC1A2,RFX4,MACF1,CDH20,GLI3,DST,RYR3,CSGALNACT1,PITPNC1,NRG3,PARD3B,SORBS1,ABLIM1,NEBL,GPM6A,PTPRZ1,CTNNA2,BMPR1B,PRKCA,FMN2,CTNND2,TNIK,TRPM3 |
1.043e-03 | -6.87 | synapse | cellular component | GO:0045202 | 1473 | 11 | 19108 | 49 |
SPARCL1,DTNA,SLC1A3,ATP1A2,NRG3,CTNND2,NTRK2,GPM6A,TNIK,PTPRZ1,SLC1A2 |
1.053e-03 | -6.86 | LCK (LCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3932 | 455 | 6 | 19454 | 50 |
MACF1,CTNND2,PRKCA,DST,FMN2,DTNA |
1.059e-03 | -6.85 | Oxytocin signaling pathway | KEGG pathways | ko04921 | 152 | 4 | 7161 | 22 |
ADCY2,PRKCA,RYR3,ITPR2 |
1.059e-03 | -6.85 | Oxytocin signaling pathway | KEGG pathways | hsa04921 | 152 | 4 | 7161 | 22 |
PRKCA,RYR3,ADCY2,ITPR2 |
1.065e-03 | -6.84 | GSK3A (glycogen synthase kinase 3 alpha) | protein interactions | 2931 | 456 | 6 | 19454 | 50 |
NHSL1,TNIK,PRKCA,DST,GLI3,MACF1 |
1.090e-03 | -6.82 | EF-hand | gene3d domains | 1.10.238.10 | 272 | 5 | 14470 | 42 |
DTNA,MACF1,DST,RYR3,SPARCL1 |
1.113e-03 | -6.80 | skin-arm-malignant_melanoma | COSMIC cancer mutations | skin-arm-malignant_melanoma | 1308 | 11 | 16828 | 49 |
ATP1A2,PRKCA,PARD3B,MACF1,DPP10,NPAS3,TRPM3,SORBS1,NTM,ZBTB20,SLC4A4 |
1.118e-03 | -6.80 | cell communication | biological process | GO:0007154 | 5010 | 24 | 18204 | 49 |
DTNA,BMPR1B,PRKCA,FMN2,NTRK2,CTNND2,TNIK,ADCY2,SORBS1,GLI3,ITPR2,ATP1A2,MAML2,DST,PITPNC1,RYR3,SLC1A3,RORA,NRG3,NFIA,SPARCL1,SLC1A2,PREX2,MACF1 |
1.134e-03 | -6.78 | spleen | COSMIC cancer mutations | spleen | 408 | 6 | 16828 | 49 |
PTPRZ1,TNIK,PARD3B,NTM,ADCY2,SORBS1 |
1.154e-03 | -6.76 | cell projection organization | biological process | GO:0030030 | 1200 | 10 | 18204 | 49 |
PREX2,ABLIM1,GLI3,BMPR1B,CTNNA2,TNIK,PTPRZ1,RFX4,CTNND2,GPM6A |
1.165e-03 | -6.76 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 49 | 16828 | 49 |
NFIA,MAML2,PRKCA,ATP1A2,ITPR2,NEBL,CSGALNACT1,MACF1,BMPR1B,ADCY2,CDH20,NTRK2,PITPNC1,DST,SPARCL1,NHSL1,SOX5,TNIK,SLC1A3,NTM,GPM6A,PREX2,TRPM3,NPAS3,MGAT4C,SLC1A2,FBXL7,NKAIN3,PTPRZ1,LSAMP,RORA,GLI3,RFX4,GLIS3,ZBTB20,NRG3,TPD52L1,SLC4A4,FMN2,CTNND2,DPP10,MSI2,PARD3B,ABLIM1,SORBS1,DTNA,PAMR1,RYR3,GPC5 |
1.165e-03 | -6.75 | membrane protein complex | cellular component | GO:0098796 | 1261 | 10 | 19108 | 49 |
BMPR1B,CTNNA2,PRKCA,CDH20,RYR3,DPP10,SLC1A2,ATP1A2,SLC1A3,SORBS1 |
1.179e-03 | -6.74 | cartilage condensation | biological process | GO:0001502 | 19 | 2 | 18204 | 49 |
SOX5,BMPR1B |
1.210e-03 | -6.72 | positive regulation of carbohydrate metabolic process | biological process | GO:0045913 | 78 | 3 | 18204 | 49 |
SLC4A4,ZBTB20,SORBS1 |
1.210e-03 | -6.72 | dicarboxylic acid transport | biological process | GO:0006835 | 78 | 3 | 18204 | 49 |
SLC1A2,NTRK2,SLC1A3 |
1.247e-03 | -6.69 | solute:sodium symporter activity | molecular function | GO:0015370 | 80 | 3 | 18094 | 48 |
SLC1A3,SLC1A2,SLC4A4 |
1.250e-03 | -6.68 | inorganic cation transmembrane transport | biological process | GO:0098662 | 618 | 7 | 18204 | 49 |
SLC4A4,ITPR2,ATP1A2,GPM6A,RYR3,SLC1A3,TRPM3 |
1.257e-03 | -6.68 | Bile secretion | KEGG pathways | hsa04976 | 71 | 3 | 7161 | 22 |
ADCY2,ATP1A2,SLC4A4 |
1.257e-03 | -6.68 | Bile secretion | KEGG pathways | ko04976 | 71 | 3 | 7161 | 22 |
ATP1A2,ADCY2,SLC4A4 |
1.261e-03 | -6.68 | behavior | biological process | GO:0007610 | 619 | 7 | 18204 | 49 |
SLC1A3,PTPRZ1,SLC1A2,PREX2,ATP1A2,NTRK2,GLI3 |
1.263e-03 | -6.67 | monoatomic ion transmembrane transport | biological process | GO:0034220 | 804 | 8 | 18204 | 49 |
TRPM3,SLC1A3,RYR3,GPM6A,ATP1A2,ITPR2,SLC1A2,SLC4A4 |
1.274e-03 | -6.67 | central nervous system neuron differentiation | biological process | GO:0021953 | 176 | 4 | 18204 | 49 |
BMPR1B,NTRK2,RORA,GLI3 |
1.284e-03 | -6.66 | arm | COSMIC cancer mutations | arm | 1331 | 11 | 16828 | 49 |
MACF1,DPP10,SORBS1,NTM,ZBTB20,SLC4A4,NPAS3,TRPM3,ATP1A2,PARD3B,PRKCA |
1.290e-03 | -6.65 | plasma membrane region | cellular component | GO:0098590 | 1278 | 10 | 19108 | 49 |
MACF1,SLC4A4,PARD3B,TNIK,SLC1A2,DST,SLC1A3,SORBS1,ATP1A2,GPM6A |
1.307e-03 | -6.64 | aspartate transmembrane transport | biological process | GO:0015810 | 20 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
1.314e-03 | -6.63 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 8 | 16828 | 49 |
DPP10,SLC1A3,CTNND2,SOX5,ITPR2,NEBL,DTNA,NTRK2 |
1.318e-03 | -6.63 | TENM1 (teneurin transmembrane protein 1) | protein interactions | 10178 | 21 | 2 | 19454 | 50 |
MACF1,SORBS1 |
1.318e-03 | -6.63 | ovary-carcinoma | COSMIC cancer mutations | ovary-carcinoma | 933 | 9 | 16828 | 49 |
NTRK2,PRKCA,PREX2,BMPR1B,ITPR2,TNIK,MACF1,ATP1A2,DST |
1.321e-03 | -6.63 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 22 | 16828 | 49 |
NRG3,RFX4,SLC4A4,NEBL,FMN2,MACF1,CTNND2,CSGALNACT1,RORA,GLI3,PRKCA,ATP1A2,ITPR2,PREX2,MGAT4C,SLC1A2,PAMR1,GPC5,PARD3B,CDH20,DST,ABLIM1 |
1.396e-03 | -6.57 | metal ion transport | biological process | GO:0030001 | 630 | 7 | 18204 | 49 |
RYR3,GPM6A,TRPM3,SLC1A3,SLC4A4,ATP1A2,ITPR2 |
1.443e-03 | -6.54 | positive regulation of purine nucleotide catabolic process | biological process | GO:0033123 | 21 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
1.443e-03 | -6.54 | cell aggregation | biological process | GO:0098743 | 21 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
1.443e-03 | -6.54 | positive regulation of nucleotide catabolic process | biological process | GO:0030813 | 21 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
1.443e-03 | -6.54 | positive regulation of glycolytic process | biological process | GO:0045821 | 21 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
1.471e-03 | -6.52 | regulation of carbohydrate metabolic process | biological process | GO:0006109 | 183 | 4 | 18204 | 49 |
RORA,SLC4A4,SORBS1,ZBTB20 |
1.474e-03 | -6.52 | monoatomic cation transmembrane transport | biological process | GO:0098655 | 636 | 7 | 18204 | 49 |
SLC4A4,ATP1A2,ITPR2,RYR3,GPM6A,TRPM3,SLC1A3 |
1.506e-03 | -6.50 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 9 | 16828 | 49 |
DPP10,GPC5,TRPM3,MACF1,GLI3,ITPR2,FMN2,SLC1A2,PREX2 |
1.506e-03 | -6.50 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 9 | 16828 | 49 |
FMN2,SLC1A2,DPP10,GPC5,ITPR2,MACF1,PREX2,TRPM3,GLI3 |
1.550e-03 | -6.47 | chondrocyte differentiation | biological process | GO:0002062 | 85 | 3 | 18204 | 49 |
SOX5,GLI3,BMPR1B |
1.550e-03 | -6.47 | oligodendrocyte differentiation | biological process | GO:0048709 | 85 | 3 | 18204 | 49 |
NTRK2,GLI3,PTPRZ1 |
1.578e-03 | -6.45 | YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta) | protein interactions | 7533 | 1083 | 9 | 19454 | 50 |
PARD3B,MACF1,PITPNC1,SORBS1,NHSL1,FMN2,DST,ABLIM1,TPD52L1 |
1.584e-03 | -6.45 | intracellular sodium ion homeostasis | biological process | GO:0006883 | 22 | 2 | 18204 | 49 |
SLC1A3,ATP1A2 |
1.594e-03 | -6.44 | DEP_dom | interpro domains | IPR000591 | 22 | 2 | 18521 | 50 |
PREX2,FMN2 |
1.683e-03 | -6.39 | amino acid:sodium symporter activity | molecular function | GO:0005283 | 23 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
1.704e-03 | -6.37 | Opioid Signalling | REACTOME pathways | R-HSA-111885 | 85 | 3 | 10285 | 29 |
ADCY2,PRKCA,ITPR2 |
1.712e-03 | -6.37 | SHC1 events in ERBB2 signaling | REACTOME pathways | R-HSA-1250196 | 22 | 2 | 10285 | 29 |
PRKCA,NRG3 |
1.715e-03 | -6.37 | human chr17q24.2 | chromosome location | human chr17q24.2 | 32 | 2 | 26134 | 50 |
PRKCA,PITPNC1 |
1.743e-03 | -6.35 | Actinin_actin-bd_CS | interpro domains | IPR001589 | 23 | 2 | 18521 | 50 |
DST,MACF1 |
1.745e-03 | -6.35 | Calcium Regulation in the Cardiac Cell | WikiPathways | WP536 | 151 | 4 | 5310 | 19 |
ADCY2,RYR3,PRKCA,ITPR2 |
1.757e-03 | -6.34 | TIAM1 (TIAM Rac1 associated GEF 1) | protein interactions | 7074 | 201 | 4 | 19454 | 50 |
RYR3,PRKCA,ATP1A2,DTNA |
1.781e-03 | -6.33 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 41 | 16828 | 49 |
FBXL7,SLC1A2,RYR3,PAMR1,PTPRZ1,GPC5,LSAMP,PREX2,SORBS1,NTM,NPAS3,TRPM3,DTNA,MGAT4C,DST,NHSL1,TNIK,SOX5,SLC1A3,ADCY2,MSI2,CDH20,PARD3B,NTRK2,FMN2,MACF1,CTNND2,CSGALNACT1,DPP10,BMPR1B,NRG3,GLIS3,ZBTB20,SLC4A4,NEBL,ATP1A2,ITPR2,RORA,MAML2,GLI3,PRKCA |
1.792e-03 | -6.32 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 17 | 16828 | 49 |
PITPNC1,NHSL1,SPARCL1,TNIK,ITPR2,PREX2,NRG3,TPD52L1,SLC4A4,TRPM3,FMN2,NKAIN3,RYR3,MACF1,CTNND2,PTPRZ1,DPP10 |
1.792e-03 | -6.32 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 17 | 16828 | 49 |
SPARCL1,NHSL1,PITPNC1,ITPR2,TNIK,FMN2,NKAIN3,DPP10,CTNND2,PTPRZ1,MACF1,RYR3,SLC4A4,NRG3,TPD52L1,PREX2,TRPM3 |
1.817e-03 | -6.31 | WWC1 (WW and C2 domain containing 1) | protein interactions | 23286 | 94 | 3 | 19454 | 50 |
ABLIM1,PRKCA,TNIK |
1.898e-03 | -6.27 | Spectrin_repeat | interpro domains | IPR002017 | 24 | 2 | 18521 | 50 |
MACF1,DST |
1.905e-03 | -6.26 | Aldosterone synthesis and secretion | KEGG pathways | hsa04925 | 82 | 3 | 7161 | 22 |
ITPR2,PRKCA,ADCY2 |
1.905e-03 | -6.26 | Aldosterone synthesis and secretion | KEGG pathways | ko04925 | 82 | 3 | 7161 | 22 |
ITPR2,ADCY2,PRKCA |
1.911e-03 | -6.26 | cell-cell junction | cellular component | GO:0005911 | 513 | 6 | 19108 | 49 |
CDH20,SORBS1,PARD3B,ATP1A2,CTNNA2,CTNND2 |
1.911e-03 | -6.26 | cellular component organization or biogenesis | biological process | GO:0071840 | 5850 | 26 | 18204 | 49 |
SORBS1,PARD3B,ABLIM1,NEBL,GPM6A,PTPRZ1,CTNNA2,BMPR1B,PRKCA,FMN2,CTNND2,TNIK,TRPM3,NFIA,SPARCL1,PREX2,SLC1A2,RFX4,MACF1,CDH20,GLI3,DST,CSGALNACT1,RYR3,PITPNC1,NRG3 |
1.913e-03 | -6.26 | human chr9q21.12-q21.13 | chromosome location | human chr9q21.12-q21.13 | 1 | 1 | 26134 | 50 |
TRPM3 |
1.913e-03 | -6.26 | human chr15q13.3-q14 | chromosome location | human chr15q13.3-q14 | 1 | 1 | 26134 | 50 |
RYR3 |
1.913e-03 | -6.26 | human chr12q21.31-q21.32 | chromosome location | human chr12q21.31-q21.32 | 1 | 1 | 26134 | 50 |
MGAT4C |
1.913e-03 | -6.26 | human chr3q26.2-q26.31 | chromosome location | human chr3q26.2-q26.31 | 1 | 1 | 26134 | 50 |
TNIK |
1.960e-03 | -6.23 | synapse organization | biological process | GO:0050808 | 333 | 5 | 18204 | 49 |
SPARCL1,CTNND2,NFIA,GPM6A,NRG3 |
1.972e-03 | -6.23 | Spectrin | pfam domains | PF00435 | 24 | 2 | 17795 | 49 |
MACF1,DST |
2.012e-03 | -6.21 | camera-type eye development | biological process | GO:0043010 | 335 | 5 | 18204 | 49 |
NFIA,GPM6A,BMPR1B,GLI3,NTRK2 |
2.019e-03 | -6.21 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 22 | 16828 | 49 |
GLIS3,DPP10,CTNND2,MACF1,FMN2,GLI3,RORA,MAML2,NFIA,TRPM3,NPAS3,SORBS1,PREX2,PTPRZ1,PAMR1,RYR3,PARD3B,CDH20,ADCY2,SLC1A3,SPARCL1,NHSL1 |
2.022e-03 | -6.20 | Calcium signaling pathway | KEGG pathways | ko04020 | 181 | 4 | 7161 | 22 |
ITPR2,RYR3,PRKCA,ADCY2 |
2.022e-03 | -6.20 | Calcium signaling pathway | KEGG pathways | hsa04020 | 181 | 4 | 7161 | 22 |
ITPR2,PRKCA,RYR3,ADCY2 |
2.039e-03 | -6.20 | Glutamate Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-210500 | 24 | 2 | 10285 | 29 |
SLC1A2,SLC1A3 |
2.047e-03 | -6.19 | L-glutamate transmembrane transport | biological process | GO:0015813 | 25 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
2.061e-03 | -6.18 | ABI1 (abl interactor 1) | protein interactions | 10006 | 210 | 4 | 19454 | 50 |
NHSL1,DST,SORBS1,SLC1A3 |
2.063e-03 | -6.18 | Myometrial Relaxation and Contraction Pathways | WikiPathways | WP289 | 158 | 4 | 5310 | 19 |
ITPR2,PRKCA,ADCY2,RYR3 |
2.112e-03 | -6.16 | Insulin secretion | KEGG pathways | hsa04911 | 85 | 3 | 7161 | 22 |
PRKCA,ADCY2,ATP1A2 |
2.152e-03 | -6.14 | extrinsic component of plasma membrane | cellular component | GO:0019897 | 100 | 3 | 19108 | 49 |
CTNNA2,DTNA,CDH20 |
2.178e-03 | -6.13 | CXADR (CXADR Ig-like cell adhesion molecule) | protein interactions | 1525 | 357 | 5 | 19454 | 50 |
SORBS1,DST,MACF1,NEBL,TNIK |
2.181e-03 | -6.13 | KCNJ12 (potassium inwardly rectifying channel subfamily J member 12) | protein interactions | 3768 | 27 | 2 | 19454 | 50 |
ABLIM1,DTNA |
2.192e-03 | -6.12 | Proximal tubule bicarbonate reclamation | KEGG pathways | ko04964 | 23 | 2 | 7161 | 22 |
SLC4A4,ATP1A2 |
2.192e-03 | -6.12 | Proximal tubule bicarbonate reclamation | KEGG pathways | hsa04964 | 23 | 2 | 7161 | 22 |
ATP1A2,SLC4A4 |
2.214e-03 | -6.11 | C4-dicarboxylate transport | biological process | GO:0015740 | 26 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
2.217e-03 | -6.11 | YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) | protein interactions | 7534 | 1138 | 9 | 19454 | 50 |
PARD3B,SORBS1,PITPNC1,MACF1,NHSL1,PRKCA,TPD52L1,ABLIM1,DST |
2.227e-03 | -6.11 | calcium ion transmembrane transport | biological process | GO:0070588 | 205 | 4 | 18204 | 49 |
RYR3,GPM6A,TRPM3,ITPR2 |
2.259e-03 | -6.09 | Transmembrane transport of small molecules | REACTOME pathways | R-HSA-382551 | 677 | 7 | 10285 | 29 |
TRPM3,SLC1A2,SLC1A3,ADCY2,SLC4A4,RYR3,ATP1A2 |
2.261e-03 | -6.09 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 7 | 16828 | 49 |
PTPRZ1,FMN2,NTM,SORBS1,PREX2,NFIA,NEBL |
2.321e-03 | -6.07 | GFAP (glial fibrillary acidic protein) | protein interactions | 2670 | 217 | 4 | 19454 | 50 |
NKAIN3,RORA,PRKCA,ABLIM1 |
2.322e-03 | -6.07 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 16 | 16828 | 49 |
GLI3,NTRK2,ADCY2,MAML2,SOX5,ATP1A2,NHSL1,TRPM3,NRG3,ZBTB20,RFX4,CTNND2,CSGALNACT1,PTPRZ1,SLC1A2,FMN2 |
2.332e-03 | -6.06 | Gap junction | KEGG pathways | hsa04540 | 88 | 3 | 7161 | 22 |
PRKCA,ADCY2,ITPR2 |
2.332e-03 | -6.06 | Gap junction | KEGG pathways | ko04540 | 88 | 3 | 7161 | 22 |
PRKCA,ADCY2,ITPR2 |
2.341e-03 | -6.06 | actin filament binding | molecular function | GO:0051015 | 211 | 4 | 18094 | 48 |
CTNNA2,NEBL,MACF1,ABLIM1 |
2.398e-03 | -6.03 | bone morphogenesis | biological process | GO:0060349 | 99 | 3 | 18204 | 49 |
GLI3,CSGALNACT1,BMPR1B |
2.403e-03 | -6.03 | cell motility | biological process | GO:0048870 | 1101 | 9 | 18204 | 49 |
GPM6A,DST,GPC5,NRG3,CTNNA2,CDH20,GLI3,FMN2,NTRK2 |
2.412e-03 | -6.03 | haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma | 323 | 5 | 16828 | 49 |
SORBS1,ADCY2,NTM,PARD3B,PTPRZ1 |
2.419e-03 | -6.02 | Muscle contraction | REACTOME pathways | R-HSA-397014 | 204 | 4 | 10285 | 29 |
ATP1A2,ITPR2,SORBS1,RYR3 |
2.439e-03 | -6.02 | signal transduction | biological process | GO:0007165 | 4637 | 22 | 18204 | 49 |
ADCY2,SORBS1,CTNND2,TNIK,DTNA,BMPR1B,PRKCA,NTRK2,FMN2,MACF1,NFIA,SPARCL1,PREX2,DST,RYR3,PITPNC1,NRG3,RORA,GLI3,MAML2,ATP1A2,ITPR2 |
2.467e-03 | -6.00 | response to alkaloid | biological process | GO:0043279 | 100 | 3 | 18204 | 49 |
RYR3,SLC1A2,SLC1A3 |
2.545e-03 | -5.97 | ACTININ_2 | prosite domains | PS00020 | 23 | 2 | 12186 | 40 |
MACF1,DST |
2.545e-03 | -5.97 | ACTININ_1 | prosite domains | PS00019 | 23 | 2 | 12186 | 40 |
MACF1,DST |
2.564e-03 | -5.97 | H zone | cellular component | GO:0031673 | 1 | 1 | 19108 | 49 |
DST |
2.570e-03 | -5.96 | fbxw7.L (F-box and WD repeat domain containing 7 L homeolog) | protein interactions | 734230 | 1 | 1 | 19454 | 50 |
PRKCA |
2.570e-03 | -5.96 | TAS2R20 (taste 2 receptor member 20) | protein interactions | 259295 | 1 | 1 | 19454 | 50 |
PRKCA |
2.570e-03 | -5.96 | EB1a (microtubule end binding protein EB1A) | protein interactions | 823923 | 1 | 1 | 19454 | 50 |
DST |
2.570e-03 | -5.96 | Bdnf (brain derived neurotrophic factor) | protein interactions | 12064 | 1 | 1 | 19454 | 50 |
NTRK2 |
2.570e-03 | -5.96 | Lztr1 (leucine-zipper-like transcriptional regulator, 1) | protein interactions | 66863 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | Hipk3 (homeodomain interacting protein kinase 3) | protein interactions | 15259 | 1 | 1 | 19454 | 50 |
GLIS3 |
2.570e-03 | -5.96 | Dcaf7 (DDB1 and CUL4 associated factor 7) | protein interactions | 71833 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | 1700006A11Rik (RIKEN cDNA 1700006A11 gene) | protein interactions | 71824 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | Isl1 (ISL1 transcription factor, LIM/homeodomain) | protein interactions | 16392 | 1 | 1 | 19454 | 50 |
GLIS3 |
2.570e-03 | -5.96 | Dynlt1 (dynein light chain Tctex-type 1) | protein interactions | 83462 | 1 | 1 | 19454 | 50 |
NTRK2 |
2.570e-03 | -5.96 | mal3 (EB1 family Mal3) | protein interactions | 2542123 | 1 | 1 | 19454 | 50 |
DST |
2.570e-03 | -5.96 | Agtrap (angiotensin II, type I receptor-associated protein) | protein interactions | 11610 | 1 | 1 | 19454 | 50 |
PITPNC1 |
2.603e-03 | -5.95 | MAPRE3 (microtubule associated protein RP/EB family member 3) | protein interactions | 22924 | 224 | 4 | 19454 | 50 |
ABLIM1,DST,GPM6A,MACF1 |
2.648e-03 | -5.93 | GnRH signaling pathway | KEGG pathways | hsa04912 | 92 | 3 | 7161 | 22 |
PRKCA,ADCY2,ITPR2 |
2.648e-03 | -5.93 | GnRH signaling pathway | KEGG pathways | ko04912 | 92 | 3 | 7161 | 22 |
ITPR2,ADCY2,PRKCA |
2.653e-03 | -5.93 | peptidoglycan glycosyltransferase activity | molecular function | GO:0008955 | 1 | 1 | 18094 | 48 |
CSGALNACT1 |
2.653e-03 | -5.93 | brain-derived neurotrophic factor receptor activity | molecular function | GO:0060175 | 1 | 1 | 18094 | 48 |
NTRK2 |
2.673e-03 | -5.92 | ligand-gated calcium channel activity | molecular function | GO:0099604 | 29 | 2 | 18094 | 48 |
ITPR2,RYR3 |
2.673e-03 | -5.92 | amino acid:monoatomic cation symporter activity | molecular function | GO:0005416 | 29 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
2.681e-03 | -5.92 | marginal_zone_lymphoma | COSMIC cancer mutations | marginal_zone_lymphoma | 331 | 5 | 16828 | 49 |
PARD3B,PTPRZ1,SORBS1,ADCY2,NTM |
2.692e-03 | -5.92 | olfactory cortex development | biological process | GO:0021989 | 1 | 1 | 18204 | 49 |
ATP1A2 |
2.692e-03 | -5.92 | homologous chromosome movement towards spindle pole in meiosis I anaphase | biological process | GO:0051758 | 1 | 1 | 18204 | 49 |
FMN2 |
2.692e-03 | -5.92 | sagittal suture morphogenesis | biological process | GO:0060367 | 1 | 1 | 18204 | 49 |
GLI3 |
2.692e-03 | -5.92 | positive regulation of angiotensin-activated signaling pathway | biological process | GO:0110063 | 1 | 1 | 18204 | 49 |
PRKCA |
2.692e-03 | -5.92 | negative regulation of calcium:sodium antiporter activity | biological process | GO:1903280 | 1 | 1 | 18204 | 49 |
ATP1A2 |
2.692e-03 | -5.92 | lambdoid suture morphogenesis | biological process | GO:0060366 | 1 | 1 | 18204 | 49 |
GLI3 |
2.692e-03 | -5.92 | directional guidance of interneurons involved in migration from the subpallium to the cortex | biological process | GO:0021840 | 1 | 1 | 18204 | 49 |
NRG3 |
2.692e-03 | -5.92 | chemorepulsion involved in interneuron migration from the subpallium to the cortex | biological process | GO:0021842 | 1 | 1 | 18204 | 49 |
NRG3 |
2.692e-03 | -5.92 | trans-synaptic signaling by neuropeptide, modulating synaptic transmission | biological process | GO:0099551 | 1 | 1 | 18204 | 49 |
NTRK2 |
2.692e-03 | -5.92 | lateral semicircular canal development | biological process | GO:0060875 | 1 | 1 | 18204 | 49 |
GLI3 |
2.692e-03 | -5.92 | trans-synaptic signaling by neuropeptide | biological process | GO:0099540 | 1 | 1 | 18204 | 49 |
NTRK2 |
2.692e-03 | -5.92 | lateral ganglionic eminence cell proliferation | biological process | GO:0022018 | 1 | 1 | 18204 | 49 |
GLI3 |
2.692e-03 | -5.92 | anterior semicircular canal development | biological process | GO:0060873 | 1 | 1 | 18204 | 49 |
GLI3 |
2.692e-03 | -5.92 | subpallium cell proliferation in forebrain | biological process | GO:0022012 | 1 | 1 | 18204 | 49 |
GLI3 |
2.700e-03 | -5.91 | MAML2_TAD | interpro domains | IPR048452 | 1 | 1 | 18521 | 50 |
MAML2 |
2.700e-03 | -5.91 | Nebulette_SH3 | interpro domains | IPR035631 | 1 | 1 | 18521 | 50 |
NEBL |
2.700e-03 | -5.91 | NTRK2 | interpro domains | IPR020455 | 1 | 1 | 18521 | 50 |
NTRK2 |
2.700e-03 | -5.91 | cPKC_alpha | interpro domains | IPR034663 | 1 | 1 | 18521 | 50 |
PRKCA |
2.700e-03 | -5.91 | SORBS1_SH3_2 | interpro domains | IPR035611 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | SORBS1_SH3_1 | interpro domains | IPR035610 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | SPARC-like_p1 | interpro domains | IPR016359 | 1 | 1 | 18521 | 50 |
SPARCL1 |
2.700e-03 | -5.91 | Rex2_DEP_1 | interpro domains | IPR037367 | 1 | 1 | 18521 | 50 |
PREX2 |
2.700e-03 | -5.91 | SORBS1_SH3 | interpro domains | IPR035606 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.709e-03 | -5.91 | large_intestine-caecum-carcinoma-adenocarcinoma | COSMIC cancer mutations | large_intestine-caecum-carcinoma-adenocarcinoma | 14236 | 48 | 16828 | 49 |
BMPR1B,MACF1,CSGALNACT1,NEBL,ATP1A2,ITPR2,MAML2,NFIA,PRKCA,NKAIN3,FBXL7,SLC1A2,LSAMP,PTPRZ1,PREX2,GPM6A,NTM,MGAT4C,NPAS3,TRPM3,NHSL1,SPARCL1,DST,PITPNC1,SLC1A3,TNIK,SOX5,ADCY2,NTRK2,CDH20,FMN2,DPP10,CTNND2,SLC4A4,NRG3,TPD52L1,GLIS3,ZBTB20,RFX4,RORA,GLI3,GPC5,RYR3,PAMR1,SORBS1,DTNA,ABLIM1,PARD3B |
2.754e-03 | -5.89 | MAML2_TAD | pfam domains | PF20804 | 1 | 1 | 17795 | 49 |
MAML2 |
2.773e-03 | -5.89 | Calmodulin induced events | REACTOME pathways | R-HSA-111933 | 28 | 2 | 10285 | 29 |
PRKCA,ADCY2 |
2.773e-03 | -5.89 | CaM pathway | REACTOME pathways | R-HSA-111997 | 28 | 2 | 10285 | 29 |
PRKCA,ADCY2 |
2.809e-03 | -5.87 | caecum | COSMIC cancer mutations | caecum | 14248 | 48 | 16828 | 49 |
NKAIN3,FBXL7,SLC1A2,LSAMP,PTPRZ1,GPM6A,PREX2,NTM,MGAT4C,NPAS3,TRPM3,NHSL1,SPARCL1,DST,PITPNC1,SLC1A3,TNIK,SOX5,ADCY2,NTRK2,CDH20,BMPR1B,MACF1,CSGALNACT1,NEBL,ATP1A2,ITPR2,MAML2,NFIA,PRKCA,GPC5,RYR3,PAMR1,SORBS1,DTNA,ABLIM1,PARD3B,FMN2,DPP10,CTNND2,SLC4A4,TPD52L1,NRG3,RFX4,ZBTB20,GLIS3,RORA,GLI3 |
2.815e-03 | -5.87 | EF_hand_dom | interpro domains | IPR002048 | 218 | 4 | 18521 | 50 |
RYR3,DST,MACF1,SPARCL1 |
2.827e-03 | -5.87 | glial cell differentiation | biological process | GO:0010001 | 219 | 4 | 18204 | 49 |
GLI3,PTPRZ1,NTRK2,NFIA |
2.857e-03 | -5.86 | cell body | cellular component | GO:0044297 | 556 | 6 | 19108 | 49 |
SLC1A3,ATP1A2,CTNND2,GPM6A,SLC1A2,BMPR1B |
2.857e-03 | -5.86 | catenin complex | cellular component | GO:0016342 | 31 | 2 | 19108 | 49 |
CDH20,CTNNA2 |
2.859e-03 | -5.86 | inorganic ion transmembrane transport | biological process | GO:0098660 | 715 | 7 | 18204 | 49 |
SLC4A4,ITPR2,ATP1A2,RYR3,GPM6A,TRPM3,SLC1A3 |
2.870e-03 | -5.85 | AVPR1B (arginine vasopressin receptor 1B) | protein interactions | 553 | 31 | 2 | 19454 | 50 |
PRKCA,FMN2 |
2.942e-03 | -5.83 | L-glutamate import | biological process | GO:0051938 | 30 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
2.961e-03 | -5.82 | Spectrin/alpha-actinin | interpro domains | IPR018159 | 30 | 2 | 18521 | 50 |
MACF1,DST |
2.964e-03 | -5.82 | cell migration | biological process | GO:0016477 | 921 | 8 | 18204 | 49 |
GLI3,FMN2,NTRK2,CTNNA2,CDH20,NRG3,GPM6A,GPC5 |
2.989e-03 | -5.81 | Circadian entrainment | KEGG pathways | ko04713 | 96 | 3 | 7161 | 22 |
RYR3,PRKCA,ADCY2 |
2.989e-03 | -5.81 | Circadian entrainment | KEGG pathways | hsa04713 | 96 | 3 | 7161 | 22 |
ADCY2,RYR3,PRKCA |
2.993e-03 | -5.81 | YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) | protein interactions | 7529 | 965 | 8 | 19454 | 50 |
DST,TPD52L1,ABLIM1,NHSL1,MACF1,PITPNC1,SORBS1,PARD3B |
3.005e-03 | -5.81 | SH3_domain | interpro domains | IPR001452 | 222 | 4 | 18521 | 50 |
NEBL,SORBS1,DST,MACF1 |
3.026e-03 | -5.80 | Transmission across Chemical Synapses | REACTOME pathways | R-HSA-112315 | 217 | 4 | 10285 | 29 |
PRKCA,ADCY2,SLC1A3,SLC1A2 |
3.051e-03 | -5.79 | intracellularly ligand-gated monoatomic ion channel activity | molecular function | GO:0005217 | 31 | 2 | 18094 | 48 |
ITPR2,RYR3 |
3.078e-03 | -5.78 | Inflammatory mediator regulation of TRP channels | KEGG pathways | ko04750 | 97 | 3 | 7161 | 22 |
ADCY2,PRKCA,ITPR2 |
3.078e-03 | -5.78 | Inflammatory mediator regulation of TRP channels | KEGG pathways | hsa04750 | 97 | 3 | 7161 | 22 |
ADCY2,PRKCA,ITPR2 |
3.132e-03 | -5.77 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 14 | 16828 | 49 |
SLC4A4,PREX2,DTNA,BMPR1B,PTPRZ1,NFIA,ADCY2,NTRK2,GLI3,PRKCA,PARD3B,ATP1A2,TNIK,SOX5 |
3.179e-03 | -5.75 | Ion_trans_dom | interpro domains | IPR005821 | 109 | 3 | 18521 | 50 |
RYR3,ITPR2,TRPM3 |
3.180e-03 | -5.75 | Ca-dependent events | REACTOME pathways | R-HSA-111996 | 30 | 2 | 10285 | 29 |
PRKCA,ADCY2 |
3.224e-03 | -5.74 | human chr11p13 | chromosome location | human chr11p13 | 44 | 2 | 26134 | 50 |
PAMR1,SLC1A2 |
3.266e-03 | -5.72 | skeletal system morphogenesis | biological process | GO:0048705 | 228 | 4 | 18204 | 49 |
SOX5,GLI3,CSGALNACT1,BMPR1B |
3.286e-03 | -5.72 | Transport of inorganic cations/anions and amino acids/oligopeptides | REACTOME pathways | R-HSA-425393 | 107 | 3 | 10285 | 29 |
SLC1A3,SLC1A2,SLC4A4 |
3.289e-03 | -5.72 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 22 | 16828 | 49 |
MACF1,CTNND2,DPP10,FMN2,NRG3,GLIS3,RFX4,ATP1A2,GLI3,RYR3,PTPRZ1,TRPM3,DTNA,MGAT4C,PREX2,GPM6A,ABLIM1,SOX5,SLC1A3,DST,NHSL1,ADCY2 |
3.289e-03 | -5.72 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 22 | 16828 | 49 |
SLC1A3,ABLIM1,SOX5,NHSL1,ATP1A2,DST,GLI3,ADCY2,DPP10,MACF1,RYR3,CTNND2,PTPRZ1,FMN2,DTNA,MGAT4C,TRPM3,NRG3,PREX2,GPM6A,GLIS3,RFX4 |
3.336e-03 | -5.70 | GJA1 (gap junction protein alpha 1) | protein interactions | 2697 | 572 | 6 | 19454 | 50 |
TNIK,DTNA,PRKCA,MACF1,ITPR2,DST |
3.344e-03 | -5.70 | transepithelial transport | biological process | GO:0070633 | 32 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
3.344e-03 | -5.70 | positive regulation of ATP metabolic process | biological process | GO:1903580 | 32 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
3.356e-03 | -5.70 | Ion_trans | pfam domains | PF00520 | 109 | 3 | 17795 | 49 |
RYR3,TRPM3,ITPR2 |
3.452e-03 | -5.67 | Retrograde endocannabinoid signaling | KEGG pathways | hsa04723 | 101 | 3 | 7161 | 22 |
ITPR2,ADCY2,PRKCA |
3.452e-03 | -5.67 | Retrograde endocannabinoid signaling | KEGG pathways | ko04723 | 101 | 3 | 7161 | 22 |
ADCY2,PRKCA,ITPR2 |
3.486e-03 | -5.66 | dendrite development | biological process | GO:0016358 | 113 | 3 | 18204 | 49 |
CTNND2,CTNNA2,PREX2 |
3.497e-03 | -5.66 | acinar_carcinoma | COSMIC cancer mutations | acinar_carcinoma | 1978 | 13 | 16828 | 49 |
NHSL1,ATP1A2,SOX5,GLI3,PARD3B,FMN2,CSGALNACT1,PTPRZ1,CTNND2,BMPR1B,DPP10,ZBTB20,TRPM3 |
3.497e-03 | -5.66 | pancreas-carcinoma-acinar_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-acinar_carcinoma | 1978 | 13 | 16828 | 49 |
ATP1A2,NHSL1,SOX5,PARD3B,GLI3,FMN2,DPP10,BMPR1B,CTNND2,CSGALNACT1,PTPRZ1,ZBTB20,TRPM3 |
3.504e-03 | -5.65 | eye development | biological process | GO:0001654 | 381 | 5 | 18204 | 49 |
BMPR1B,NFIA,GPM6A,NTRK2,GLI3 |
3.553e-03 | -5.64 | response to auditory stimulus | biological process | GO:0010996 | 33 | 2 | 18204 | 49 |
ATP1A2,SLC1A3 |
3.602e-03 | -5.63 | DELLA | smart domains | SM01129 | 1 | 1 | 9717 | 35 |
MACF1 |
3.621e-03 | -5.62 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 41 | 16828 | 49 |
CDH20,PARD3B,NTRK2,MSI2,ADCY2,SOX5,TNIK,SLC1A3,DST,NHSL1,TRPM3,NPAS3,MGAT4C,DTNA,NTM,SORBS1,PREX2,PTPRZ1,PAMR1,RYR3,LSAMP,GPC5,SLC1A2,FBXL7,GLI3,PRKCA,MAML2,RORA,ITPR2,ATP1A2,GLIS3,ZBTB20,NRG3,NEBL,SLC4A4,CTNND2,CSGALNACT1,MACF1,DPP10,BMPR1B,FMN2 |
3.635e-03 | -5.62 | NTKRECEPTOR2 | prints domains | PR01941 | 1 | 1 | 5227 | 19 |
NTRK2 |
3.644e-03 | -5.61 | Integration of energy metabolism | REACTOME pathways | R-HSA-163685 | 111 | 3 | 10285 | 29 |
PRKCA,ADCY2,ITPR2 |
3.649e-03 | -5.61 | TPRA1 (transmembrane protein adipocyte associated 1) | protein interactions | 131601 | 35 | 2 | 19454 | 50 |
ITPR2,BMPR1B |
3.653e-03 | -5.61 | response to endogenous stimulus | biological process | GO:0009719 | 1402 | 10 | 18204 | 49 |
SLC1A3,RYR3,SOX5,SLC1A2,ATP1A2,ITPR2,NTRK2,NFIA,SORBS1,BMPR1B |
3.663e-03 | -5.61 | visual system development | biological process | GO:0150063 | 385 | 5 | 18204 | 49 |
GPM6A,NFIA,BMPR1B,GLI3,NTRK2 |
3.688e-03 | -5.60 | solute:monoatomic cation symporter activity | molecular function | GO:0015294 | 117 | 3 | 18094 | 48 |
SLC1A2,SLC4A4,SLC1A3 |
3.815e-03 | -5.57 | metal ion binding | molecular function | GO:0046872 | 4239 | 20 | 18094 | 48 |
SLC1A3,PRKCA,RYR3,ITPR2,ZBTB20,MGAT4C,GLIS3,GLI3,PAMR1,SPARCL1,DST,ADCY2,SLC1A2,ATP1A2,DTNA,BMPR1B,MACF1,CSGALNACT1,RORA,ABLIM1 |
3.878e-03 | -5.55 | organic acid:sodium symporter activity | molecular function | GO:0005343 | 35 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
3.885e-03 | -5.55 | SH3 Domains | gene3d domains | 2.30.30.40 | 223 | 4 | 14470 | 42 |
NEBL,SORBS1,MACF1,DST |
3.912e-03 | -5.54 | sensory system development | biological process | GO:0048880 | 391 | 5 | 18204 | 49 |
BMPR1B,GPM6A,NFIA,NTRK2,GLI3 |
3.916e-03 | -5.54 | monoatomic ion transport | biological process | GO:0006811 | 964 | 8 | 18204 | 49 |
ITPR2,ATP1A2,SLC1A2,SLC4A4,TRPM3,SLC1A3,RYR3,GPM6A |
3.936e-03 | -5.54 | rhabdomyosarcoma | COSMIC cancer mutations | rhabdomyosarcoma | 4150 | 21 | 16828 | 49 |
CTNND2,PAMR1,PTPRZ1,MACF1,RYR3,FMN2,TRPM3,NPAS3,GLIS3,PREX2,SORBS1,SLC1A3,SPARCL1,NHSL1,CDH20,PARD3B,GLI3,NFIA,ADCY2,RORA,MAML2 |
3.969e-03 | -5.53 | NCK2 (NCK adaptor protein 2) | protein interactions | 8440 | 252 | 4 | 19454 | 50 |
NTRK2,SORBS1,NHSL1,TNIK |
3.979e-03 | -5.53 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 5 | 19108 | 49 |
SPARCL1,GPM6A,TNIK,NRG3,SLC1A2 |
3.990e-03 | -5.52 | neuron fate specification | biological process | GO:0048665 | 35 | 2 | 18204 | 49 |
GLI3,NFIA |
4.003e-03 | -5.52 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 14 | 16828 | 49 |
RFX4,ZBTB20,NRG3,TRPM3,FMN2,SLC1A2,CTNND2,PTPRZ1,MAML2,NTRK2,GLI3,ATP1A2,NHSL1,SOX5 |
4.071e-03 | -5.50 | PADI3 (peptidyl arginine deiminase 3) | protein interactions | 51702 | 37 | 2 | 19454 | 50 |
CSGALNACT1,SPARCL1 |
4.094e-03 | -5.50 | transporter activity | molecular function | GO:0005215 | 1211 | 9 | 18094 | 48 |
SLC4A4,SLC1A2,GPM6A,ATP1A2,SLC1A3,RYR3,PITPNC1,TRPM3,ITPR2 |
4.127e-03 | -5.49 | striated muscle contraction | biological process | GO:0006941 | 120 | 3 | 18204 | 49 |
DTNA,RYR3,ATP1A2 |
4.138e-03 | -5.49 | NGF signalling via TRKA from the plasma membrane | REACTOME pathways | R-HSA-187037 | 387 | 5 | 10285 | 29 |
NTRK2,NRG3,ITPR2,ADCY2,PRKCA |
4.183e-03 | -5.48 | monoatomic cation transport | biological process | GO:0006812 | 766 | 7 | 18204 | 49 |
ATP1A2,ITPR2,SLC4A4,SLC1A3,TRPM3,GPM6A,RYR3 |
4.281e-03 | -5.45 | positive regulation of neurogenesis | biological process | GO:0050769 | 246 | 4 | 18204 | 49 |
MACF1,NTRK2,GLI3,PTPRZ1 |
4.289e-03 | -5.45 | superficial_spreading | COSMIC cancer mutations | superficial_spreading | 1110 | 9 | 16828 | 49 |
MGAT4C,GLI3,SLC4A4,NTM,SORBS1,PREX2,ADCY2,CTNND2,MACF1 |
4.335e-03 | -5.44 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 40 | 16828 | 49 |
RFX4,ZBTB20,TPD52L1,NRG3,NEBL,FMN2,CTNND2,CSGALNACT1,MACF1,RORA,MAML2,GLI3,PRKCA,ATP1A2,ITPR2,GPM6A,PREX2,SORBS1,TRPM3,NPAS3,MGAT4C,DTNA,SLC1A2,FBXL7,NKAIN3,PTPRZ1,PAMR1,RYR3,LSAMP,GPC5,ADCY2,CDH20,NTRK2,DST,SPARCL1,NHSL1,SOX5,ABLIM1,TNIK,SLC1A3 |
4.432e-03 | -5.42 | chondroitin biosynthesis | BIOCYC pathways | HUMAN_PWY-6566 | 2 | 1 | 902 | 2 |
CSGALNACT1 |
4.448e-03 | -5.42 | Lima1 (LIM domain and actin binding 1) | protein interactions | 65970 | 129 | 3 | 19454 | 50 |
ZBTB20,ABLIM1,ITPR2 |
4.451e-03 | -5.41 | positive regulation of purine nucleotide metabolic process | biological process | GO:1900544 | 37 | 2 | 18204 | 49 |
SLC4A4,ZBTB20 |
4.451e-03 | -5.41 | positive regulation of nucleotide metabolic process | biological process | GO:0045981 | 37 | 2 | 18204 | 49 |
SLC4A4,ZBTB20 |
4.451e-03 | -5.41 | positive regulation of glucose import | biological process | GO:0046326 | 37 | 2 | 18204 | 49 |
SORBS1,SLC1A2 |
4.470e-03 | -5.41 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 9 | 16828 | 49 |
ADCY2,NRG3,CDH20,SLC1A2,DST,FMN2,SOX5,RYR3,GPC5 |
4.494e-03 | -5.41 | DIRAS3 (DIRAS family GTPase 3) | protein interactions | 9077 | 261 | 4 | 19454 | 50 |
MACF1,DST,DTNA,FMN2 |
4.506e-03 | -5.40 | cellular component assembly | biological process | GO:0022607 | 2472 | 14 | 18204 | 49 |
NEBL,GPM6A,RFX4,ABLIM1,SLC1A2,SORBS1,NRG3,TNIK,TRPM3,DST,RYR3,PRKCA,FMN2,CDH20 |
4.512e-03 | -5.40 | Z disc | cellular component | GO:0030018 | 130 | 3 | 19108 | 49 |
NEBL,DST,RYR3 |
4.543e-03 | -5.39 | animal organ morphogenesis | biological process | GO:0009887 | 988 | 8 | 18204 | 49 |
CSGALNACT1,NRG3,BMPR1B,CTNNA2,NTRK2,GLI3,SOX5,ABLIM1 |
4.597e-03 | -5.38 | calcium ion transport | biological process | GO:0006816 | 251 | 4 | 18204 | 49 |
RYR3,GPM6A,ITPR2,TRPM3 |
4.606e-03 | -5.38 | - | gene3d domains | 1.20.58.60 | 35 | 2 | 14470 | 42 |
DST,MACF1 |
4.619e-03 | -5.38 | Cholinergic synapse | KEGG pathways | hsa04725 | 112 | 3 | 7161 | 22 |
PRKCA,ADCY2,ITPR2 |
4.676e-03 | -5.37 | functioning | COSMIC cancer mutations | functioning | 1803 | 12 | 16828 | 49 |
SLC1A2,FMN2,PTPRZ1,NRG3,ZBTB20,RFX4,TRPM3,NHSL1,SOX5,MAML2,GLI3,NTRK2 |
4.676e-03 | -5.37 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | 1803 | 12 | 16828 | 49 |
GLI3,NTRK2,MAML2,SOX5,NHSL1,TRPM3,ZBTB20,RFX4,NRG3,PTPRZ1,SLC1A2,FMN2 |
4.691e-03 | -5.36 | amino acid import across plasma membrane | biological process | GO:0089718 | 38 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
4.814e-03 | -5.34 | SPEC | smart domains | SM00150 | 29 | 2 | 9717 | 35 |
DST,MACF1 |
4.852e-03 | -5.33 | cellular process | biological process | GO:0009987 | 14996 | 47 | 18204 | 49 |
MSI2,PARD3B,GPC5,TRPM3,NHSL1,ZBTB20,BMPR1B,SOX5,PRKCA,FMN2,RFX4,SLC1A2,PREX2,DST,RYR3,MGAT4C,NRG3,CDH20,LSAMP,GLI3,NTM,ATP1A2,GPM6A,NEBL,PTPRZ1,TPD52L1,GLIS3,SORBS1,ADCY2,ABLIM1,FBXL7,CTNND2,TNIK,CTNNA2,DTNA,DPP10,NTRK2,MACF1,NFIA,SPARCL1,PITPNC1,CSGALNACT1,SLC1A3,RORA,SLC4A4,MAML2,ITPR2 |
4.868e-03 | -5.33 | dendrite | cellular component | GO:0030425 | 620 | 6 | 19108 | 49 |
NTRK2,BMPR1B,ATP1A2,CTNND2,GPM6A,ADCY2 |
4.918e-03 | -5.31 | cell differentiation | biological process | GO:0030154 | 3645 | 18 | 18204 | 49 |
NTRK2,FMN2,NTM,GLI3,SOX5,BMPR1B,CTNNA2,NHSL1,RORA,TNIK,SLC1A3,CTNND2,PREX2,NFIA,MSI2,PTPRZ1,NEBL,GPM6A |
4.936e-03 | -5.31 | sodium ion homeostasis | biological process | GO:0055078 | 39 | 2 | 18204 | 49 |
ATP1A2,SLC1A3 |
4.944e-03 | -5.31 | dendritic tree | cellular component | GO:0097447 | 622 | 6 | 19108 | 49 |
ADCY2,ATP1A2,CTNND2,GPM6A,BMPR1B,NTRK2 |
4.963e-03 | -5.31 | cellular developmental process | biological process | GO:0048869 | 3648 | 18 | 18204 | 49 |
GPM6A,NEBL,PTPRZ1,MSI2,NFIA,PREX2,CTNND2,SLC1A3,RORA,NHSL1,TNIK,CTNNA2,BMPR1B,GLI3,SOX5,NTM,FMN2,NTRK2 |
5.049e-03 | -5.29 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 3 | 19454 | 50 |
ABLIM1,ITPR2,DST |
5.090e-03 | -5.28 | cation binding | molecular function | GO:0043169 | 4341 | 20 | 18094 | 48 |
RYR3,PRKCA,SLC1A3,PAMR1,GLI3,GLIS3,ZBTB20,MGAT4C,ITPR2,CSGALNACT1,BMPR1B,MACF1,ATP1A2,DTNA,ADCY2,SLC1A2,DST,SPARCL1,RORA,ABLIM1 |
5.127e-03 | -5.27 | RHOB (ras homolog family member B) | protein interactions | 388 | 832 | 7 | 19454 | 50 |
DTNA,FMN2,ABLIM1,TNIK,PARD3B,MACF1,SLC1A3 |
5.131e-03 | -5.27 | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 120 | 3 | 16828 | 49 |
CTNND2,DST,FMN2 |
5.134e-03 | -5.27 | Zmym2 (zinc finger, MYM-type 2) | protein interactions | 76007 | 2 | 1 | 19454 | 50 |
GLIS3 |
5.134e-03 | -5.27 | Bcr (BCR activator of RhoGEF and GTPase) | protein interactions | 110279 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Grin2c (glutamate ionotropic receptor NMDA type subunit 2C) | protein interactions | 24411 | 2 | 1 | 19454 | 50 |
PRKCA |
5.134e-03 | -5.27 | Klhl1 (kelch-like 1) | protein interactions | 93688 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Irf7 (interferon regulatory factor 7) | protein interactions | 54123 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Sh3kbp1 (SH3-domain kinase binding protein 1) | protein interactions | 58194 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Ppp3cc (protein phosphatase 3, catalytic subunit, gamma isoform) | protein interactions | 19057 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Kdm4c (lysine (K)-specific demethylase 4C) | protein interactions | 76804 | 2 | 1 | 19454 | 50 |
GLIS3 |
5.134e-03 | -5.27 | Fbxo34 (F-box protein 34) | protein interactions | 78938 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | numb (numb) | protein interactions | 34263 | 2 | 1 | 19454 | 50 |
PRKCA |
5.134e-03 | -5.27 | Fkbp1a (FK506 binding protein 1a) | protein interactions | 14225 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Fkbp1b (FK506 binding protein 1b) | protein interactions | 14226 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Bmpr2 (bone morphogenetic protein receptor type 2) | protein interactions | 12168 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Mknk2 (MAP kinase-interacting serine/threonine kinase 2) | protein interactions | 17347 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.187e-03 | -5.26 | cyclic purine nucleotide metabolic process | biological process | GO:0052652 | 40 | 2 | 18204 | 49 |
ADCY2,RORA |
5.198e-03 | -5.26 | RDX (radixin) | protein interactions | 5962 | 272 | 4 | 19454 | 50 |
NEBL,MACF1,DST,ABLIM1 |
5.220e-03 | -5.26 | GRIA2 (glutamate ionotropic receptor AMPA type subunit 2) | protein interactions | 2891 | 42 | 2 | 19454 | 50 |
PRKCA,GPM6A |
5.238e-03 | -5.25 | EF_HAND_2 | prosite domains | PS50222 | 215 | 4 | 12186 | 40 |
RYR3,SPARCL1,DST,MACF1 |
5.299e-03 | -5.24 | histone H3T6 kinase activity | molecular function | GO:0035403 | 2 | 1 | 18094 | 48 |
PRKCA |
5.299e-03 | -5.24 | calcium,diacylglycerol-dependent serine/threonine kinase activity | molecular function | GO:0004698 | 2 | 1 | 18094 | 48 |
PRKCA |
5.302e-03 | -5.24 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 6 | 16828 | 49 |
FBXL7,RYR3,CTNND2,SLC4A4,ADCY2,NTRK2 |
5.312e-03 | -5.24 | SYNE3 (spectrin repeat containing nuclear envelope family member 3) | protein interactions | 161176 | 440 | 5 | 19454 | 50 |
SORBS1,ABLIM1,MACF1,GLI3,DST |
5.376e-03 | -5.23 | UDP-glucuronate metabolic process | biological process | GO:0046398 | 2 | 1 | 18204 | 49 |
CSGALNACT1 |
5.376e-03 | -5.23 | mammary gland specification | biological process | GO:0060594 | 2 | 1 | 18204 | 49 |
GLI3 |
5.376e-03 | -5.23 | positive regulation of dense core granule biogenesis | biological process | GO:2000707 | 2 | 1 | 18204 | 49 |
PRKCA |
5.376e-03 | -5.23 | larynx development | biological process | GO:0120224 | 2 | 1 | 18204 | 49 |
GLI3 |
5.376e-03 | -5.23 | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | biological process | GO:0021776 | 2 | 1 | 18204 | 49 |
GLI3 |
5.376e-03 | -5.23 | larynx morphogenesis | biological process | GO:0120223 | 2 | 1 | 18204 | 49 |
GLI3 |
5.376e-03 | -5.23 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | biological process | GO:0050653 | 2 | 1 | 18204 | 49 |
CSGALNACT1 |
5.377e-03 | -5.23 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 7 | 19108 | 49 |
SLC1A3,GPM6A,ATP1A2,ADCY2,CTNND2,BMPR1B,NTRK2 |
5.383e-03 | -5.22 | amino acid transport | biological process | GO:0006865 | 132 | 3 | 18204 | 49 |
SLC1A2,NTRK2,SLC1A3 |
5.392e-03 | -5.22 | Distrobrevin | interpro domains | IPR017432 | 2 | 1 | 18521 | 50 |
DTNA |
5.392e-03 | -5.22 | Osteonectin_CS | interpro domains | IPR001999 | 2 | 1 | 18521 | 50 |
SPARCL1 |
5.392e-03 | -5.22 | Formin_Cappuccino_subfam | interpro domains | IPR001265 | 2 | 1 | 18521 | 50 |
FMN2 |
5.392e-03 | -5.22 | MSI_RRM2 | interpro domains | IPR034126 | 2 | 1 | 18521 | 50 |
MSI2 |
5.392e-03 | -5.22 | Par3/HAL_N | interpro domains | IPR021922 | 2 | 1 | 18521 | 50 |
PARD3B |
5.392e-03 | -5.22 | Alpha_CARP_receptor-type | interpro domains | IPR041887 | 2 | 1 | 18521 | 50 |
PTPRZ1 |
5.394e-03 | -5.22 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 6 | 16828 | 49 |
CTNND2,RYR3,FBXL7,NTRK2,SLC4A4,ADCY2 |
5.422e-03 | -5.22 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 2081 | 13 | 16828 | 49 |
ATP1A2,SOX5,TNIK,NFIA,ADCY2,NTRK2,GLI3,PRKCA,BMPR1B,PTPRZ1,SLC4A4,PREX2,DTNA |
5.432e-03 | -5.22 | Ig_I-set | interpro domains | IPR013098 | 132 | 3 | 18521 | 50 |
NTM,LSAMP,NTRK2 |
5.440e-03 | -5.21 | sarcoplasmic reticulum membrane | cellular component | GO:0033017 | 43 | 2 | 19108 | 49 |
ITPR2,RYR3 |
5.443e-03 | -5.21 | cyclic nucleotide metabolic process | biological process | GO:0009187 | 41 | 2 | 18204 | 49 |
ADCY2,RORA |
5.443e-03 | -5.21 | cell-substrate junction assembly | biological process | GO:0007044 | 41 | 2 | 18204 | 49 |
SORBS1,DST |
5.462e-03 | -5.21 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 49 | 16828 | 49 |
SORBS1,DTNA,PAMR1,RYR3,GPC5,MSI2,PARD3B,ABLIM1,GLIS3,RFX4,ZBTB20,TPD52L1,NRG3,SLC4A4,FMN2,CTNND2,DPP10,RORA,GLI3,NTM,GPM6A,PREX2,TRPM3,NPAS3,MGAT4C,SLC1A2,FBXL7,NKAIN3,PTPRZ1,LSAMP,ADCY2,CDH20,NTRK2,PITPNC1,DST,SPARCL1,NHSL1,SOX5,TNIK,SLC1A3,NEBL,CSGALNACT1,MACF1,BMPR1B,NFIA,MAML2,PRKCA,ATP1A2,ITPR2 |
5.497e-03 | -5.20 | regulation of sequestering of calcium ion | biological process | GO:0051282 | 133 | 3 | 18204 | 49 |
RYR3,ITPR2,ATP1A2 |
5.500e-03 | -5.20 | Par3_HAL_N_term | pfam domains | PF12053 | 2 | 1 | 17795 | 49 |
PARD3B |
5.545e-03 | -5.19 | neutral L-amino acid transmembrane transporter activity | molecular function | GO:0015175 | 42 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
5.611e-03 | -5.18 | cytoskeleton organization | biological process | GO:0007010 | 1251 | 9 | 18204 | 49 |
CTNNA2,PARD3B,SORBS1,ABLIM1,FMN2,DST,NEBL,MACF1,TNIK |
5.623e-03 | -5.18 | Aldosterone-regulated sodium reabsorption | KEGG pathways | hsa04960 | 37 | 2 | 7161 | 22 |
ATP1A2,PRKCA |
5.623e-03 | -5.18 | Aldosterone-regulated sodium reabsorption | KEGG pathways | ko04960 | 37 | 2 | 7161 | 22 |
PRKCA,ATP1A2 |
5.731e-03 | -5.16 | I-set | pfam domains | PF07679 | 132 | 3 | 17795 | 49 |
NTM,NTRK2,LSAMP |
5.732e-03 | -5.16 | Vascular smooth muscle contraction | KEGG pathways | hsa04270 | 121 | 3 | 7161 | 22 |
ITPR2,ADCY2,PRKCA |
5.732e-03 | -5.16 | Vascular smooth muscle contraction | KEGG pathways | ko04270 | 121 | 3 | 7161 | 22 |
PRKCA,ADCY2,ITPR2 |
5.755e-03 | -5.16 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 47 | 16828 | 49 |
SORBS1,DTNA,GPC5,PAMR1,RYR3,MSI2,PARD3B,ABLIM1,SLC4A4,ZBTB20,GLIS3,TPD52L1,NRG3,FMN2,DPP10,CTNND2,RORA,GLI3,GPM6A,PREX2,MGAT4C,TRPM3,NPAS3,NKAIN3,SLC1A2,FBXL7,LSAMP,PTPRZ1,ADCY2,NTRK2,CDH20,SPARCL1,NHSL1,PITPNC1,DST,SLC1A3,SOX5,TNIK,NEBL,BMPR1B,CSGALNACT1,MACF1,MAML2,NFIA,PRKCA,ATP1A2,ITPR2 |
5.755e-03 | -5.16 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 47 | 16828 | 49 |
PTPRZ1,LSAMP,FBXL7,SLC1A2,NKAIN3,NPAS3,TRPM3,MGAT4C,GPM6A,PREX2,TNIK,SOX5,SLC1A3,DST,PITPNC1,NHSL1,SPARCL1,CDH20,NTRK2,ADCY2,MACF1,CSGALNACT1,BMPR1B,NEBL,ITPR2,ATP1A2,PRKCA,NFIA,MAML2,RYR3,PAMR1,GPC5,DTNA,SORBS1,ABLIM1,PARD3B,MSI2,CTNND2,DPP10,FMN2,NRG3,TPD52L1,ZBTB20,GLIS3,SLC4A4,GLI3,RORA |
5.767e-03 | -5.16 | sarcolemma | cellular component | GO:0042383 | 142 | 3 | 19108 | 49 |
ATP1A2,DTNA,RYR3 |
5.775e-03 | -5.15 | YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta) | protein interactions | 10971 | 1076 | 8 | 19454 | 50 |
NHSL1,DST,PRKCA,TPD52L1,ABLIM1,PARD3B,MACF1,SORBS1 |
5.797e-03 | -5.15 | Vinculin, Vh2 four-helix bundle | gene3d domains | 1.20.120.810 | 2 | 1 | 14470 | 42 |
CTNNA2 |
5.797e-03 | -5.15 | - | gene3d domains | 6.20.350.10 | 2 | 1 | 14470 | 42 |
RYR3 |
5.862e-03 | -5.14 | SH3 | prosite domains | PS50002 | 222 | 4 | 12186 | 40 |
SORBS1,MACF1,NEBL,DST |
5.885e-03 | -5.14 | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | 249 | 4 | 16828 | 49 |
GLIS3,PTPRZ1,MACF1,MGAT4C |
5.890e-03 | -5.13 | response to wounding | biological process | GO:0009611 | 431 | 5 | 18204 | 49 |
NFIA,DST,MACF1,SLC1A3,SLC1A2 |
5.935e-03 | -5.13 | active monoatomic ion transmembrane transporter activity | molecular function | GO:0022853 | 274 | 4 | 18094 | 48 |
ATP1A2,SLC1A2,SLC4A4,SLC1A3 |
5.968e-03 | -5.12 | small_intestine | COSMIC cancer mutations | small_intestine | 250 | 4 | 16828 | 49 |
MGAT4C,CSGALNACT1,TNIK,MACF1 |
5.974e-03 | -5.12 | cell-substrate junction organization | biological process | GO:0150115 | 43 | 2 | 18204 | 49 |
DST,SORBS1 |
5.994e-03 | -5.12 | I band | cellular component | GO:0031674 | 144 | 3 | 19108 | 49 |
DST,NEBL,RYR3 |
6.088e-03 | -5.10 | regulation of generation of precursor metabolites and energy | biological process | GO:0043467 | 138 | 3 | 18204 | 49 |
SLC4A4,SORBS1,ZBTB20 |
6.107e-03 | -5.10 | axon | cellular component | GO:0030424 | 650 | 6 | 19108 | 49 |
GPM6A,SLC1A2,DST,CTNNA2,NTRK2,DTNA |
6.174e-03 | -5.09 | vascular process in circulatory system | biological process | GO:0003018 | 273 | 4 | 18204 | 49 |
SLC1A3,SLC1A2,ATP1A2,SLC4A4 |
6.247e-03 | -5.08 | positive regulation of glucose transmembrane transport | biological process | GO:0010828 | 44 | 2 | 18204 | 49 |
SORBS1,SLC1A2 |
6.247e-03 | -5.08 | mammary gland morphogenesis | biological process | GO:0060443 | 44 | 2 | 18204 | 49 |
NRG3,GLI3 |
6.272e-03 | -5.07 | DSCR9 (Down syndrome critical region 9) | protein interactions | 257203 | 146 | 3 | 19454 | 50 |
SPARCL1,MACF1,DST |
6.281e-03 | -5.07 | animal organ development | biological process | GO:0048513 | 2846 | 15 | 18204 | 49 |
RORA,NRG3,CSGALNACT1,SOX5,GLI3,ATP1A2,NTRK2,CTNNA2,BMPR1B,NEBL,GPM6A,RFX4,ABLIM1,SLC1A2,NFIA |
6.286e-03 | -5.07 | CCDC8 (coiled-coil domain containing 8) | protein interactions | 83987 | 652 | 6 | 19454 | 50 |
NTRK2,ABLIM1,PRKCA,MACF1,DST,ITPR2 |
6.334e-03 | -5.06 | gliogenesis | biological process | GO:0042063 | 275 | 4 | 18204 | 49 |
NFIA,NTRK2,GLI3,PTPRZ1 |
6.335e-03 | -5.06 | neurotransmitter transport | biological process | GO:0006836 | 140 | 3 | 18204 | 49 |
ATP1A2,SLC1A2,SLC1A3 |
6.348e-03 | -5.06 | VASP (vasodilator stimulated phosphoprotein) | protein interactions | 7408 | 288 | 4 | 19454 | 50 |
SORBS1,NEBL,FMN2,NHSL1 |
6.368e-03 | -5.06 | prostate-adenoma | COSMIC cancer mutations | prostate-adenoma | 1634 | 11 | 16828 | 49 |
GPC5,MACF1,PTPRZ1,NPAS3,TRPM3,NEBL,ZBTB20,SOX5,DST,PRKCA,GLI3 |
6.416e-03 | -5.05 | cellular response to oxygen-containing compound | biological process | GO:1901701 | 1047 | 8 | 18204 | 49 |
ITPR2,SLC1A2,ZBTB20,ADCY2,SORBS1,SLC1A3,RORA,RYR3 |
6.441e-03 | -5.05 | membrane raft | cellular component | GO:0045121 | 290 | 4 | 19108 | 49 |
ATP1A2,SORBS1,ADCY2,SLC1A2 |
6.500e-03 | -5.04 | CNTN1 (contactin 1) | protein interactions | 1272 | 47 | 2 | 19454 | 50 |
GPM6A,PTPRZ1 |
6.500e-03 | -5.04 | PTGER4 (prostaglandin E receptor 4) | protein interactions | 5734 | 47 | 2 | 19454 | 50 |
CTNND2,DST |
6.554e-03 | -5.03 | OSTEONECTIN_1 | prosite domains | PS00612 | 2 | 1 | 12186 | 40 |
SPARCL1 |
6.554e-03 | -5.03 | OSTEONECTIN_2 | prosite domains | PS00613 | 2 | 1 | 12186 | 40 |
SPARCL1 |
6.588e-03 | -5.02 | monoatomic anion transmembrane transport | biological process | GO:0098656 | 142 | 3 | 18204 | 49 |
SLC1A3,SLC1A2,SLC4A4 |
6.588e-03 | -5.02 | positive regulation of small molecule metabolic process | biological process | GO:0062013 | 142 | 3 | 18204 | 49 |
SORBS1,ZBTB20,SLC4A4 |
6.597e-03 | -5.02 | membrane microdomain | cellular component | GO:0098857 | 292 | 4 | 19108 | 49 |
SLC1A2,ATP1A2,SORBS1,ADCY2 |
6.634e-03 | -5.02 | GSE1 (Gse1 coiled-coil protein) | protein interactions | 23199 | 149 | 3 | 19454 | 50 |
SOX5,TNIK,NFIA |
6.646e-03 | -5.01 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 15 | 16828 | 49 |
MAML2,CDH20,DST,ATP1A2,SOX5,SLC1A3,NRG3,PREX2,NEBL,MGAT4C,CTNND2,PTPRZ1,RYR3,DPP10,LSAMP |
6.691e-03 | -5.01 | Signaling by Hedgehog | REACTOME pathways | R-HSA-5358351 | 138 | 3 | 10285 | 29 |
GPC5,GLI3,ADCY2 |
6.757e-03 | -5.00 | KDM2B (lysine demethylase 2B) | protein interactions | 84678 | 150 | 3 | 19454 | 50 |
NFIA,GLI3,SOX5 |
6.881e-03 | -4.98 | TNIK (TRAF2 and NCK interacting kinase) | protein interactions | 23043 | 151 | 3 | 19454 | 50 |
MACF1,DST,TNIK |
6.941e-03 | -4.97 | lung-carcinoma-bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-bronchioloalveolar_adenocarcinoma | 778 | 7 | 16828 | 49 |
BMPR1B,TNIK,SOX5,CTNND2,NTRK2,PRKCA,ADCY2 |
6.941e-03 | -4.97 | bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | bronchioloalveolar_adenocarcinoma | 778 | 7 | 16828 | 49 |
BMPR1B,SOX5,CTNND2,TNIK,ADCY2,NTRK2,PRKCA |
7.009e-03 | -4.96 | response to organic cyclic compound | biological process | GO:0014070 | 843 | 7 | 18204 | 49 |
ITPR2,ATP1A2,SLC1A2,ADCY2,SLC1A3,RORA,RYR3 |
7.087e-03 | -4.95 | symporter activity | molecular function | GO:0015293 | 148 | 3 | 18094 | 48 |
SLC1A2,SLC4A4,SLC1A3 |
7.103e-03 | -4.95 | regulation of neuron migration | biological process | GO:2001222 | 47 | 2 | 18204 | 49 |
NRG3,CTNNA2 |
7.111e-03 | -4.95 | mitotic cell cycle phase transition | biological process | GO:0044772 | 146 | 3 | 18204 | 49 |
FBXL7,TPD52L1,NFIA |
7.111e-03 | -4.95 | adult behavior | biological process | GO:0030534 | 146 | 3 | 18204 | 49 |
ATP1A2,PREX2,SLC1A2 |
7.119e-03 | -4.94 | oligoastrocytoma_Grade_III | COSMIC cancer mutations | oligoastrocytoma_Grade_III | 263 | 4 | 16828 | 49 |
SOX5,RYR3,SLC1A2,PREX2 |
7.240e-03 | -4.93 | Cardiac conduction | REACTOME pathways | R-HSA-5576891 | 142 | 3 | 10285 | 29 |
ITPR2,RYR3,ATP1A2 |
7.257e-03 | -4.93 | FORMIN | prints domains | PR00828 | 2 | 1 | 5227 | 19 |
FMN2 |
7.364e-03 | -4.91 | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | 2414 | 14 | 16828 | 49 |
SLC1A3,SPARCL1,NHSL1,CDH20,PARD3B,NFIA,PAMR1,RYR3,MACF1,FMN2,TRPM3,NPAS3,PREX2,SORBS1 |
7.364e-03 | -4.91 | alveolar | COSMIC cancer mutations | alveolar | 2414 | 14 | 16828 | 49 |
CDH20,PARD3B,NFIA,SLC1A3,NHSL1,SPARCL1,NPAS3,TRPM3,SORBS1,PREX2,RYR3,MACF1,PAMR1,FMN2 |
7.404e-03 | -4.91 | large_intestine-adenoma | COSMIC cancer mutations | large_intestine-adenoma | 266 | 4 | 16828 | 49 |
SOX5,RYR3,CDH20,GLI3 |
7.572e-03 | -4.88 | positive regulation of cell development | biological process | GO:0010720 | 458 | 5 | 18204 | 49 |
NTRK2,GLI3,PTPRZ1,PRKCA,MACF1 |
7.592e-03 | -4.88 | haematopoietic_and_lymphoid_tissue-small_intestine-lymphoid_neoplasm-enteropathy_type_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-small_intestine-lymphoid_neoplasm-enteropathy_type_T_cell_lymphoma | 45 | 2 | 16828 | 49 |
MGAT4C,MACF1 |
7.592e-03 | -4.88 | enteropathy_type_T_cell_lymphoma | COSMIC cancer mutations | enteropathy_type_T_cell_lymphoma | 45 | 2 | 16828 | 49 |
MACF1,MGAT4C |
7.607e-03 | -4.88 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 24 | 18204 | 49 |
SLC1A2,NFIA,SORBS1,PTPRZ1,NPAS3,GLIS3,TPD52L1,GPM6A,RFX4,MACF1,PRKCA,SOX5,GLI3,NTRK2,MAML2,FMN2,DPP10,SLC4A4,BMPR1B,ZBTB20,SLC1A3,RORA,TNIK,GPC5 |
7.617e-03 | -4.88 | Ndc80 (NDC80 kinetochore complex component) | protein interactions | 67052 | 51 | 2 | 19454 | 50 |
NHSL1,MACF1 |
7.647e-03 | -4.87 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | 1440 | 10 | 16828 | 49 |
CDH20,PREX2,RFX4,NEBL,MACF1,RYR3,CTNND2,PTPRZ1,DST,FMN2 |
7.647e-03 | -4.87 | hairy_cell_leukaemia | COSMIC cancer mutations | hairy_cell_leukaemia | 1440 | 10 | 16828 | 49 |
FMN2,DST,MACF1,RYR3,CTNND2,PTPRZ1,NEBL,PREX2,RFX4,CDH20 |
7.674e-03 | -4.87 | alphav-beta3 integrin-PKCalpha complex | cellular component | GO:0035866 | 3 | 1 | 19108 | 49 |
PRKCA |
7.691e-03 | -4.87 | Stk35 (serine/threonine kinase 35) | protein interactions | 67333 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | BCO1 (beta-carotene oxygenase 1) | protein interactions | 53630 | 3 | 1 | 19454 | 50 |
ABLIM1 |
7.691e-03 | -4.87 | Usp45 (ubiquitin specific petidase 45) | protein interactions | 77593 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Shh (sonic hedgehog) | protein interactions | 20423 | 3 | 1 | 19454 | 50 |
GLI3 |
7.691e-03 | -4.87 | Rap2a (RAS related protein 2a) | protein interactions | 76108 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | IL34 (interleukin 34) | protein interactions | 146433 | 3 | 1 | 19454 | 50 |
PTPRZ1 |
7.691e-03 | -4.87 | Chn1 (chimerin 1) | protein interactions | 108699 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Smad6 (SMAD family member 6) | protein interactions | 17130 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Spop (speckle-type BTB/POZ protein) | protein interactions | 20747 | 3 | 1 | 19454 | 50 |
GLIS3 |
7.691e-03 | -4.87 | Fbxw5 (F-box and WD-40 domain protein 5) | protein interactions | 30839 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Grm5 (glutamate metabotropic receptor 5) | protein interactions | 24418 | 3 | 1 | 19454 | 50 |
PRKCA |
7.691e-03 | -4.87 | Atg16l1 (autophagy related 16 like 1) | protein interactions | 77040 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Plekhb1 (pleckstrin homology domain containing, family B (evectins) member 1) | protein interactions | 27276 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | QRFPR (pyroglutamylated RFamide peptide receptor) | protein interactions | 84109 | 3 | 1 | 19454 | 50 |
NTM |
7.700e-03 | -4.87 | G2/M transition of mitotic cell cycle | biological process | GO:0000086 | 49 | 2 | 18204 | 49 |
FBXL7,TPD52L1 |
7.720e-03 | -4.86 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 10 | 16828 | 49 |
CTNND2,RYR3,TNIK,LSAMP,GPC5,DST,FMN2,TRPM3,SORBS1,SLC4A4 |
7.762e-03 | -4.86 | anchoring junction | cellular component | GO:0070161 | 902 | 7 | 19108 | 49 |
CTNND2,CTNNA2,PARD3B,ATP1A2,SORBS1,CDH20,DST |
7.800e-03 | -4.85 | abdomen | COSMIC cancer mutations | abdomen | 603 | 6 | 16828 | 49 |
FMN2,DST,PREX2,DPP10,CTNND2,ITPR2 |
7.909e-03 | -4.84 | SH2B2 (SH2B adaptor protein 2) | protein interactions | 10603 | 52 | 2 | 19454 | 50 |
NTRK2,SORBS1 |
7.923e-03 | -4.84 | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-follicular_lymphoma | 46 | 2 | 16828 | 49 |
ITPR2,DPP10 |
7.928e-03 | -4.84 | DTNBP1 (dystrobrevin binding protein 1) | protein interactions | 84062 | 159 | 3 | 19454 | 50 |
DST,MACF1,DTNA |
7.938e-03 | -4.84 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | molecular function | GO:0008454 | 3 | 1 | 18094 | 48 |
MGAT4C |
7.938e-03 | -4.84 | cysteine transmembrane transporter activity | molecular function | GO:0033229 | 3 | 1 | 18094 | 48 |
SLC1A2 |
7.938e-03 | -4.84 | inositol 1,4,5-trisphosphate-gated calcium channel activity | molecular function | GO:0005220 | 3 | 1 | 18094 | 48 |
ITPR2 |
7.938e-03 | -4.84 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | molecular function | GO:0047237 | 3 | 1 | 18094 | 48 |
CSGALNACT1 |
7.991e-03 | -4.83 | G alpha (z) signalling events | REACTOME pathways | R-HSA-418597 | 48 | 2 | 10285 | 29 |
ADCY2,PRKCA |
8.054e-03 | -4.82 | regulation of calcium:sodium antiporter activity | biological process | GO:1903279 | 3 | 1 | 18204 | 49 |
ATP1A2 |
8.054e-03 | -4.82 | meiotic chromosome movement towards spindle pole | biological process | GO:0016344 | 3 | 1 | 18204 | 49 |
FMN2 |
8.054e-03 | -4.82 | radial glia guided migration of Purkinje cell | biological process | GO:0021942 | 3 | 1 | 18204 | 49 |
CTNNA2 |
8.054e-03 | -4.82 | mammary placode formation | biological process | GO:0060596 | 3 | 1 | 18204 | 49 |
NRG3 |
8.054e-03 | -4.82 | cysteine transport | biological process | GO:0042883 | 3 | 1 | 18204 | 49 |
SLC1A2 |
8.054e-03 | -4.82 | formin-nucleated actin cable assembly | biological process | GO:0070649 | 3 | 1 | 18204 | 49 |
FMN2 |
8.054e-03 | -4.82 | smoothened signaling pathway involved in ventral spinal cord patterning | biological process | GO:0021910 | 3 | 1 | 18204 | 49 |
GLI3 |
8.054e-03 | -4.82 | regulation of dense core granule biogenesis | biological process | GO:2000705 | 3 | 1 | 18204 | 49 |
PRKCA |
8.054e-03 | -4.82 | nose morphogenesis | biological process | GO:0043585 | 3 | 1 | 18204 | 49 |
GLI3 |
8.054e-03 | -4.82 | trans-synaptic signaling by BDNF, modulating synaptic transmission | biological process | GO:0099183 | 3 | 1 | 18204 | 49 |
NTRK2 |
8.054e-03 | -4.82 | formin-nucleated actin cable organization | biological process | GO:0110009 | 3 | 1 | 18204 | 49 |
FMN2 |
8.054e-03 | -4.82 | smoothened signaling pathway involved in ventral spinal cord interneuron specification | biological process | GO:0021775 | 3 | 1 | 18204 | 49 |
GLI3 |
8.054e-03 | -4.82 | cysteine transmembrane transport | biological process | GO:1903712 | 3 | 1 | 18204 | 49 |
SLC1A2 |
8.054e-03 | -4.82 | UDP-N-acetylgalactosamine metabolic process | biological process | GO:0019276 | 3 | 1 | 18204 | 49 |
CSGALNACT1 |
8.054e-03 | -4.82 | cardiac muscle thin filament assembly | biological process | GO:0071691 | 3 | 1 | 18204 | 49 |
NEBL |
8.078e-03 | -4.82 | SPRY3_RyR | interpro domains | IPR035762 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | NTRK_LRRCT | interpro domains | IPR031635 | 3 | 1 | 18521 | 50 |
NTRK2 |
8.078e-03 | -4.82 | Myelin_PLP_CS | interpro domains | IPR018237 | 3 | 1 | 18521 | 50 |
GPM6A |
8.078e-03 | -4.82 | SPRY2_RyR | interpro domains | IPR035764 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | NTRK | interpro domains | IPR020777 | 3 | 1 | 18521 | 50 |
NTRK2 |
8.078e-03 | -4.82 | RYDR_Jsol | interpro domains | IPR048581 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Mastermind-like_N | interpro domains | IPR019082 | 3 | 1 | 18521 | 50 |
MAML2 |
8.078e-03 | -4.82 | MAML1-3 | interpro domains | IPR046369 | 3 | 1 | 18521 | 50 |
MAML2 |
8.078e-03 | -4.82 | SPRY1_RyR | interpro domains | IPR035761 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Protein_kinase_C_a/b/g | interpro domains | IPR014375 | 3 | 1 | 18521 | 50 |
PRKCA |
8.078e-03 | -4.82 | Vinculin_CS | interpro domains | IPR000633 | 3 | 1 | 18521 | 50 |
CTNNA2 |
8.078e-03 | -4.82 | Ryanodine_rcpt | interpro domains | IPR003032 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | ROR_rcpt | interpro domains | IPR003079 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | MAML_N_sf | interpro domains | IPR046370 | 3 | 1 | 18521 | 50 |
MAML2 |
8.078e-03 | -4.82 | Myelin_PLP | interpro domains | IPR001614 | 3 | 1 | 18521 | 50 |
GPM6A |
8.078e-03 | -4.82 | NR_DBD_ROR | interpro domains | IPR044101 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | Neuregulin | interpro domains | IPR040180 | 3 | 1 | 18521 | 50 |
NRG3 |
8.078e-03 | -4.82 | InsP3_rcpt | interpro domains | IPR000493 | 3 | 1 | 18521 | 50 |
ITPR2 |
8.078e-03 | -4.82 | Ryanrecept_TM4-6 | interpro domains | IPR009460 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | SoHo_dom | interpro domains | IPR003127 | 3 | 1 | 18521 | 50 |
SORBS1 |
8.078e-03 | -4.82 | Ryan_recept | interpro domains | IPR013333 | 3 | 1 | 18521 | 50 |
RYR3 |
8.100e-03 | -4.82 | AFDN (afadin, adherens junction formation factor) | protein interactions | 4301 | 309 | 4 | 19454 | 50 |
MACF1,DST,SORBS1,DTNA |
8.124e-03 | -4.81 | neuronal cell body | cellular component | GO:0043025 | 489 | 5 | 19108 | 49 |
SLC1A3,CTNND2,GPM6A,ATP1A2,BMPR1B |
8.135e-03 | -4.81 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 47 | 16828 | 49 |
MGAT4C,TRPM3,NPAS3,NTM,PREX2,GPM6A,LSAMP,PTPRZ1,SLC1A2,FBXL7,NTRK2,CDH20,ADCY2,SLC1A3,SOX5,TNIK,SPARCL1,PITPNC1,DST,NEBL,BMPR1B,CSGALNACT1,MACF1,PRKCA,MAML2,NFIA,ITPR2,ATP1A2,DTNA,SORBS1,GPC5,PAMR1,RYR3,PARD3B,MSI2,ABLIM1,SLC4A4,GLIS3,RFX4,ZBTB20,TPD52L1,NRG3,DPP10,CTNND2,FMN2,GLI3,RORA |
8.172e-03 | -4.81 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 4 | 18204 | 49 |
NTRK2,PTPRZ1,GLI3,MACF1 |
8.206e-03 | -4.80 | MAL2 (mal, T cell differentiation protein 2) | protein interactions | 114569 | 53 | 2 | 19454 | 50 |
PITPNC1,TPD52L1 |
8.230e-03 | -4.80 | calcium-mediated signaling | biological process | GO:0019722 | 154 | 3 | 18204 | 49 |
ITPR2,ATP1A2,RYR3 |
8.238e-03 | -4.80 | RR_TM4-6 | pfam domains | PF06459 | 3 | 1 | 17795 | 49 |
RYR3 |
8.238e-03 | -4.80 | Sorb | pfam domains | PF02208 | 3 | 1 | 17795 | 49 |
SORBS1 |
8.238e-03 | -4.80 | MamL-1 | pfam domains | PF09596 | 3 | 1 | 17795 | 49 |
MAML2 |
8.238e-03 | -4.80 | RyR | pfam domains | PF02026 | 3 | 1 | 17795 | 49 |
RYR3 |
8.238e-03 | -4.80 | LRRCT_2 | pfam domains | PF16920 | 3 | 1 | 17795 | 49 |
NTRK2 |
8.238e-03 | -4.80 | RYDR_Jsol | pfam domains | PF21119 | 3 | 1 | 17795 | 49 |
RYR3 |
8.238e-03 | -4.80 | Myelin_PLP | pfam domains | PF01275 | 3 | 1 | 17795 | 49 |
GPM6A |
8.244e-03 | -4.80 | transmembrane transporter activity | molecular function | GO:0022857 | 1110 | 8 | 18094 | 48 |
ITPR2,TRPM3,ATP1A2,GPM6A,SLC1A2,SLC4A4,RYR3,SLC1A3 |
8.247e-03 | -4.80 | Apelin signaling pathway | KEGG pathways | hsa04371 | 138 | 3 | 7161 | 22 |
ITPR2,ADCY2,RYR3 |
8.387e-03 | -4.78 | cell cortex | cellular component | GO:0005938 | 313 | 4 | 19108 | 49 |
ITPR2,PARD3B,FMN2,DST |
8.436e-03 | -4.78 | GLI proteins bind promoters of Hh responsive genes to promote transcription | REACTOME pathways | R-HSA-5635851 | 3 | 1 | 10285 | 29 |
GLI3 |
8.476e-03 | -4.77 | integrin binding | molecular function | GO:0005178 | 158 | 3 | 18094 | 48 |
PRKCA,PTPRZ1,DST |
8.638e-03 | -4.75 | regulation of purine nucleotide catabolic process | biological process | GO:0033121 | 52 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
8.638e-03 | -4.75 | regulation of glycolytic process | biological process | GO:0006110 | 52 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
8.638e-03 | -4.75 | regulation of nucleotide catabolic process | biological process | GO:0030811 | 52 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
8.683e-03 | -4.75 | - | gene3d domains | 1.10.490.160 | 3 | 1 | 14470 | 42 |
RYR3 |
8.683e-03 | -4.75 | - | gene3d domains | 6.10.250.2510 | 3 | 1 | 14470 | 42 |
CTNNA2 |
8.683e-03 | -4.75 | - | gene3d domains | 6.10.250.970 | 3 | 1 | 14470 | 42 |
MAML2 |
8.748e-03 | -4.74 | ZYX (zyxin) | protein interactions | 7791 | 316 | 4 | 19454 | 50 |
NEBL,ABLIM1,SORBS1,MACF1 |
8.917e-03 | -4.72 | SCLT1 (sodium channel and clathrin linker 1) | protein interactions | 132320 | 166 | 3 | 19454 | 50 |
NEBL,ATP1A2,ABLIM1 |
8.959e-03 | -4.72 | Endocrine and other factor-regulated calcium reabsorption | KEGG pathways | ko04961 | 47 | 2 | 7161 | 22 |
PRKCA,ATP1A2 |
8.959e-03 | -4.72 | Endocrine and other factor-regulated calcium reabsorption | KEGG pathways | hsa04961 | 47 | 2 | 7161 | 22 |
PRKCA,ATP1A2 |
8.962e-03 | -4.71 | neutral amino acid transport | biological process | GO:0015804 | 53 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
8.979e-03 | -4.71 | cell cycle phase transition | biological process | GO:0044770 | 159 | 3 | 18204 | 49 |
TPD52L1,FBXL7,NFIA |
8.979e-03 | -4.71 | monoatomic anion transport | biological process | GO:0006820 | 159 | 3 | 18204 | 49 |
SLC4A4,SLC1A2,SLC1A3 |
8.986e-03 | -4.71 | Chondroitin sulfate/dermatan sulfate metabolism | REACTOME pathways | R-HSA-1793185 | 51 | 2 | 10285 | 29 |
GPC5,CSGALNACT1 |
8.986e-03 | -4.71 | Signaling by ERBB2 | REACTOME pathways | R-HSA-1227986 | 51 | 2 | 10285 | 29 |
PRKCA,NRG3 |
8.986e-03 | -4.71 | Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-112310 | 51 | 2 | 10285 | 29 |
SLC1A2,SLC1A3 |
9.015e-03 | -4.71 | calcium ion binding | molecular function | GO:0005509 | 683 | 6 | 18094 | 48 |
ITPR2,PAMR1,SPARCL1,DST,RYR3,MACF1 |
9.231e-03 | -4.69 | ACTA1 (actin alpha 1, skeletal muscle) | protein interactions | 58 | 321 | 4 | 19454 | 50 |
MACF1,PRKCA,SORBS1,DTNA |
9.268e-03 | -4.68 | Adrenergic signaling in cardiomyocytes | KEGG pathways | ko04261 | 144 | 3 | 7161 | 22 |
PRKCA,ADCY2,ATP1A2 |
9.268e-03 | -4.68 | Adrenergic signaling in cardiomyocytes | KEGG pathways | hsa04261 | 144 | 3 | 7161 | 22 |
ADCY2,ATP1A2,PRKCA |
9.290e-03 | -4.68 | cell cycle G2/M phase transition | biological process | GO:0044839 | 54 | 2 | 18204 | 49 |
FBXL7,TPD52L1 |
9.621e-03 | -4.64 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 47 | 16828 | 49 |
NEBL,BMPR1B,MACF1,CSGALNACT1,MAML2,NFIA,PRKCA,ATP1A2,ITPR2,GPM6A,PREX2,NTM,MGAT4C,NPAS3,TRPM3,FBXL7,SLC1A2,LSAMP,PTPRZ1,ADCY2,NTRK2,CDH20,SPARCL1,DST,PITPNC1,SLC1A3,TNIK,SOX5,SLC4A4,NRG3,TPD52L1,ZBTB20,RFX4,GLIS3,FMN2,DPP10,CTNND2,RORA,GLI3,SORBS1,DTNA,GPC5,RYR3,PAMR1,MSI2,PARD3B,ABLIM1 |
9.621e-03 | -4.64 | bladder | COSMIC cancer mutations | bladder | 14112 | 47 | 16828 | 49 |
SLC4A4,RFX4,GLIS3,ZBTB20,TPD52L1,NRG3,DPP10,CTNND2,FMN2,GLI3,RORA,DTNA,SORBS1,GPC5,PAMR1,RYR3,PARD3B,MSI2,ABLIM1,NEBL,BMPR1B,CSGALNACT1,MACF1,PRKCA,MAML2,NFIA,ITPR2,ATP1A2,MGAT4C,TRPM3,NPAS3,NTM,GPM6A,PREX2,LSAMP,PTPRZ1,SLC1A2,FBXL7,NTRK2,CDH20,ADCY2,SLC1A3,SOX5,TNIK,SPARCL1,PITPNC1,DST |
9.625e-03 | -4.64 | response to cocaine | biological process | GO:0042220 | 55 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
9.634e-03 | -4.64 | biliary_tract | COSMIC cancer mutations | biliary_tract | 15309 | 49 | 16828 | 49 |
NFIA,MAML2,PRKCA,ATP1A2,ITPR2,NEBL,CSGALNACT1,MACF1,BMPR1B,ADCY2,CDH20,NTRK2,PITPNC1,DST,SPARCL1,NHSL1,SOX5,TNIK,SLC1A3,NTM,GPM6A,PREX2,TRPM3,NPAS3,MGAT4C,SLC1A2,FBXL7,NKAIN3,PTPRZ1,LSAMP,RORA,GLI3,GLIS3,RFX4,ZBTB20,NRG3,TPD52L1,SLC4A4,FMN2,CTNND2,DPP10,MSI2,PARD3B,ABLIM1,SORBS1,DTNA,PAMR1,RYR3,GPC5 |
9.634e-03 | -4.64 | LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1) | protein interactions | 55004 | 714 | 6 | 19454 | 50 |
TPD52L1,SLC1A3,DST,FMN2,DTNA,TNIK |
9.670e-03 | -4.64 | haematopoietic_and_lymphoid_tissue-tonsil-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-tonsil-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 51 | 2 | 16828 | 49 |
ITPR2,DPP10 |
9.751e-03 | -4.63 | dendritic spine | cellular component | GO:0043197 | 172 | 3 | 19108 | 49 |
NTRK2,ATP1A2,GPM6A |
9.763e-03 | -4.63 | SNAP25 (synaptosome associated protein 25) | protein interactions | 6616 | 58 | 2 | 19454 | 50 |
PRKCA,GPM6A |
9.816e-03 | -4.62 | VINCULIN_1 | prosite domains | PS00663 | 3 | 1 | 12186 | 40 |
CTNNA2 |
9.816e-03 | -4.62 | MYELIN_PLP_2 | prosite domains | PS01004 | 3 | 1 | 12186 | 40 |
GPM6A |
9.816e-03 | -4.62 | MYELIN_PLP_1 | prosite domains | PS00575 | 3 | 1 | 12186 | 40 |
GPM6A |
9.816e-03 | -4.62 | SOHO | prosite domains | PS50831 | 3 | 1 | 12186 | 40 |
SORBS1 |
9.914e-03 | -4.61 | Signalling by NGF | REACTOME pathways | R-HSA-166520 | 477 | 5 | 10285 | 29 |
NTRK2,NRG3,ITPR2,ADCY2,PRKCA |
9.929e-03 | -4.61 | import across plasma membrane | biological process | GO:0098739 | 165 | 3 | 18204 | 49 |
SLC1A3,SLC1A2,ATP1A2 |
9.950e-03 | -4.61 | CAV1 (caveolin 1) | protein interactions | 857 | 719 | 6 | 19454 | 50 |
DST,MACF1,SLC1A3,TNIK,DTNA,FMN2 |
9.964e-03 | -4.61 | release of sequestered calcium ion into cytosol | biological process | GO:0051209 | 56 | 2 | 18204 | 49 |
ITPR2,RYR3 |
1.006e-02 | -4.60 | neuron spine | cellular component | GO:0044309 | 174 | 3 | 19108 | 49 |
ATP1A2,GPM6A,NTRK2 |
1.009e-02 | -4.60 | HTATIP2 (HIV-1 Tat interactive protein 2) | protein interactions | 10553 | 59 | 2 | 19454 | 50 |
PRKCA,PITPNC1 |
1.013e-02 | -4.59 | APPL1 (adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1) | protein interactions | 26060 | 174 | 3 | 19454 | 50 |
DST,NTRK2,DTNA |
1.022e-02 | -4.58 | extrinsic component of membrane | cellular component | GO:0019898 | 175 | 3 | 19108 | 49 |
DTNA,CDH20,CTNNA2 |
1.022e-02 | -4.58 | GLI-SUFU complex | cellular component | GO:1990788 | 4 | 1 | 19108 | 49 |
GLI3 |
1.023e-02 | -4.58 | positive regulation of cell differentiation | biological process | GO:0045597 | 906 | 7 | 18204 | 49 |
MACF1,PTPRZ1,BMPR1B,PRKCA,SOX5,GLI3,NTRK2 |
1.024e-02 | -4.58 | Cdk14 (cyclin dependent kinase 14) | protein interactions | 18647 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Nkiras1 (NFKB inhibitor interacting Ras-like protein 1) | protein interactions | 69721 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Rhebl1 (Ras homolog enriched in brain like 1) | protein interactions | 69159 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Nme2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 18103 | 4 | 1 | 19454 | 50 |
RORA |
1.024e-02 | -4.58 | CCDC126 (coiled-coil domain containing 126) | protein interactions | 90693 | 4 | 1 | 19454 | 50 |
GPM6A |
1.024e-02 | -4.58 | Srgap1 (SLIT-ROBO Rho GTPase activating protein 1) | protein interactions | 117600 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Dnaja1 (DnaJ heat shock protein family (Hsp40) member A1) | protein interactions | 15502 | 4 | 1 | 19454 | 50 |
GLIS3 |
1.024e-02 | -4.58 | Naa20 (N(alpha)-acetyltransferase 20, NatB catalytic subunit) | protein interactions | 67877 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Pick1 (protein interacting with PRKCA 1) | protein interactions | 84591 | 4 | 1 | 19454 | 50 |
PRKCA |
1.024e-02 | -4.58 | Sufu (SUFU negative regulator of hedgehog signaling) | protein interactions | 24069 | 4 | 1 | 19454 | 50 |
GLI3 |
1.024e-02 | -4.58 | Tpd52 (tumor protein D52) | protein interactions | 21985 | 4 | 1 | 19454 | 50 |
TPD52L1 |
1.024e-02 | -4.58 | Arhgef6 (Rac/Cdc42 guanine nucleotide exchange factor 6) | protein interactions | 73341 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Ilkap (integrin-linked kinase-associated serine/threonine phosphatase 2C) | protein interactions | 67444 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | AVPR1A (arginine vasopressin receptor 1A) | protein interactions | 552 | 4 | 1 | 19454 | 50 |
PRKCA |
1.031e-02 | -4.57 | neuroblast proliferation | biological process | GO:0007405 | 57 | 2 | 18204 | 49 |
GLI3,SOX5 |
1.031e-02 | -4.57 | visual behavior | biological process | GO:0007632 | 57 | 2 | 18204 | 49 |
SLC1A2,ATP1A2 |
1.031e-02 | -4.57 | negative regulation of sequestering of calcium ion | biological process | GO:0051283 | 57 | 2 | 18204 | 49 |
ITPR2,RYR3 |
1.037e-02 | -4.57 | cellular component biogenesis | biological process | GO:0044085 | 2716 | 14 | 18204 | 49 |
TNIK,NRG3,TRPM3,RYR3,DST,FMN2,PRKCA,CDH20,RFX4,NEBL,GPM6A,SLC1A2,ABLIM1,SORBS1 |
1.057e-02 | -4.55 | brain-derived neurotrophic factor binding | molecular function | GO:0048403 | 4 | 1 | 18094 | 48 |
NTRK2 |
1.057e-02 | -4.55 | mediator complex binding | molecular function | GO:0036033 | 4 | 1 | 18094 | 48 |
GLI3 |
1.057e-02 | -4.55 | ryanodine-sensitive calcium-release channel activity | molecular function | GO:0005219 | 4 | 1 | 18094 | 48 |
RYR3 |
1.065e-02 | -4.54 | ovary-other-neoplasm | COSMIC cancer mutations | ovary-other-neoplasm | 12717 | 44 | 16828 | 49 |
BMPR1B,MACF1,CSGALNACT1,NEBL,ATP1A2,ITPR2,MAML2,PRKCA,NKAIN3,FBXL7,SLC1A2,LSAMP,GPM6A,PREX2,NTM,MGAT4C,TRPM3,NHSL1,SPARCL1,DST,SLC1A3,TNIK,SOX5,ADCY2,NTRK2,CDH20,FMN2,DPP10,CTNND2,SLC4A4,NRG3,TPD52L1,RFX4,GLIS3,ZBTB20,RORA,GLI3,GPC5,RYR3,PAMR1,SORBS1,ABLIM1,MSI2,PARD3B |
1.072e-02 | -4.54 | frontal suture morphogenesis | biological process | GO:0060364 | 4 | 1 | 18204 | 49 |
GLI3 |
1.072e-02 | -4.54 | regulation of angiotensin-activated signaling pathway | biological process | GO:0110061 | 4 | 1 | 18204 | 49 |
PRKCA |
1.072e-02 | -4.54 | ovarian cumulus expansion | biological process | GO:0001550 | 4 | 1 | 18204 | 49 |
BMPR1B |
1.072e-02 | -4.54 | trans-synaptic signaling by BDNF | biological process | GO:0099191 | 4 | 1 | 18204 | 49 |
NTRK2 |
1.072e-02 | -4.54 | brain-derived neurotrophic factor receptor signaling pathway | biological process | GO:0031547 | 4 | 1 | 18204 | 49 |
NTRK2 |
1.072e-02 | -4.54 | regulation of glutamate uptake involved in transmission of nerve impulse | biological process | GO:0051946 | 4 | 1 | 18204 | 49 |
ATP1A2 |
1.072e-02 | -4.54 | positive regulation of mesenchymal stem cell differentiation | biological process | GO:2000741 | 4 | 1 | 18204 | 49 |
SOX5 |
1.072e-02 | -4.54 | desmosome assembly | biological process | GO:0002159 | 4 | 1 | 18204 | 49 |
PRKCA |
1.072e-02 | -4.54 | response to glycoside | biological process | GO:1903416 | 4 | 1 | 18204 | 49 |
ATP1A2 |
1.072e-02 | -4.54 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | biological process | GO:0060831 | 4 | 1 | 18204 | 49 |
GLI3 |
1.072e-02 | -4.54 | regulation of amino acid uptake involved in synaptic transmission | biological process | GO:0051941 | 4 | 1 | 18204 | 49 |
ATP1A2 |
1.076e-02 | -4.53 | TRPM_tetra | interpro domains | IPR032415 | 4 | 1 | 18521 | 50 |
TRPM3 |
1.076e-02 | -4.53 | NHS-like | interpro domains | IPR024845 | 4 | 1 | 18521 | 50 |
NHSL1 |
1.076e-02 | -4.53 | CTF/NFI_DNA-bd_N | interpro domains | IPR019548 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | CTF/NFI_DNA-bd_CS | interpro domains | IPR019739 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | CTF/NFI | interpro domains | IPR000647 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | CTF/NFI_DNA-bd-dom | interpro domains | IPR020604 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | Na/K-Atpase_Interacting | interpro domains | IPR008516 | 4 | 1 | 18521 | 50 |
NKAIN3 |
1.076e-02 | -4.53 | Nebulin_repeat | interpro domains | IPR000900 | 4 | 1 | 18521 | 50 |
NEBL |
1.076e-02 | -4.53 | AbLIM_anchor | interpro domains | IPR032402 | 4 | 1 | 18521 | 50 |
ABLIM1 |
1.076e-02 | -4.53 | Alpha_catenin | interpro domains | IPR001033 | 4 | 1 | 18521 | 50 |
CTNNA2 |
1.076e-02 | -4.53 | TPD52 | interpro domains | IPR007327 | 4 | 1 | 18521 | 50 |
TPD52L1 |
1.076e-02 | -4.53 | TRPM_tetra_sf | interpro domains | IPR037162 | 4 | 1 | 18521 | 50 |
TRPM3 |
1.076e-02 | -4.53 | Glyco_transf_54 | interpro domains | IPR006759 | 4 | 1 | 18521 | 50 |
MGAT4C |
1.076e-02 | -4.53 | PRKG1 (protein kinase cGMP-dependent 1) | protein interactions | 5592 | 61 | 2 | 19454 | 50 |
TNIK,PRKCA |
1.077e-02 | -4.53 | MamL-1 | smart domains | SM01275 | 3 | 1 | 9717 | 35 |
MAML2 |
1.077e-02 | -4.53 | PLP | smart domains | SM00002 | 3 | 1 | 9717 | 35 |
GPM6A |
1.077e-02 | -4.53 | Sorb | smart domains | SM00459 | 3 | 1 | 9717 | 35 |
SORBS1 |
1.077e-02 | -4.53 | CEP63 (centrosomal protein 63) | protein interactions | 80254 | 178 | 3 | 19454 | 50 |
DST,MACF1,TNIK |
1.082e-02 | -4.53 | skeletal system development | biological process | GO:0001501 | 500 | 5 | 18204 | 49 |
CSGALNACT1,BMPR1B,NFIA,SOX5,GLI3 |
1.087e-02 | -4.52 | RYANODINER | prints domains | PR00795 | 3 | 1 | 5227 | 19 |
RYR3 |
1.087e-02 | -4.52 | MYELINPLP | prints domains | PR00214 | 3 | 1 | 5227 | 19 |
GPM6A |
1.087e-02 | -4.52 | INSP3RECEPTR | prints domains | PR00779 | 3 | 1 | 5227 | 19 |
ITPR2 |
1.087e-02 | -4.52 | RORNUCRECPTR | prints domains | PR01293 | 3 | 1 | 5227 | 19 |
RORA |
1.087e-02 | -4.52 | NTKRECEPTOR | prints domains | PR01939 | 3 | 1 | 5227 | 19 |
NTRK2 |
1.096e-02 | -4.51 | mucosal | COSMIC cancer mutations | mucosal | 2009 | 12 | 16828 | 49 |
BMPR1B,CTNND2,FMN2,MGAT4C,NEBL,SORBS1,PREX2,NRG3,ABLIM1,SPARCL1,ATP1A2,RORA |
1.096e-02 | -4.51 | skin-mucosal-malignant_melanoma | COSMIC cancer mutations | skin-mucosal-malignant_melanoma | 2009 | 12 | 16828 | 49 |
MGAT4C,PREX2,SORBS1,NRG3,NEBL,CTNND2,BMPR1B,FMN2,RORA,ABLIM1,SPARCL1,ATP1A2 |
1.097e-02 | -4.51 | TPD52 | pfam domains | PF04201 | 4 | 1 | 17795 | 49 |
TPD52L1 |
1.097e-02 | -4.51 | NHS | pfam domains | PF15273 | 4 | 1 | 17795 | 49 |
NHSL1 |
1.097e-02 | -4.51 | TRPM_tetra | pfam domains | PF16519 | 4 | 1 | 17795 | 49 |
TRPM3 |
1.097e-02 | -4.51 | CTF_NFI | pfam domains | PF00859 | 4 | 1 | 17795 | 49 |
NFIA |
1.097e-02 | -4.51 | Glyco_transf_54 | pfam domains | PF04666 | 4 | 1 | 17795 | 49 |
MGAT4C |
1.097e-02 | -4.51 | AbLIM_anchor | pfam domains | PF16182 | 4 | 1 | 17795 | 49 |
ABLIM1 |
1.097e-02 | -4.51 | NKAIN | pfam domains | PF05640 | 4 | 1 | 17795 | 49 |
NKAIN3 |
1.097e-02 | -4.51 | Nebulin | pfam domains | PF00880 | 4 | 1 | 17795 | 49 |
NEBL |
1.097e-02 | -4.51 | NfI_DNAbd_pre-N | pfam domains | PF10524 | 4 | 1 | 17795 | 49 |
NFIA |
1.098e-02 | -4.51 | bone-tibia-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-tibia-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 649 | 6 | 16828 | 49 |
ABLIM1,MACF1,TNIK,DST,TRPM3,PREX2 |
1.098e-02 | -4.51 | primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | primitive_neuroectodermal_tumour-medulloblastoma | 15350 | 49 | 16828 | 49 |
MSI2,PARD3B,ABLIM1,SORBS1,DTNA,RYR3,PAMR1,GPC5,RORA,GLI3,NRG3,TPD52L1,ZBTB20,RFX4,GLIS3,SLC4A4,FMN2,CTNND2,DPP10,ADCY2,CDH20,NTRK2,DST,PITPNC1,NHSL1,SPARCL1,TNIK,SOX5,SLC1A3,GPM6A,PREX2,NTM,NPAS3,TRPM3,MGAT4C,FBXL7,SLC1A2,NKAIN3,PTPRZ1,LSAMP,NFIA,MAML2,PRKCA,ATP1A2,ITPR2,NEBL,MACF1,CSGALNACT1,BMPR1B |
1.101e-02 | -4.51 | endochondral bone morphogenesis | biological process | GO:0060350 | 59 | 2 | 18204 | 49 |
CSGALNACT1,BMPR1B |
1.106e-02 | -4.50 | chondroitin biosynthesis | BIOCYC pathways | META_PWY-6566 | 5 | 1 | 902 | 2 |
CSGALNACT1 |
1.110e-02 | -4.50 | MYOD1 (myogenic differentiation 1) | protein interactions | 4654 | 180 | 3 | 19454 | 50 |
RORA,PRKCA,NFIA |
1.118e-02 | -4.49 | parathyroid-carcinoma | COSMIC cancer mutations | parathyroid-carcinoma | 300 | 4 | 16828 | 49 |
MACF1,RYR3,PAMR1,GPC5 |
1.121e-02 | -4.49 | EF_Hand_1_Ca_BS | interpro domains | IPR018247 | 172 | 3 | 18521 | 50 |
DST,MACF1,SPARCL1 |
1.126e-02 | -4.49 | cellular response to organonitrogen compound | biological process | GO:0071417 | 505 | 5 | 18204 | 49 |
RYR3,SORBS1,SLC1A3,ITPR2,SLC1A2 |
1.137e-02 | -4.48 | monoatomic cation channel activity | molecular function | GO:0005261 | 331 | 4 | 18094 | 48 |
GPM6A,RYR3,TRPM3,ITPR2 |
1.137e-02 | -4.48 | proteoglycan biosynthetic process | biological process | GO:0030166 | 60 | 2 | 18204 | 49 |
CSGALNACT1,BMPR1B |
1.137e-02 | -4.48 | transmission of nerve impulse | biological process | GO:0019226 | 60 | 2 | 18204 | 49 |
ATP1A2,NTRK2 |
1.137e-02 | -4.48 | export across plasma membrane | biological process | GO:0140115 | 60 | 2 | 18204 | 49 |
SLC4A4,ATP1A2 |
1.137e-02 | -4.48 | regulation of glucose import | biological process | GO:0046324 | 60 | 2 | 18204 | 49 |
SORBS1,SLC1A2 |
1.143e-02 | -4.47 | human chr4q34.2 | chromosome location | human chr4q34.2 | 6 | 1 | 26134 | 50 |
GPM6A |
1.143e-02 | -4.47 | human chr14q13.1 | chromosome location | human chr14q13.1 | 6 | 1 | 26134 | 50 |
NPAS3 |
1.156e-02 | -4.46 | oligodendroglioma_Grade_III | COSMIC cancer mutations | oligodendroglioma_Grade_III | 303 | 4 | 16828 | 49 |
GLIS3,MGAT4C,MACF1,PTPRZ1 |
1.156e-02 | -4.46 | TRPM, tetramerisation domain | gene3d domains | 1.20.5.1010 | 4 | 1 | 14470 | 42 |
TRPM3 |
1.160e-02 | -4.46 | skin-lower_leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma-nodular | 4 | 1 | 16828 | 49 |
PREX2 |
1.160e-02 | -4.46 | skin-face-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-face-malignant_melanoma-superficial_spreading | 4 | 1 | 16828 | 49 |
PREX2 |
1.165e-02 | -4.45 | Activation of PKC Through G Protein-Coupled Receptor | SMPDB pathways | SMP0000749 | 4 | 1 | 1369 | 4 |
PRKCA |
1.167e-02 | -4.45 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified | 162 | 3 | 16828 | 49 |
MACF1,RYR3,ITPR2 |
1.179e-02 | -4.44 | SYNC (syncoilin, intermediate filament protein) | protein interactions | 81493 | 64 | 2 | 19454 | 50 |
DTNA,MAML2 |
1.179e-02 | -4.44 | VSX1 (visual system homeobox 1) | protein interactions | 30813 | 64 | 2 | 19454 | 50 |
DST,NFIA |
1.184e-02 | -4.44 | cadherin binding | molecular function | GO:0045296 | 335 | 4 | 18094 | 48 |
CTNNA2,CDH20,MACF1,CTNND2 |
1.188e-02 | -4.43 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 47 | 16828 | 49 |
FMN2,DPP10,CTNND2,SLC4A4,NRG3,RFX4,GLIS3,ZBTB20,RORA,GLI3,GPC5,RYR3,PAMR1,SORBS1,DTNA,ABLIM1,PARD3B,BMPR1B,MACF1,CSGALNACT1,NEBL,ATP1A2,ITPR2,MAML2,NFIA,PRKCA,NKAIN3,FBXL7,SLC1A2,LSAMP,PTPRZ1,PREX2,GPM6A,NTM,MGAT4C,NPAS3,TRPM3,NHSL1,SPARCL1,DST,PITPNC1,SLC1A3,TNIK,SOX5,ADCY2,NTRK2,CDH20 |
1.196e-02 | -4.43 | regulation of small molecule metabolic process | biological process | GO:0062012 | 331 | 4 | 18204 | 49 |
RORA,SORBS1,ZBTB20,SLC4A4 |
1.198e-02 | -4.42 | membrane | cellular component | GO:0016020 | 9220 | 32 | 19108 | 49 |
PREX2,ITPR2,CTNNA2,LSAMP,MGAT4C,SORBS1,NKAIN3,ATP1A2,CDH20,TRPM3,NTRK2,GPM6A,SLC1A2,NTM,DPP10,DTNA,BMPR1B,SLC4A4,SLC1A3,CSGALNACT1,NRG3,FMN2,RYR3,GPC5,DST,ADCY2,PRKCA,PARD3B,CTNND2,MACF1,PTPRZ1,TNIK |
1.209e-02 | -4.42 | kidney | COSMIC cancer mutations | kidney | 15380 | 49 | 16828 | 49 |
NKAIN3,FBXL7,SLC1A2,LSAMP,PTPRZ1,PREX2,GPM6A,NTM,MGAT4C,NPAS3,TRPM3,NHSL1,SPARCL1,DST,PITPNC1,SLC1A3,TNIK,SOX5,ADCY2,NTRK2,CDH20,BMPR1B,MACF1,CSGALNACT1,NEBL,ATP1A2,ITPR2,MAML2,NFIA,PRKCA,GPC5,RYR3,PAMR1,SORBS1,DTNA,ABLIM1,MSI2,PARD3B,FMN2,DPP10,CTNND2,SLC4A4,TPD52L1,NRG3,RFX4,GLIS3,ZBTB20,RORA,GLI3 |
1.211e-02 | -4.41 | positive regulation of protein localization to plasma membrane | biological process | GO:1903078 | 62 | 2 | 18204 | 49 |
SORBS1,DPP10 |
1.211e-02 | -4.41 | regulation of carbohydrate catabolic process | biological process | GO:0043470 | 62 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
1.211e-02 | -4.41 | telencephalon cell migration | biological process | GO:0022029 | 62 | 2 | 18204 | 49 |
GLI3,NRG3 |
1.216e-02 | -4.41 | parathyroid | COSMIC cancer mutations | parathyroid | 476 | 5 | 16828 | 49 |
PAMR1,RYR3,MACF1,GPC5,GPM6A |
1.250e-02 | -4.38 | MAML1 (mastermind like transcriptional coactivator 1) | protein interactions | 9794 | 66 | 2 | 19454 | 50 |
MAML2,NFIA |
1.266e-02 | -4.37 | peripheral_T_cell_lymphoma_unspecified | COSMIC cancer mutations | peripheral_T_cell_lymphoma_unspecified | 167 | 3 | 16828 | 49 |
RYR3,MACF1,ITPR2 |
1.267e-02 | -4.37 | Ca2+ pathway | REACTOME pathways | R-HSA-4086398 | 61 | 2 | 10285 | 29 |
ITPR2,PRKCA |
1.279e-02 | -4.36 | Rhoj (ras homolog family member J) | protein interactions | 80837 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | Cdk4 (cyclin dependent kinase 4) | protein interactions | 12567 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | RFX4 (regulatory factor X4) | protein interactions | 5992 | 5 | 1 | 19454 | 50 |
RFX4 |
1.279e-02 | -4.36 | DPP10 (dipeptidyl peptidase like 10) | protein interactions | 57628 | 5 | 1 | 19454 | 50 |
DPP10 |
1.279e-02 | -4.36 | DLX3 (distal-less homeobox 3) | protein interactions | 1747 | 5 | 1 | 19454 | 50 |
PRKCA |
1.279e-02 | -4.36 | Rab6b (RAB6B, member RAS oncogene family) | protein interactions | 270192 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | SUI2 (translation initiation factor eIF2 subunit alpha) | protein interactions | 853463 | 5 | 1 | 19454 | 50 |
PRKCA |
1.279e-02 | -4.36 | Rhobtb1 (Rho-related BTB domain containing 1) | protein interactions | 69288 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | Rras2 (related RAS viral (r-ras) oncogene 2) | protein interactions | 66922 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | GABRR2 (gamma-aminobutyric acid type A receptor subunit rho2) | protein interactions | 2570 | 5 | 1 | 19454 | 50 |
PRKCA |
1.279e-02 | -4.36 | TRPM6 (transient receptor potential cation channel subfamily M member 6) | protein interactions | 140803 | 5 | 1 | 19454 | 50 |
TRPM3 |
1.279e-02 | -4.36 | Rab38 (RAB38, member RAS oncogene family) | protein interactions | 72433 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | SLC10A3 (solute carrier family 10 member 3) | protein interactions | 8273 | 5 | 1 | 19454 | 50 |
SORBS1 |
1.279e-02 | -4.36 | CFHR3 (complement factor H related 3) | protein interactions | 10878 | 5 | 1 | 19454 | 50 |
PRKCA |
1.279e-02 | -4.36 | Wwp2 (WW domain containing E3 ubiquitin protein ligase 2) | protein interactions | 66894 | 5 | 1 | 19454 | 50 |
GLIS3 |
1.287e-02 | -4.35 | cranial nerve development | biological process | GO:0021545 | 64 | 2 | 18204 | 49 |
GLI3,SLC1A3 |
1.287e-02 | -4.35 | actin filament bundle assembly | biological process | GO:0051017 | 64 | 2 | 18204 | 49 |
SORBS1,FMN2 |
1.296e-02 | -4.35 | regulation of Wnt signaling pathway | biological process | GO:0030111 | 339 | 4 | 18204 | 49 |
CTNND2,MACF1,GPC5,GLI3 |
1.298e-02 | -4.34 | cGMP-PKG signaling pathway | KEGG pathways | hsa04022 | 163 | 3 | 7161 | 22 |
ITPR2,ADCY2,ATP1A2 |
1.298e-02 | -4.34 | cGMP-PKG signaling pathway | KEGG pathways | ko04022 | 163 | 3 | 7161 | 22 |
ITPR2,ATP1A2,ADCY2 |
1.302e-02 | -4.34 | pancreas-carcinoma | COSMIC cancer mutations | pancreas-carcinoma | 14770 | 48 | 16828 | 49 |
BMPR1B,MACF1,CSGALNACT1,NEBL,ITPR2,ATP1A2,PRKCA,MAML2,NFIA,LSAMP,PTPRZ1,NKAIN3,FBXL7,SLC1A2,MGAT4C,NPAS3,TRPM3,GPM6A,PREX2,NTM,SLC1A3,TNIK,SOX5,NHSL1,SPARCL1,DST,PITPNC1,NTRK2,CDH20,ADCY2,DPP10,CTNND2,FMN2,SLC4A4,NRG3,TPD52L1,ZBTB20,GLIS3,RFX4,GLI3,RORA,GPC5,RYR3,PAMR1,SORBS1,ABLIM1,PARD3B,MSI2 |
1.304e-02 | -4.34 | SH3_9 | pfam domains | PF14604 | 63 | 2 | 17795 | 49 |
NEBL,SORBS1 |
1.307e-02 | -4.34 | CTF_NFI_2 | prosite domains | PS51080 | 4 | 1 | 12186 | 40 |
NFIA |
1.307e-02 | -4.34 | CTF_NFI_1 | prosite domains | PS00349 | 4 | 1 | 12186 | 40 |
NFIA |
1.307e-02 | -4.34 | NEBULIN | prosite domains | PS51216 | 4 | 1 | 12186 | 40 |
NEBL |
1.312e-02 | -4.33 | regulation of protein localization to membrane | biological process | GO:1905475 | 183 | 3 | 18204 | 49 |
GPC5,SORBS1,DPP10 |
1.320e-02 | -4.33 | transforming growth factor beta receptor activity, type I | molecular function | GO:0005025 | 5 | 1 | 18094 | 48 |
BMPR1B |
1.320e-02 | -4.33 | neurotrophin receptor activity | molecular function | GO:0005030 | 5 | 1 | 18094 | 48 |
NTRK2 |
1.325e-02 | -4.32 | forebrain cell migration | biological process | GO:0021885 | 65 | 2 | 18204 | 49 |
NRG3,GLI3 |
1.327e-02 | -4.32 | L-amino acid transmembrane transporter activity | molecular function | GO:0015179 | 66 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
1.328e-02 | -4.32 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 10 | 18204 | 49 |
BMPR1B,ZBTB20,ATP1A2,NTRK2,PRKCA,GLI3,SOX5,MACF1,RORA,PTPRZ1 |
1.330e-02 | -4.32 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 25 | 18204 | 49 |
MAML2,ITPR2,ATP1A2,GLI3,RYR3,PITPNC1,DST,NRG3,RORA,SLC1A3,SPARCL1,NFIA,SLC1A2,PREX2,MACF1,BMPR1B,ZBTB20,DTNA,NTRK2,FMN2,PRKCA,CTNND2,TNIK,SORBS1,ADCY2 |
1.332e-02 | -4.32 | testis-germ_cell_tumour-non_seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-non_seminoma | 487 | 5 | 16828 | 49 |
BMPR1B,NTRK2,PRKCA,TNIK,MACF1 |
1.332e-02 | -4.32 | human chr8q13.2 | chromosome location | human chr8q13.2 | 7 | 1 | 26134 | 50 |
PREX2 |
1.339e-02 | -4.31 | negative regulation of chondrocyte proliferation | biological process | GO:1902731 | 5 | 1 | 18204 | 49 |
BMPR1B |
1.339e-02 | -4.31 | amygdala development | biological process | GO:0021764 | 5 | 1 | 18204 | 49 |
ATP1A2 |
1.339e-02 | -4.31 | synaptic signaling via neuropeptide | biological process | GO:0099538 | 5 | 1 | 18204 | 49 |
NTRK2 |
1.339e-02 | -4.31 | polar body extrusion after meiotic divisions | biological process | GO:0040038 | 5 | 1 | 18204 | 49 |
FMN2 |
1.343e-02 | -4.31 | Follistatin/Osteonectin_EGF | interpro domains | IPR015369 | 5 | 1 | 18521 | 50 |
SPARCL1 |
1.343e-02 | -4.31 | Vinculin/catenin | interpro domains | IPR006077 | 5 | 1 | 18521 | 50 |
CTNNA2 |
1.343e-02 | -4.31 | PI_transfer | interpro domains | IPR001666 | 5 | 1 | 18521 | 50 |
PITPNC1 |
1.343e-02 | -4.31 | Na/HCO3_transpt | interpro domains | IPR003024 | 5 | 1 | 18521 | 50 |
SLC4A4 |
1.351e-02 | -4.30 | Ectoderm Differentiation | WikiPathways | WP2858 | 143 | 3 | 5310 | 19 |
GLI3,CTNNA2,CTNND2 |
1.352e-02 | -4.30 | NS-malignant_melanoma | COSMIC cancer mutations | NS-malignant_melanoma | 3420 | 17 | 16828 | 49 |
PRKCA,ADCY2,ITPR2,ATP1A2,PITPNC1,MGAT4C,TRPM3,NEBL,GLIS3,RFX4,NRG3,PREX2,GPC5,PTPRZ1,CTNND2,MACF1,FMN2 |
1.364e-02 | -4.29 | L-alpha-amino acid transmembrane transport | biological process | GO:1902475 | 66 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
1.367e-02 | -4.29 | neoplasm | COSMIC cancer mutations | neoplasm | 14787 | 48 | 16828 | 49 |
SLC4A4,TPD52L1,NRG3,RFX4,GLIS3,ZBTB20,FMN2,DPP10,CTNND2,RORA,GLI3,SORBS1,DTNA,GPC5,RYR3,PAMR1,MSI2,PARD3B,ABLIM1,NEBL,BMPR1B,MACF1,CSGALNACT1,MAML2,NFIA,PRKCA,ATP1A2,ITPR2,GPM6A,PREX2,NTM,MGAT4C,NPAS3,TRPM3,NKAIN3,FBXL7,SLC1A2,LSAMP,PTPRZ1,ADCY2,NTRK2,CDH20,NHSL1,SPARCL1,DST,SLC1A3,TNIK,SOX5 |
1.369e-02 | -4.29 | Vinculin | pfam domains | PF01044 | 5 | 1 | 17795 | 49 |
CTNNA2 |
1.369e-02 | -4.29 | FOLN | pfam domains | PF09289 | 5 | 1 | 17795 | 49 |
SPARCL1 |
1.369e-02 | -4.29 | IP_trans | pfam domains | PF02121 | 5 | 1 | 17795 | 49 |
PITPNC1 |
1.376e-02 | -4.29 | Myh9 (myosin, heavy polypeptide 9, non-muscle) | protein interactions | 17886 | 195 | 3 | 19454 | 50 |
ZBTB20,ABLIM1,DST |
1.379e-02 | -4.28 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 7 | 19454 | 50 |
SLC1A3,PRKCA,DST,MACF1,PREX2,FMN2,DTNA |
1.385e-02 | -4.28 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 25 | 18204 | 49 |
DPP10,SLC4A4,BMPR1B,ZBTB20,PRKCA,SOX5,GLI3,ATP1A2,NTRK2,MAML2,FMN2,GPC5,SLC1A3,RORA,TNIK,NFIA,SORBS1,SLC1A2,GPM6A,RFX4,MACF1,PTPRZ1,NPAS3,GLIS3,TPD52L1 |
1.387e-02 | -4.28 | non_seminoma | COSMIC cancer mutations | non_seminoma | 492 | 5 | 16828 | 49 |
TNIK,MACF1,PRKCA,NTRK2,BMPR1B |
1.396e-02 | -4.27 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 35 | 16828 | 49 |
FBXL7,NKAIN3,PAMR1,PTPRZ1,RYR3,LSAMP,GPC5,SORBS1,PREX2,TRPM3,MGAT4C,PITPNC1,DST,NHSL1,SOX5,TNIK,MSI2,ADCY2,CDH20,PARD3B,NTRK2,FMN2,CTNND2,MACF1,BMPR1B,GLIS3,NEBL,SLC4A4,ATP1A2,ITPR2,NFIA,MAML2,RORA,PRKCA,GLI3 |
1.399e-02 | -4.27 | PCDH20 (protocadherin 20) | protein interactions | 64881 | 70 | 2 | 19454 | 50 |
MGAT4C,CTNNA2 |
1.402e-02 | -4.27 | NGF-independant TRKA activation | REACTOME pathways | R-HSA-187024 | 5 | 1 | 10285 | 29 |
NTRK2 |
1.402e-02 | -4.27 | Disinhibition of SNARE formation | REACTOME pathways | R-HSA-114516 | 5 | 1 | 10285 | 29 |
PRKCA |
1.407e-02 | -4.26 | RAB35 (RAB35, member RAS oncogene family) | protein interactions | 11021 | 559 | 5 | 19454 | 50 |
DTNA,FMN2,DST,MACF1,SLC1A3 |
1.418e-02 | -4.26 | liver-carcinoma-hepatocellular_carcinoma | COSMIC cancer mutations | liver-carcinoma-hepatocellular_carcinoma | 14800 | 48 | 16828 | 49 |
GPC5,PAMR1,RYR3,SORBS1,DTNA,ABLIM1,PARD3B,FMN2,DPP10,CTNND2,SLC4A4,GLIS3,ZBTB20,RFX4,TPD52L1,NRG3,RORA,GLI3,NKAIN3,SLC1A2,FBXL7,LSAMP,PTPRZ1,NTM,GPM6A,PREX2,MGAT4C,TRPM3,NPAS3,SPARCL1,NHSL1,PITPNC1,DST,SLC1A3,SOX5,TNIK,ADCY2,NTRK2,CDH20,BMPR1B,CSGALNACT1,MACF1,NEBL,ATP1A2,ITPR2,MAML2,NFIA,PRKCA |
1.418e-02 | -4.26 | hepatocellular_carcinoma | COSMIC cancer mutations | hepatocellular_carcinoma | 14800 | 48 | 16828 | 49 |
SLC4A4,TPD52L1,NRG3,RFX4,ZBTB20,GLIS3,DPP10,CTNND2,FMN2,GLI3,RORA,DTNA,SORBS1,GPC5,RYR3,PAMR1,PARD3B,ABLIM1,NEBL,BMPR1B,MACF1,CSGALNACT1,PRKCA,MAML2,NFIA,ITPR2,ATP1A2,MGAT4C,NPAS3,TRPM3,GPM6A,PREX2,NTM,LSAMP,PTPRZ1,NKAIN3,FBXL7,SLC1A2,NTRK2,CDH20,ADCY2,SLC1A3,TNIK,SOX5,NHSL1,SPARCL1,DST,PITPNC1 |
1.432e-02 | -4.25 | Long-term depression | KEGG pathways | ko04730 | 60 | 2 | 7161 | 22 |
ITPR2,PRKCA |
1.432e-02 | -4.25 | Long-term depression | KEGG pathways | hsa04730 | 60 | 2 | 7161 | 22 |
ITPR2,PRKCA |
1.433e-02 | -4.25 | NEBU | smart domains | SM00227 | 4 | 1 | 9717 | 35 |
NEBL |
1.435e-02 | -4.24 | small_intestine-carcinoid-endocrine_tumour | COSMIC cancer mutations | small_intestine-carcinoid-endocrine_tumour | 175 | 3 | 16828 | 49 |
CSGALNACT1,TNIK,MACF1 |
1.437e-02 | -4.24 | AKR7L (aldo-keto reductase family 7 like (gene/pseudogene)) | protein interactions | 246181 | 71 | 2 | 19454 | 50 |
DST,MACF1 |
1.437e-02 | -4.24 | CRYBG1 (crystallin beta-gamma domain containing 1) | protein interactions | 202 | 71 | 2 | 19454 | 50 |
CSGALNACT1,SPARCL1 |
1.437e-02 | -4.24 | ANK2 (ankyrin 2) | protein interactions | 287 | 71 | 2 | 19454 | 50 |
TNIK,GPM6A |
1.444e-02 | -4.24 | actin filament bundle organization | biological process | GO:0061572 | 68 | 2 | 18204 | 49 |
SORBS1,FMN2 |
1.446e-02 | -4.24 | Synaptic Vesicle Pathway | WikiPathways | WP2267 | 52 | 2 | 5310 | 19 |
ATP1A2,SLC1A3 |
1.446e-02 | -4.24 | ALPHACATENIN | prints domains | PR00805 | 4 | 1 | 5227 | 19 |
CTNNA2 |
1.448e-02 | -4.24 | skin-lower_leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma-superficial_spreading | 5 | 1 | 16828 | 49 |
PREX2 |
1.455e-02 | -4.23 | Corticotropin Activation of Cortisol Production | SMPDB pathways | SMP0000310 | 5 | 1 | 1369 | 4 |
ADCY2 |
1.455e-02 | -4.23 | Ion Channel and Phorbal Esters Signaling Pathway | SMPDB pathways | SMP0090032 | 5 | 1 | 1369 | 4 |
PRKCA |
1.466e-02 | -4.22 | CH | pfam domains | PF00307 | 67 | 2 | 17795 | 49 |
MACF1,DST |
1.476e-02 | -4.22 | PPP3CC (protein phosphatase 3 catalytic subunit gamma) | protein interactions | 5533 | 72 | 2 | 19454 | 50 |
BMPR1B,PARD3B |
1.476e-02 | -4.22 | DPYSL3 (dihydropyrimidinase like 3) | protein interactions | 1809 | 72 | 2 | 19454 | 50 |
GPM6A,TNIK |
1.480e-02 | -4.21 | cytoskeletal protein binding | molecular function | GO:0008092 | 989 | 7 | 18094 | 48 |
NEBL,ABLIM1,CTNNA2,MACF1,SORBS1,FMN2,DST |
1.491e-02 | -4.21 | DBN1 (drebrin 1) | protein interactions | 1627 | 370 | 4 | 19454 | 50 |
SOX5,PRKCA,ABLIM1,DST |
1.500e-02 | -4.20 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 8 | 16828 | 49 |
RYR3,TNIK,CTNND2,PRKCA,NTRK2,MGAT4C,MAML2,RORA |
1.509e-02 | -4.19 | cell surface receptor signaling pathway | biological process | GO:0007166 | 1992 | 11 | 18204 | 49 |
SORBS1,NFIA,MACF1,BMPR1B,NTRK2,MAML2,GLI3,CTNND2,DST,NRG3,TNIK |
1.531e-02 | -4.18 | DPYSL2 (dihydropyrimidinase like 2) | protein interactions | 1808 | 203 | 3 | 19454 | 50 |
TNIK,TPD52L1,GPM6A |
1.532e-02 | -4.18 | ADCY1 (adenylate cyclase 1) | protein interactions | 107 | 6 | 1 | 19454 | 50 |
ADCY2 |
1.532e-02 | -4.18 | Itch (itchy, E3 ubiquitin protein ligase) | protein interactions | 16396 | 6 | 1 | 19454 | 50 |
GLIS3 |
1.532e-02 | -4.18 | Map2k3 (mitogen-activated protein kinase kinase 3) | protein interactions | 26397 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | SOX11 (SRY-box transcription factor 11) | protein interactions | 6664 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | GDF6 (growth differentiation factor 6) | protein interactions | 392255 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | SLC12A5 (solute carrier family 12 member 5) | protein interactions | 57468 | 6 | 1 | 19454 | 50 |
GPM6A |
1.532e-02 | -4.18 | ARMS2 (age-related maculopathy susceptibility 2) | protein interactions | 387715 | 6 | 1 | 19454 | 50 |
PRKCA |
1.532e-02 | -4.18 | SOX1 (SRY-box transcription factor 1) | protein interactions | 6656 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | Zbtb2 (zinc finger and BTB domain containing 2) | protein interactions | 381990 | 6 | 1 | 19454 | 50 |
SORBS1 |
1.532e-02 | -4.18 | Fancl (Fanconi anemia, complementation group L) | protein interactions | 67030 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | Csnk1d (casein kinase 1, delta) | protein interactions | 64462 | 6 | 1 | 19454 | 50 |
PRKCA |
1.532e-02 | -4.18 | DRP2 (dystrophin related protein 2) | protein interactions | 1821 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | CYRIA (CYFIP related Rac1 interactor A) | protein interactions | 81553 | 6 | 1 | 19454 | 50 |
GPM6A |
1.532e-02 | -4.18 | GPR135 (G protein-coupled receptor 135) | protein interactions | 64582 | 6 | 1 | 19454 | 50 |
TPD52L1 |
1.532e-02 | -4.18 | Tiam2 (T cell lymphoma invasion and metastasis 2) | protein interactions | 24001 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | Rhod (ras homolog family member D) | protein interactions | 11854 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.546e-02 | -4.17 | Axon guidance | KEGG pathways | hsa04360 | 174 | 3 | 7161 | 22 |
PRKCA,BMPR1B,ABLIM1 |
1.546e-02 | -4.17 | Axon guidance | KEGG pathways | ko04360 | 174 | 3 | 7161 | 22 |
PRKCA,ABLIM1,BMPR1B |
1.549e-02 | -4.17 | skin-ear-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-ear-carcinoma-squamous_cell_carcinoma | 506 | 5 | 16828 | 49 |
DPP10,MGAT4C,NPAS3,SPARCL1,ZBTB20 |
1.550e-02 | -4.17 | LIM | pfam domains | PF00412 | 69 | 2 | 17795 | 49 |
ABLIM1,NEBL |
1.552e-02 | -4.17 | CASK (calcium/calmodulin dependent serine protein kinase) | protein interactions | 8573 | 204 | 3 | 19454 | 50 |
ABLIM1,DTNA,PARD3B |
1.554e-02 | -4.16 | ErbB Signaling Pathway | WikiPathways | WP673 | 54 | 2 | 5310 | 19 |
PRKCA,NRG3 |
1.554e-02 | -4.16 | bone development | biological process | GO:0060348 | 195 | 3 | 18204 | 49 |
CSGALNACT1,BMPR1B,GLI3 |
1.576e-02 | -4.15 | Znf_LIM | interpro domains | IPR001781 | 71 | 2 | 18521 | 50 |
NEBL,ABLIM1 |
1.581e-02 | -4.15 | sodium:bicarbonate symporter activity | molecular function | GO:0008510 | 6 | 1 | 18094 | 48 |
SLC4A4 |
1.581e-02 | -4.15 | calcium-induced calcium release activity | molecular function | GO:0048763 | 6 | 1 | 18094 | 48 |
RYR3 |
1.581e-02 | -4.15 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | molecular function | GO:0047238 | 6 | 1 | 18094 | 48 |
CSGALNACT1 |
1.581e-02 | -4.15 | steroid hormone binding | molecular function | GO:1990239 | 6 | 1 | 18094 | 48 |
ATP1A2 |
1.583e-02 | -4.15 | Neuronal System | REACTOME pathways | R-HSA-112316 | 349 | 4 | 10285 | 29 |
ADCY2,SLC1A3,PRKCA,SLC1A2 |
1.597e-02 | -4.14 | protein localization to plasma membrane | biological process | GO:0072659 | 197 | 3 | 18204 | 49 |
MACF1,DPP10,TNIK |
1.600e-02 | -4.13 | other | COSMIC cancer mutations | other | 14843 | 48 | 16828 | 49 |
PARD3B,MSI2,ABLIM1,DTNA,SORBS1,RYR3,PAMR1,GPC5,GLI3,RORA,TPD52L1,NRG3,RFX4,GLIS3,ZBTB20,SLC4A4,CTNND2,DPP10,FMN2,CDH20,NTRK2,ADCY2,TNIK,SOX5,SLC1A3,DST,NHSL1,SPARCL1,NPAS3,TRPM3,MGAT4C,GPM6A,PREX2,NTM,PTPRZ1,LSAMP,FBXL7,SLC1A2,NKAIN3,PRKCA,NFIA,MAML2,ITPR2,ATP1A2,NEBL,MACF1,CSGALNACT1,BMPR1B |
1.604e-02 | -4.13 | gamma-aminobutyric acid biosynthetic process | biological process | GO:0009449 | 6 | 1 | 18204 | 49 |
SLC1A3 |
1.604e-02 | -4.13 | hemidesmosome assembly | biological process | GO:0031581 | 6 | 1 | 18204 | 49 |
DST |
1.604e-02 | -4.13 | asymmetric neuroblast division | biological process | GO:0055059 | 6 | 1 | 18204 | 49 |
SOX5 |
1.604e-02 | -4.13 | fused antrum stage | biological process | GO:0048165 | 6 | 1 | 18204 | 49 |
BMPR1B |
1.604e-02 | -4.13 | ERBB4-ERBB4 signaling pathway | biological process | GO:0038138 | 6 | 1 | 18204 | 49 |
NRG3 |
1.604e-02 | -4.13 | positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | biological process | GO:0106071 | 6 | 1 | 18204 | 49 |
PRKCA |
1.604e-02 | -4.13 | optic nerve morphogenesis | biological process | GO:0021631 | 6 | 1 | 18204 | 49 |
GLI3 |
1.604e-02 | -4.13 | establishment of meiotic spindle localization | biological process | GO:0051295 | 6 | 1 | 18204 | 49 |
FMN2 |
1.609e-02 | -4.13 | G3BP1 (G3BP stress granule assembly factor 1) | protein interactions | 10146 | 799 | 6 | 19454 | 50 |
SOX5,MACF1,CTNNA2,DST,MSI2,SORBS1 |
1.609e-02 | -4.13 | EF-hand_dom_typ2 | interpro domains | IPR015154 | 6 | 1 | 18521 | 50 |
DTNA |
1.609e-02 | -4.13 | Glypican_CS | interpro domains | IPR019803 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | Glypican | interpro domains | IPR001863 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | P-type_ATPase_IIC | interpro domains | IPR005775 | 6 | 1 | 18521 | 50 |
ATP1A2 |
1.609e-02 | -4.13 | Adcy_conserved_dom | interpro domains | IPR009398 | 6 | 1 | 18521 | 50 |
ADCY2 |
1.609e-02 | -4.13 | Peptidase_S9B_N | interpro domains | IPR002469 | 6 | 1 | 18521 | 50 |
DPP10 |
1.609e-02 | -4.13 | EF-hand_dom_typ1 | interpro domains | IPR015153 | 6 | 1 | 18521 | 50 |
DTNA |
1.609e-02 | -4.13 | regulation of ATP metabolic process | biological process | GO:1903578 | 72 | 2 | 18204 | 49 |
SLC4A4,ZBTB20 |
1.616e-02 | -4.13 | bone-femur-other-chondroblastoma | COSMIC cancer mutations | bone-femur-other-chondroblastoma | 183 | 3 | 16828 | 49 |
NRG3,RYR3,GPC5 |
1.622e-02 | -4.12 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 8 | 16828 | 49 |
RORA,MAML2,NTRK2,MGAT4C,PRKCA,RYR3,TNIK,CTNND2 |
1.627e-02 | -4.12 | protein-containing complex binding | molecular function | GO:0044877 | 1772 | 10 | 18094 | 48 |
DST,PTPRZ1,PRKCA,SPARCL1,MACF1,CTNNA2,ABLIM1,NFIA,NEBL,GLI3 |
1.627e-02 | -4.12 | sarcoplasmic reticulum | cellular component | GO:0016529 | 76 | 2 | 19108 | 49 |
RYR3,ITPR2 |
1.629e-02 | -4.12 | MKRN2 (makorin ring finger protein 2) | protein interactions | 23609 | 380 | 4 | 19454 | 50 |
PRKCA,GLI3,MACF1,BMPR1B |
1.629e-02 | -4.12 | Downstream signal transduction | REACTOME pathways | R-HSA-186763 | 352 | 4 | 10285 | 29 |
ADCY2,PRKCA,NRG3,ITPR2 |
1.641e-02 | -4.11 | Glypican | pfam domains | PF01153 | 6 | 1 | 17795 | 49 |
GPC5 |
1.641e-02 | -4.11 | EF-hand_3 | pfam domains | PF09069 | 6 | 1 | 17795 | 49 |
DTNA |
1.641e-02 | -4.11 | Adcy_cons_dom | pfam domains | PF06327 | 6 | 1 | 17795 | 49 |
ADCY2 |
1.641e-02 | -4.11 | DPPIV_N | pfam domains | PF00930 | 6 | 1 | 17795 | 49 |
DPP10 |
1.641e-02 | -4.11 | EF-hand_2 | pfam domains | PF09068 | 6 | 1 | 17795 | 49 |
DTNA |
1.652e-02 | -4.10 | neuron fate commitment | biological process | GO:0048663 | 73 | 2 | 18204 | 49 |
GLI3,NFIA |
1.665e-02 | -4.10 | cytoskeleton | cellular component | GO:0005856 | 2412 | 12 | 19108 | 49 |
ABLIM1,TNIK,FMN2,DST,FBXL7,SORBS1,DTNA,MACF1,NEBL,PRKCA,CTNNA2,GLI3 |
1.673e-02 | -4.09 | axonogenesis | biological process | GO:0007409 | 366 | 4 | 18204 | 49 |
CTNNA2,BMPR1B,GLI3,PTPRZ1 |
1.675e-02 | -4.09 | skin-head_neck-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-head_neck-malignant_melanoma-superficial_spreading | 923 | 7 | 16828 | 49 |
CTNND2,MACF1,PREX2,ADCY2,SORBS1,GLI3,MGAT4C |
1.680e-02 | -4.09 | Activation of TRKA receptors | REACTOME pathways | R-HSA-187015 | 6 | 1 | 10285 | 29 |
NTRK2 |
1.691e-02 | -4.08 | DAP12 signaling | REACTOME pathways | R-HSA-2424491 | 356 | 4 | 10285 | 29 |
PRKCA,ADCY2,ITPR2,NRG3 |
1.695e-02 | -4.08 | positive regulation of protein localization to cell periphery | biological process | GO:1904377 | 74 | 2 | 18204 | 49 |
DPP10,SORBS1 |
1.709e-02 | -4.07 | human chr4q22.3 | chromosome location | human chr4q22.3 | 9 | 1 | 26134 | 50 |
BMPR1B |
1.716e-02 | -4.07 | MARCKS (myristoylated alanine rich protein kinase C substrate) | protein interactions | 4082 | 588 | 5 | 19454 | 50 |
DTNA,ABLIM1,SLC1A3,PRKCA,MACF1 |
1.717e-02 | -4.06 | ATP2B3 (ATPase plasma membrane Ca2+ transporting 3) | protein interactions | 492 | 78 | 2 | 19454 | 50 |
CSGALNACT1,GPM6A |
1.717e-02 | -4.06 | ANKRD40 (ankyrin repeat domain 40) | protein interactions | 91369 | 78 | 2 | 19454 | 50 |
MSI2,SOX5 |
1.717e-02 | -4.06 | Nedd4 (NEDD4 E3 ubiquitin protein ligase) | protein interactions | 25489 | 78 | 2 | 19454 | 50 |
NTRK2,BMPR1B |
1.722e-02 | -4.06 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 17 | 16828 | 49 |
DPP10,GPC5,CTNND2,PTPRZ1,MACF1,RYR3,FMN2,TRPM3,NPAS3,SLC4A4,ZBTB20,PREX2,ATP1A2,DST,PARD3B,GLI3,ADCY2 |
1.729e-02 | -4.06 | RNF123 (ring finger protein 123) | protein interactions | 63891 | 812 | 6 | 19454 | 50 |
DST,FMN2,CDH20,ITPR2,TRPM3,FBXL7 |
1.729e-02 | -4.06 | Dipeptidylpeptidase IV, N-terminal domain | gene3d domains | 2.140.10.30 | 6 | 1 | 14470 | 42 |
DPP10 |
1.735e-02 | -4.05 | skin-forearm-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-forearm-malignant_melanoma-superficial_spreading | 6 | 1 | 16828 | 49 |
PREX2 |
1.735e-02 | -4.05 | skin-head_neck-malignant_melanoma | COSMIC cancer mutations | skin-head_neck-malignant_melanoma | 6 | 1 | 16828 | 49 |
PREX2 |
1.735e-02 | -4.05 | autonomic_ganglia-paraganglioma-benign | COSMIC cancer mutations | autonomic_ganglia-paraganglioma-benign | 6 | 1 | 16828 | 49 |
NHSL1 |
1.744e-02 | -4.05 | Dopamine Activation of Neurological Reward System | SMPDB pathways | SMP0000308 | 6 | 1 | 1369 | 4 |
ADCY2 |
1.744e-02 | -4.05 | Intracellular Signalling Through PGD2 receptor and Prostaglandin D2 | SMPDB pathways | SMP0000343 | 6 | 1 | 1369 | 4 |
ADCY2 |
1.744e-02 | -4.05 | Phospholipase C Signaling Pathway | SMPDB pathways | SMP0063783 | 6 | 1 | 1369 | 4 |
PRKCA |
1.761e-02 | -4.04 | NCK1 (NCK adaptor protein 1) | protein interactions | 4690 | 214 | 3 | 19454 | 50 |
NTRK2,TNIK,NHSL1 |
1.766e-02 | -4.04 | Long-term potentiation | KEGG pathways | hsa04720 | 67 | 2 | 7161 | 22 |
ITPR2,PRKCA |
1.766e-02 | -4.04 | Long-term potentiation | KEGG pathways | ko04720 | 67 | 2 | 7161 | 22 |
ITPR2,PRKCA |
1.767e-02 | -4.04 | mannosyl-glycoprotein N-acetylglucosaminyltransferases | BIOCYC pathways | META_PWY-7426 | 8 | 1 | 902 | 2 |
MGAT4C |
1.771e-02 | -4.03 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 9 | 18204 | 49 |
ITPR2,ATP1A2,FMN2,PREX2,PRKCA,ADCY2,TNIK,NRG3,RYR3 |
1.782e-02 | -4.03 | alpha-beta T cell differentiation | biological process | GO:0046632 | 76 | 2 | 18204 | 49 |
GLI3,RORA |
1.786e-02 | -4.03 | SLC16A5 (solute carrier family 16 member 5) | protein interactions | 9121 | 7 | 1 | 19454 | 50 |
PTPRZ1 |
1.786e-02 | -4.03 | Fbxo3 (F-box protein 3) | protein interactions | 57443 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | Smad7 (SMAD family member 7) | protein interactions | 17131 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | Smurf1 (SMAD specific E3 ubiquitin protein ligase 1) | protein interactions | 75788 | 7 | 1 | 19454 | 50 |
GLIS3 |
1.786e-02 | -4.03 | ZBTB45 (zinc finger and BTB domain containing 45) | protein interactions | 84878 | 7 | 1 | 19454 | 50 |
ZBTB20 |
1.786e-02 | -4.03 | RGMB (repulsive guidance molecule BMP co-receptor b) | protein interactions | 285704 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | ABCC12 (ATP binding cassette subfamily C member 12) | protein interactions | 94160 | 7 | 1 | 19454 | 50 |
NPAS3 |
1.786e-02 | -4.03 | Uhmk1 (U2AF homology motif (UHM) kinase 1) | protein interactions | 16589 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | SASH3 (SAM and SH3 domain containing 3) | protein interactions | 54440 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.801e-02 | -4.02 | GJB1 (gap junction protein beta 1) | protein interactions | 2705 | 80 | 2 | 19454 | 50 |
PRKCA,MSI2 |
1.805e-02 | -4.01 | NAHCO3TRSPRT | prints domains | PR01232 | 5 | 1 | 5227 | 19 |
SLC4A4 |
1.805e-02 | -4.01 | PITRANSFER | prints domains | PR00391 | 5 | 1 | 5227 | 19 |
PITPNC1 |
1.821e-02 | -4.01 | Signaling by EGFR | REACTOME pathways | R-HSA-177929 | 364 | 4 | 10285 | 29 |
ADCY2,PRKCA,NRG3,ITPR2 |
1.827e-02 | -4.00 | positive regulation of axonogenesis | biological process | GO:0050772 | 77 | 2 | 18204 | 49 |
MACF1,NTRK2 |
1.827e-02 | -4.00 | neural retina development | biological process | GO:0003407 | 77 | 2 | 18204 | 49 |
NTRK2,GPM6A |
1.827e-02 | -4.00 | BMP signaling pathway | biological process | GO:0030509 | 77 | 2 | 18204 | 49 |
NFIA,BMPR1B |
1.830e-02 | -4.00 | Glycosaminoglycan biosynthesis, chondroitin sulfate backbone | KEGG pathways | M00058 | 6 | 1 | 7161 | 22 |
CSGALNACT1 |
1.830e-02 | -4.00 | Glycosaminoglycan biosynthesis, chondroitin sulfate backbone | KEGG pathways | hsa_M00058 | 6 | 1 | 7161 | 22 |
CSGALNACT1 |
1.836e-02 | -4.00 | sarcomere | cellular component | GO:0030017 | 218 | 3 | 19108 | 49 |
DST,NEBL,RYR3 |
1.843e-02 | -3.99 | P-type sodium transporter activity | molecular function | GO:0008554 | 7 | 1 | 18094 | 48 |
ATP1A2 |
1.843e-02 | -3.99 | phosphatidic acid transfer activity | molecular function | GO:1990050 | 7 | 1 | 18094 | 48 |
PITPNC1 |
1.843e-02 | -3.99 | P-type sodium:potassium-exchanging transporter activity | molecular function | GO:0005391 | 7 | 1 | 18094 | 48 |
ATP1A2 |
1.844e-02 | -3.99 | regulation of neurogenesis | biological process | GO:0050767 | 377 | 4 | 18204 | 49 |
GLI3,PTPRZ1,NTRK2,MACF1 |
1.865e-02 | -3.98 | Protein_kinase_ATP_BS | interpro domains | IPR017441 | 377 | 4 | 18521 | 50 |
TNIK,PRKCA,NTRK2,BMPR1B |
1.867e-02 | -3.98 | transmembrane transport | biological process | GO:0055085 | 1264 | 8 | 18204 | 49 |
ATP1A2,ITPR2,SLC1A2,SLC4A4,TRPM3,SLC1A3,RYR3,GPM6A |
1.869e-02 | -3.98 | ventral spinal cord interneuron specification | biological process | GO:0021521 | 7 | 1 | 18204 | 49 |
GLI3 |
1.869e-02 | -3.98 | glial cell fate specification | biological process | GO:0021780 | 7 | 1 | 18204 | 49 |
NFIA |
1.869e-02 | -3.98 | hindgut morphogenesis | biological process | GO:0007442 | 7 | 1 | 18204 | 49 |
GLI3 |
1.869e-02 | -3.98 | cell fate specification involved in pattern specification | biological process | GO:0060573 | 7 | 1 | 18204 | 49 |
GLI3 |
1.869e-02 | -3.98 | chromosome movement towards spindle pole | biological process | GO:0051305 | 7 | 1 | 18204 | 49 |
FMN2 |
1.869e-02 | -3.98 | parallel actin filament bundle assembly | biological process | GO:0030046 | 7 | 1 | 18204 | 49 |
FMN2 |
1.869e-02 | -3.98 | cellular response to magnesium ion | biological process | GO:0071286 | 7 | 1 | 18204 | 49 |
RYR3 |
1.869e-02 | -3.98 | negative regulation of Arp2/3 complex-mediated actin nucleation | biological process | GO:0034316 | 7 | 1 | 18204 | 49 |
CTNNA2 |
1.869e-02 | -3.98 | positive regulation of transcription of Notch receptor target | biological process | GO:0007221 | 7 | 1 | 18204 | 49 |
MAML2 |
1.869e-02 | -3.98 | interneuron migration from the subpallium to the cortex | biological process | GO:0021830 | 7 | 1 | 18204 | 49 |
NRG3 |
1.869e-02 | -3.98 | forebrain dorsal/ventral pattern formation | biological process | GO:0021798 | 7 | 1 | 18204 | 49 |
GLI3 |
1.869e-02 | -3.98 | regulation of oligodendrocyte progenitor proliferation | biological process | GO:0070445 | 7 | 1 | 18204 | 49 |
PTPRZ1 |
1.869e-02 | -3.98 | forebrain radial glial cell differentiation | biological process | GO:0021861 | 7 | 1 | 18204 | 49 |
GLI3 |
1.872e-02 | -3.98 | regulation of glucose transmembrane transport | biological process | GO:0010827 | 78 | 2 | 18204 | 49 |
SLC1A2,SORBS1 |
1.872e-02 | -3.98 | positive regulation of osteoblast differentiation | biological process | GO:0045669 | 78 | 2 | 18204 | 49 |
GLI3,BMPR1B |
1.875e-02 | -3.98 | SPARC/Testican_Ca-bd-dom | interpro domains | IPR019577 | 7 | 1 | 18521 | 50 |
SPARCL1 |
1.875e-02 | -3.98 | GS_dom | interpro domains | IPR003605 | 7 | 1 | 18521 | 50 |
BMPR1B |
1.875e-02 | -3.98 | Alpha-catenin/vinculin-like_sf | interpro domains | IPR036723 | 7 | 1 | 18521 | 50 |
CTNNA2 |
1.875e-02 | -3.98 | Plakophilin/d_Catenin | interpro domains | IPR028435 | 7 | 1 | 18521 | 50 |
CTNND2 |
1.886e-02 | -3.97 | Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways | WikiPathways | WP706 | 162 | 3 | 5310 | 19 |
SLC1A3,NTRK2,RORA |
1.886e-02 | -3.97 | GSC (goosecoid homeobox) | protein interactions | 145258 | 82 | 2 | 19454 | 50 |
NFIA,SOX5 |
1.897e-02 | -3.96 | human chr12p11.23 | chromosome location | human chr12p11.23 | 10 | 1 | 26134 | 50 |
ITPR2 |
1.897e-02 | -3.96 | human chr9p24.2 | chromosome location | human chr9p24.2 | 10 | 1 | 26134 | 50 |
GLIS3 |
1.898e-02 | -3.96 | Cysteine Rich Protein | gene3d domains | 2.10.110.10 | 73 | 2 | 14470 | 42 |
NEBL,ABLIM1 |
1.902e-02 | -3.96 | testis | COSMIC cancer mutations | testis | 733 | 6 | 16828 | 49 |
PREX2,NTRK2,PRKCA,BMPR1B,TNIK,MACF1 |
1.912e-02 | -3.96 | TGF_beta_GS | pfam domains | PF08515 | 7 | 1 | 17795 | 49 |
BMPR1B |
1.912e-02 | -3.96 | SPARC_Ca_bdg | pfam domains | PF10591 | 7 | 1 | 17795 | 49 |
SPARCL1 |
1.920e-02 | -3.95 | EF_HAND_1 | prosite domains | PS00018 | 174 | 3 | 12186 | 40 |
SPARCL1,DST,MACF1 |
1.921e-02 | -3.95 | caveola | cellular component | GO:0005901 | 83 | 2 | 19108 | 49 |
SORBS1,ATP1A2 |
1.939e-02 | -3.94 | DAP12 interactions | REACTOME pathways | R-HSA-2172127 | 371 | 4 | 10285 | 29 |
ITPR2,NRG3,PRKCA,ADCY2 |
1.942e-02 | -3.94 | cellular response to nitrogen compound | biological process | GO:1901699 | 580 | 5 | 18204 | 49 |
SORBS1,RYR3,SLC1A3,SLC1A2,ITPR2 |
1.954e-02 | -3.94 | GLYPICAN | prosite domains | PS01207 | 6 | 1 | 12186 | 40 |
GPC5 |
1.954e-02 | -3.94 | transmembrane receptor protein kinase activity | molecular function | GO:0019199 | 81 | 2 | 18094 | 48 |
BMPR1B,NTRK2 |
1.955e-02 | -3.93 | sensory organ development | biological process | GO:0007423 | 581 | 5 | 18204 | 49 |
NTRK2,GLI3,BMPR1B,GPM6A,NFIA |
1.955e-02 | -3.93 | intracellular chemical homeostasis | biological process | GO:0055082 | 581 | 5 | 18204 | 49 |
RYR3,ZBTB20,SLC4A4,ATP1A2,SLC1A3 |
1.976e-02 | -3.92 | CAPZA2 (capping actin protein of muscle Z-line subunit alpha 2) | protein interactions | 830 | 403 | 4 | 19454 | 50 |
DST,ITPR2,MACF1,ABLIM1 |
2.009e-02 | -3.91 | adult locomotory behavior | biological process | GO:0008344 | 81 | 2 | 18204 | 49 |
PREX2,ATP1A2 |
2.020e-02 | -3.90 | SOX2 (SRY-box transcription factor 2) | protein interactions | 6657 | 1342 | 8 | 19454 | 50 |
NFIA,LSAMP,SOX5,GLIS3,ITPR2,MSI2,GLI3,MACF1 |
2.021e-02 | -3.90 | CH_dom | interpro domains | IPR001715 | 81 | 2 | 18521 | 50 |
DST,MACF1 |
2.021e-02 | -3.90 | skin-upper_leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma-nodular | 7 | 1 | 16828 | 49 |
PREX2 |
2.021e-02 | -3.90 | skin-face-malignant_melanoma-nodular | COSMIC cancer mutations | skin-face-malignant_melanoma-nodular | 7 | 1 | 16828 | 49 |
PREX2 |
2.023e-02 | -3.90 | Adherens junction | KEGG pathways | ko04520 | 72 | 2 | 7161 | 22 |
CTNNA2,SORBS1 |
2.023e-02 | -3.90 | Adherens junction | KEGG pathways | hsa04520 | 72 | 2 | 7161 | 22 |
CTNNA2,SORBS1 |
2.027e-02 | -3.90 | Signaling by PDGF | REACTOME pathways | R-HSA-186797 | 376 | 4 | 10285 | 29 |
PRKCA,ADCY2,ITPR2,NRG3 |
2.032e-02 | -3.90 | Vasopressin Regulation of Water Homeostasis | SMPDB pathways | SMP0000322 | 7 | 1 | 1369 | 4 |
ADCY2 |
2.032e-02 | -3.90 | g-Secretase Mediated ErbB4 Signalling Pathway | SMPDB pathways | SMP0089975 | 7 | 1 | 1369 | 4 |
PRKCA |
2.034e-02 | -3.90 | HFE-transferrin receptor complex | cellular component | GO:1990712 | 8 | 1 | 19108 | 49 |
BMPR1B |
2.034e-02 | -3.90 | zonula adherens | cellular component | GO:0005915 | 8 | 1 | 19108 | 49 |
SORBS1 |
2.034e-02 | -3.90 | hemidesmosome | cellular component | GO:0030056 | 8 | 1 | 19108 | 49 |
DST |
2.038e-02 | -3.89 | BMP15 (bone morphogenetic protein 15) | protein interactions | 9210 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | Rasd2 (RASD family, member 2) | protein interactions | 75141 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | Mrps31 (mitochondrial ribosomal protein S31) | protein interactions | 57312 | 8 | 1 | 19454 | 50 |
DST |
2.038e-02 | -3.89 | Prkca (protein kinase C, alpha) | protein interactions | 24680 | 8 | 1 | 19454 | 50 |
PRKCA |
2.038e-02 | -3.89 | Marcks (myristoylated alanine rich protein kinase C substrate) | protein interactions | 17118 | 8 | 1 | 19454 | 50 |
PRKCA |
2.038e-02 | -3.89 | CD163 (CD163 molecule) | protein interactions | 9332 | 8 | 1 | 19454 | 50 |
PRKCA |
2.038e-02 | -3.89 | Rps27a (ribosomal protein S27A) | protein interactions | 78294 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | INSM1 (INSM transcriptional repressor 1) | protein interactions | 3642 | 8 | 1 | 19454 | 50 |
SORBS1 |
2.038e-02 | -3.89 | LHB (luteinizing hormone subunit beta) | protein interactions | 3972 | 8 | 1 | 19454 | 50 |
NTM |
2.049e-02 | -3.89 | Ion channel transport | REACTOME pathways | R-HSA-983712 | 209 | 3 | 10285 | 29 |
RYR3,TRPM3,ATP1A2 |
2.063e-02 | -3.88 | SYNJ1 (synaptojanin 1) | protein interactions | 8867 | 86 | 2 | 19454 | 50 |
GPM6A,SORBS1 |
2.067e-02 | -3.88 | kidney-Wilms_tumour | COSMIC cancer mutations | kidney-Wilms_tumour | 545 | 5 | 16828 | 49 |
NTRK2,BMPR1B,PRKCA,TNIK,FMN2 |
2.068e-02 | -3.88 | CH_dom_sf | interpro domains | IPR036872 | 82 | 2 | 18521 | 50 |
MACF1,DST |
2.075e-02 | -3.88 | response to oxygen-containing compound | biological process | GO:1901700 | 1546 | 9 | 18204 | 49 |
SLC1A2,ATP1A2,ITPR2,ADCY2,ZBTB20,SORBS1,SLC1A3,RORA,RYR3 |
2.082e-02 | -3.87 | Wilms_tumour | COSMIC cancer mutations | Wilms_tumour | 546 | 5 | 16828 | 49 |
PRKCA,TNIK,BMPR1B,NTRK2,FMN2 |
2.103e-02 | -3.86 | glutamate binding | molecular function | GO:0016595 | 8 | 1 | 18094 | 48 |
SLC1A3 |
2.103e-02 | -3.86 | P-type potassium transmembrane transporter activity | molecular function | GO:0008556 | 8 | 1 | 18094 | 48 |
ATP1A2 |
2.103e-02 | -3.86 | BMP receptor activity | molecular function | GO:0098821 | 8 | 1 | 18094 | 48 |
BMPR1B |
2.103e-02 | -3.86 | sodium ion binding | molecular function | GO:0031402 | 8 | 1 | 18094 | 48 |
ATP1A2 |
2.106e-02 | -3.86 | eye-uveal_tract-malignant_melanoma-spindle | COSMIC cancer mutations | eye-uveal_tract-malignant_melanoma-spindle | 363 | 4 | 16828 | 49 |
PREX2,CTNND2,TRPM3,MACF1 |
2.108e-02 | -3.86 | ZNF608 (zinc finger protein 608) | protein interactions | 57507 | 87 | 2 | 19454 | 50 |
NFIA,SOX5 |
2.118e-02 | -3.85 | Regulation of insulin secretion | REACTOME pathways | R-HSA-422356 | 80 | 2 | 10285 | 29 |
PRKCA,ITPR2 |
2.123e-02 | -3.85 | H1-5 (H1.5 linker histone, cluster member) | protein interactions | 3009 | 412 | 4 | 19454 | 50 |
PARD3B,PRKCA,MGAT4C,CSGALNACT1 |
2.126e-02 | -3.85 | femur | COSMIC cancer mutations | femur | 1197 | 8 | 16828 | 49 |
GLI3,NRG3,ADCY2,SLC4A4,RYR3,PTPRZ1,GPC5,FMN2 |
2.127e-02 | -3.85 | DST (dystonin) | protein interactions | 667 | 230 | 3 | 19454 | 50 |
TNIK,ATP1A2,NTRK2 |
2.130e-02 | -3.85 | leg | COSMIC cancer mutations | leg | 969 | 7 | 16828 | 49 |
PTPRZ1,FMN2,NRG3,ZBTB20,NTM,SLC4A4,NEBL |
2.134e-02 | -3.85 | regulation of synapse structural plasticity | biological process | GO:0051823 | 8 | 1 | 18204 | 49 |
CTNNA2 |
2.134e-02 | -3.85 | hindgut development | biological process | GO:0061525 | 8 | 1 | 18204 | 49 |
GLI3 |
2.134e-02 | -3.85 | ERBB4 signaling pathway | biological process | GO:0038130 | 8 | 1 | 18204 | 49 |
NRG3 |
2.134e-02 | -3.85 | cerebellar granule cell precursor proliferation | biological process | GO:0021930 | 8 | 1 | 18204 | 49 |
RORA |
2.134e-02 | -3.85 | regulation of L-glutamate import across plasma membrane | biological process | GO:0002036 | 8 | 1 | 18204 | 49 |
ATP1A2 |
2.134e-02 | -3.85 | cell proliferation in external granule layer | biological process | GO:0021924 | 8 | 1 | 18204 | 49 |
RORA |
2.134e-02 | -3.85 | dermatan sulfate proteoglycan biosynthetic process | biological process | GO:0050651 | 8 | 1 | 18204 | 49 |
CSGALNACT1 |
2.134e-02 | -3.85 | mitotic nuclear membrane disassembly | biological process | GO:0007077 | 8 | 1 | 18204 | 49 |
PRKCA |
2.134e-02 | -3.85 | meiotic cytokinesis | biological process | GO:0033206 | 8 | 1 | 18204 | 49 |
FMN2 |
2.134e-02 | -3.85 | cell proliferation in hindbrain | biological process | GO:0021534 | 8 | 1 | 18204 | 49 |
RORA |
2.134e-02 | -3.85 | gamma-aminobutyric acid metabolic process | biological process | GO:0009448 | 8 | 1 | 18204 | 49 |
SLC1A3 |
2.134e-02 | -3.85 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | biological process | GO:0015014 | 8 | 1 | 18204 | 49 |
CSGALNACT1 |
2.140e-02 | -3.84 | TRPM_SLOG | interpro domains | IPR041491 | 8 | 1 | 18521 | 50 |
TRPM3 |
2.140e-02 | -3.84 | Chond_GalNAc | interpro domains | IPR008428 | 8 | 1 | 18521 | 50 |
CSGALNACT1 |
2.140e-02 | -3.84 | Adcy | interpro domains | IPR030672 | 8 | 1 | 18521 | 50 |
ADCY2 |
2.140e-02 | -3.84 | AC_N | interpro domains | IPR032628 | 8 | 1 | 18521 | 50 |
ADCY2 |
2.140e-02 | -3.84 | Villin_headpiece | interpro domains | IPR003128 | 8 | 1 | 18521 | 50 |
ABLIM1 |
2.140e-02 | -3.84 | Villin_headpiece_dom_sf | interpro domains | IPR036886 | 8 | 1 | 18521 | 50 |
ABLIM1 |
2.140e-02 | -3.84 | RFX-like | interpro domains | IPR039779 | 8 | 1 | 18521 | 50 |
RFX4 |
2.151e-02 | -3.84 | proteoglycan metabolic process | biological process | GO:0006029 | 84 | 2 | 18204 | 49 |
BMPR1B,CSGALNACT1 |
2.151e-02 | -3.84 | L-amino acid transport | biological process | GO:0015807 | 84 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
2.151e-02 | -3.84 | regulation of sodium ion transport | biological process | GO:0002028 | 84 | 2 | 18204 | 49 |
NKAIN3,ATP1A2 |
2.153e-02 | -3.84 | HSPG2 (heparan sulfate proteoglycan 2) | protein interactions | 3339 | 88 | 2 | 19454 | 50 |
GPC5,GLI3 |
2.153e-02 | -3.84 | RAP2A (RAP2A, member of RAS oncogene family) | protein interactions | 5911 | 88 | 2 | 19454 | 50 |
TNIK,BMPR1B |
2.162e-02 | -3.83 | ACTIVIN2R | prints domains | PR00653 | 6 | 1 | 5227 | 19 |
BMPR1B |
2.177e-02 | -3.83 | cAMP signaling pathway | KEGG pathways | hsa04024 | 198 | 3 | 7161 | 22 |
GLI3,ATP1A2,ADCY2 |
2.177e-02 | -3.83 | cAMP signaling pathway | KEGG pathways | ko04024 | 198 | 3 | 7161 | 22 |
GLI3,ADCY2,ATP1A2 |
2.182e-02 | -3.82 | CHGN | pfam domains | PF05679 | 8 | 1 | 17795 | 49 |
CSGALNACT1 |
2.182e-02 | -3.82 | AC_N | pfam domains | PF16214 | 8 | 1 | 17795 | 49 |
ADCY2 |
2.182e-02 | -3.82 | VHP | pfam domains | PF02209 | 8 | 1 | 17795 | 49 |
ABLIM1 |
2.182e-02 | -3.82 | LSDAT_euk | pfam domains | PF18139 | 8 | 1 | 17795 | 49 |
TRPM3 |
2.186e-02 | -3.82 | skin-upper_arm-malignant_melanoma | COSMIC cancer mutations | skin-upper_arm-malignant_melanoma | 553 | 5 | 16828 | 49 |
PARD3B,ITPR2,PREX2,SLC4A4,FMN2 |
2.199e-02 | -3.82 | regulation of smoothened signaling pathway | biological process | GO:0008589 | 85 | 2 | 18204 | 49 |
RORA,GLI3 |
2.201e-02 | -3.82 | - | gene3d domains | 2.80.10.50 | 79 | 2 | 14470 | 42 |
ITPR2,RYR3 |
2.201e-02 | -3.82 | Calponin-like domain | gene3d domains | 1.10.418.10 | 79 | 2 | 14470 | 42 |
MACF1,DST |
2.201e-02 | -3.82 | organic anion transport | biological process | GO:0015711 | 398 | 4 | 18204 | 49 |
SLC4A4,NTRK2,SLC1A2,SLC1A3 |
2.207e-02 | -3.81 | Endochondral Ossification | WikiPathways | WP474 | 65 | 2 | 5310 | 19 |
GLI3,SOX5 |
2.215e-02 | -3.81 | Endothelins | Pathway Interaction DB | endothelinpathway | 53 | 2 | 2226 | 10 |
ADCY2,PRKCA |
2.224e-02 | -3.81 | HMG20A (high mobility group 20A) | protein interactions | 10363 | 234 | 3 | 19454 | 50 |
SOX5,DTNA,NFIA |
2.234e-02 | -3.80 | Release of Hh-Np from the secreting cell | REACTOME pathways | R-HSA-5362798 | 8 | 1 | 10285 | 29 |
GPC5 |
2.234e-02 | -3.80 | HuR (ELAVL1) binds and stabilizes mRNA | REACTOME pathways | R-HSA-450520 | 8 | 1 | 10285 | 29 |
PRKCA |
2.246e-02 | -3.80 | CTDSPL (CTD small phosphatase like) | protein interactions | 10217 | 90 | 2 | 19454 | 50 |
FMN2,DTNA |
2.249e-02 | -3.79 | MARK3 (microtubule affinity regulating kinase 3) | protein interactions | 4140 | 235 | 3 | 19454 | 50 |
NTRK2,MACF1,DTNA |
2.264e-02 | -3.79 | LIM_DOMAIN_1 | prosite domains | PS00478 | 71 | 2 | 12186 | 40 |
ABLIM1,NEBL |
2.264e-02 | -3.79 | LIM_DOMAIN_2 | prosite domains | PS50023 | 71 | 2 | 12186 | 40 |
NEBL,ABLIM1 |
2.276e-02 | -3.78 | GS | prosite domains | PS51256 | 7 | 1 | 12186 | 40 |
BMPR1B |
2.285e-02 | -3.78 | platelet dense tubular network membrane | cellular component | GO:0031095 | 9 | 1 | 19108 | 49 |
ITPR2 |
2.285e-02 | -3.78 | flotillin complex | cellular component | GO:0016600 | 9 | 1 | 19108 | 49 |
SORBS1 |
2.290e-02 | -3.78 | VEPH1 (ventricular zone expressed PH domain containing 1) | protein interactions | 79674 | 9 | 1 | 19454 | 50 |
BMPR1B |
2.290e-02 | -3.78 | Tyw3 (tRNA-yW synthesizing protein 3 homolog (S. cerevisiae)) | protein interactions | 209584 | 9 | 1 | 19454 | 50 |
CTNNA2 |
2.290e-02 | -3.78 | SCTR (secretin receptor) | protein interactions | 6344 | 9 | 1 | 19454 | 50 |
PRKCA |
2.290e-02 | -3.78 | NRXN2 (neurexin 2) | protein interactions | 9379 | 9 | 1 | 19454 | 50 |
MACF1 |
2.292e-02 | -3.78 | DGUOK (deoxyguanosine kinase) | protein interactions | 1716 | 91 | 2 | 19454 | 50 |
GPM6A,NTM |
2.292e-02 | -3.78 | SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1) | protein interactions | 6654 | 91 | 2 | 19454 | 50 |
TNIK,SORBS1 |
2.294e-02 | -3.78 | positive regulation of nucleobase-containing compound metabolic process | biological process | GO:0045935 | 2118 | 11 | 18204 | 49 |
RORA,ZBTB20,BMPR1B,SLC4A4,FMN2,MAML2,GLI3,RFX4,GLIS3,NPAS3,NFIA |
2.296e-02 | -3.77 | dorsal/ventral pattern formation | biological process | GO:0009953 | 87 | 2 | 18204 | 49 |
GLI3,BMPR1B |
2.299e-02 | -3.77 | CAMK2A (calcium/calmodulin dependent protein kinase II alpha) | protein interactions | 815 | 237 | 3 | 19454 | 50 |
ITPR2,GPM6A,SOX5 |
2.299e-02 | -3.77 | Villin headpiece domain | gene3d domains | 1.10.950.10 | 8 | 1 | 14470 | 42 |
ABLIM1 |
2.306e-02 | -3.77 | skin-chest-malignant_melanoma-nodular | COSMIC cancer mutations | skin-chest-malignant_melanoma-nodular | 8 | 1 | 16828 | 49 |
PREX2 |
2.308e-02 | -3.77 | LAMP1 (lysosomal associated membrane protein 1) | protein interactions | 3916 | 635 | 5 | 19454 | 50 |
TNIK,FMN2,MACF1,DST,SLC1A3 |
2.309e-02 | -3.77 | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | 561 | 5 | 16828 | 49 |
MAML2,NTRK2,TNIK,PRKCA,RYR3 |
2.320e-02 | -3.76 | Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin | SMPDB pathways | SMP0000354 | 8 | 1 | 1369 | 4 |
ADCY2 |
2.334e-02 | -3.76 | myofibril | cellular component | GO:0030016 | 239 | 3 | 19108 | 49 |
NEBL,RYR3,DST |
2.341e-02 | -3.75 | CH | smart domains | SM00033 | 66 | 2 | 9717 | 35 |
DST,MACF1 |
2.363e-02 | -3.75 | calcium-dependent protein serine/threonine kinase activity | molecular function | GO:0009931 | 9 | 1 | 18094 | 48 |
PRKCA |
2.381e-02 | -3.74 | cell leading edge | cellular component | GO:0031252 | 428 | 4 | 19108 | 49 |
MACF1,SLC1A2,ABLIM1,DST |
2.381e-02 | -3.74 | collagen-containing extracellular matrix | cellular component | GO:0062023 | 428 | 4 | 19108 | 49 |
PTPRZ1,GPC5,DST,SPARCL1 |
2.384e-02 | -3.74 | DISC1 (DISC1 scaffold protein) | protein interactions | 27185 | 427 | 4 | 19454 | 50 |
TNIK,SPARCL1,DST,MACF1 |
2.385e-02 | -3.74 | intermediate filament cytoskeleton | cellular component | GO:0045111 | 241 | 3 | 19108 | 49 |
MACF1,DTNA,DST |
2.387e-02 | -3.74 | ARHGEF6 (Rac/Cdc42 guanine nucleotide exchange factor 6) | protein interactions | 9459 | 93 | 2 | 19454 | 50 |
ABLIM1,BMPR1B |
2.395e-02 | -3.73 | cell fate specification | biological process | GO:0001708 | 89 | 2 | 18204 | 49 |
NFIA,GLI3 |
2.395e-02 | -3.73 | positive regulation of lipid biosynthetic process | biological process | GO:0046889 | 89 | 2 | 18204 | 49 |
ZBTB20,SORBS1 |
2.397e-02 | -3.73 | cranial suture morphogenesis | biological process | GO:0060363 | 9 | 1 | 18204 | 49 |
GLI3 |
2.397e-02 | -3.73 | embryonic neurocranium morphogenesis | biological process | GO:0048702 | 9 | 1 | 18204 | 49 |
GLI3 |
2.397e-02 | -3.73 | negative regulation of actin nucleation | biological process | GO:0051126 | 9 | 1 | 18204 | 49 |
CTNNA2 |
2.397e-02 | -3.73 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | biological process | GO:0014808 | 9 | 1 | 18204 | 49 |
RYR3 |
2.397e-02 | -3.73 | negative regulation of striated muscle contraction | biological process | GO:0045988 | 9 | 1 | 18204 | 49 |
ATP1A2 |
2.397e-02 | -3.73 | semicircular canal development | biological process | GO:0060872 | 9 | 1 | 18204 | 49 |
GLI3 |
2.397e-02 | -3.73 | hindbrain radial glia guided cell migration | biological process | GO:0021932 | 9 | 1 | 18204 | 49 |
CTNNA2 |
2.401e-02 | -3.73 | ERBIN (erbb2 interacting protein) | protein interactions | 55914 | 241 | 3 | 19454 | 50 |
DST,NTRK2,CTNND2 |
2.404e-02 | -3.73 | Activin_recp | interpro domains | IPR000472 | 9 | 1 | 18521 | 50 |
BMPR1B |
2.404e-02 | -3.73 | Peptidase_S9 | interpro domains | IPR001375 | 9 | 1 | 18521 | 50 |
DPP10 |
2.404e-02 | -3.73 | Fol_N | interpro domains | IPR003645 | 9 | 1 | 18521 | 50 |
SPARCL1 |
2.404e-02 | -3.73 | Band3_cytoplasmic_dom | interpro domains | IPR013769 | 9 | 1 | 18521 | 50 |
SLC4A4 |
2.404e-02 | -3.73 | DNA-bd_RFX | interpro domains | IPR003150 | 9 | 1 | 18521 | 50 |
RFX4 |
2.408e-02 | -3.73 | ion binding | molecular function | GO:0043167 | 6007 | 23 | 18094 | 48 |
RYR3,GLI3,ITPR2,CSGALNACT1,MACF1,DTNA,TNIK,SLC1A2,ADCY2,DST,ABLIM1,RORA,NTRK2,PRKCA,SLC1A3,PAMR1,GLIS3,MGAT4C,PITPNC1,ZBTB20,BMPR1B,ATP1A2,SPARCL1 |
2.411e-02 | -3.73 | intracellular signaling cassette | biological process | GO:0141124 | 837 | 6 | 18204 | 49 |
RYR3,ADCY2,ATP1A2,ITPR2,TNIK,PREX2 |
2.420e-02 | -3.72 | ACTG1 (actin gamma 1) | protein interactions | 71 | 429 | 4 | 19454 | 50 |
ABLIM1,PRKCA,TNIK,FMN2 |
2.435e-02 | -3.72 | QSER1 (glutamine and serine rich 1) | protein interactions | 79832 | 94 | 2 | 19454 | 50 |
SOX5,NFIA |
2.435e-02 | -3.72 | FOXP4 (forkhead box P4) | protein interactions | 116113 | 94 | 2 | 19454 | 50 |
NFIA,SOX5 |
2.435e-02 | -3.72 | TRAF3IP1 (TRAF3 interacting protein 1) | protein interactions | 26146 | 94 | 2 | 19454 | 50 |
MACF1,DST |
2.435e-02 | -3.72 | GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) | protein interactions | 2902 | 94 | 2 | 19454 | 50 |
PRKCA,NTRK2 |
2.438e-02 | -3.71 | postsynapse | cellular component | GO:0098794 | 646 | 5 | 19108 | 49 |
GPM6A,CTNND2,ATP1A2,NTRK2,TNIK |
2.446e-02 | -3.71 | regulation of purine nucleotide metabolic process | biological process | GO:1900542 | 90 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
2.452e-02 | -3.71 | Peptidase_S9 | pfam domains | PF00326 | 9 | 1 | 17795 | 49 |
DPP10 |
2.452e-02 | -3.71 | RFX_DNA_binding | pfam domains | PF02257 | 9 | 1 | 17795 | 49 |
RFX4 |
2.452e-02 | -3.71 | Band_3_cyto | pfam domains | PF07565 | 9 | 1 | 17795 | 49 |
SLC4A4 |
2.452e-02 | -3.71 | Activin_recp | pfam domains | PF01064 | 9 | 1 | 17795 | 49 |
BMPR1B |
2.459e-02 | -3.71 | human chr5p15.1 | chromosome location | human chr5p15.1 | 13 | 1 | 26134 | 50 |
FBXL7 |
2.495e-02 | -3.69 | GS | smart domains | SM00467 | 7 | 1 | 9717 | 35 |
BMPR1B |
2.496e-02 | -3.69 | regulation of nucleotide metabolic process | biological process | GO:0006140 | 91 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
2.496e-02 | -3.69 | cellular response to BMP stimulus | biological process | GO:0071773 | 91 | 2 | 18204 | 49 |
NFIA,BMPR1B |
2.496e-02 | -3.69 | response to BMP | biological process | GO:0071772 | 91 | 2 | 18204 | 49 |
BMPR1B,NFIA |
2.496e-02 | -3.69 | DNA-binding transcription factor activity, RNA polymerase II-specific | molecular function | GO:0000981 | 1355 | 8 | 18094 | 48 |
SOX5,RFX4,NPAS3,RORA,NFIA,GLIS3,GLI3,ZBTB20 |
2.504e-02 | -3.69 | upper_aerodigestive_tract-lymph_node-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-lymph_node-carcinoma-adenoid_cystic_carcinoma | 383 | 4 | 16828 | 49 |
MAML2,TNIK,PRKCA,NTRK2 |
2.504e-02 | -3.69 | salivary_gland-carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma | 383 | 4 | 16828 | 49 |
PRKCA,TNIK,NTRK2,MAML2 |
2.504e-02 | -3.69 | upper_aerodigestive_tract-head_neck-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-adenoid_cystic_carcinoma | 383 | 4 | 16828 | 49 |
MAML2,PRKCA,TNIK,NTRK2 |
2.504e-02 | -3.69 | upper_aerodigestive_tract-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-carcinoma | 383 | 4 | 16828 | 49 |
MAML2,NTRK2,TNIK,PRKCA |
2.504e-02 | -3.69 | upper_aerodigestive_tract-mouth-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-adenoid_cystic_carcinoma | 383 | 4 | 16828 | 49 |
MAML2,TNIK,PRKCA,NTRK2 |
2.510e-02 | -3.68 | EGFR Transactivation by Gastrin | REACTOME pathways | R-HSA-2179392 | 9 | 1 | 10285 | 29 |
PRKCA |
2.521e-02 | -3.68 | sarcoplasm | cellular component | GO:0016528 | 96 | 2 | 19108 | 49 |
ITPR2,RYR3 |
2.523e-02 | -3.68 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-NK-T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-NK-T_cell_lymphoma | 217 | 3 | 16828 | 49 |
DTNA,MGAT4C,RFX4 |
2.536e-02 | -3.67 | perineuronal net | cellular component | GO:0072534 | 10 | 1 | 19108 | 49 |
PTPRZ1 |
2.541e-02 | -3.67 | Vbp1 (von Hippel-Lindau binding protein 1) | protein interactions | 22327 | 10 | 1 | 19454 | 50 |
ABLIM1 |
2.541e-02 | -3.67 | TNP1 (transition protein 1) | protein interactions | 7141 | 10 | 1 | 19454 | 50 |
PRKCA |
2.541e-02 | -3.67 | SLC8A2 (solute carrier family 8 member A2) | protein interactions | 6543 | 10 | 1 | 19454 | 50 |
GPM6A |
2.541e-02 | -3.67 | BANK1 (B cell scaffold protein with ankyrin repeats 1) | protein interactions | 55024 | 10 | 1 | 19454 | 50 |
ITPR2 |
2.541e-02 | -3.67 | PPY (pancreatic polypeptide) | protein interactions | 5539 | 10 | 1 | 19454 | 50 |
PRKCA |
2.541e-02 | -3.67 | CALB2 (calbindin 2) | protein interactions | 794 | 10 | 1 | 19454 | 50 |
GPM6A |
2.541e-02 | -3.67 | Smurf2 (SMAD specific E3 ubiquitin protein ligase 2) | protein interactions | 66313 | 10 | 1 | 19454 | 50 |
GLIS3 |
2.541e-02 | -3.67 | P2rx7 (purinergic receptor P2X 7) | protein interactions | 29665 | 10 | 1 | 19454 | 50 |
PTPRZ1 |
2.541e-02 | -3.67 | GSG1 (germ cell associated 1) | protein interactions | 83445 | 10 | 1 | 19454 | 50 |
PITPNC1 |
2.548e-02 | -3.67 | protein tetramerization | biological process | GO:0051262 | 92 | 2 | 18204 | 49 |
RYR3,TRPM3 |
2.568e-02 | -3.66 | spindle | COSMIC cancer mutations | spindle | 386 | 4 | 16828 | 49 |
MACF1,CTNND2,TRPM3,PREX2 |
2.581e-02 | -3.66 | Tpm1 (tropomyosin 1, alpha) | protein interactions | 22003 | 97 | 2 | 19454 | 50 |
ABLIM1,DST |
2.585e-02 | -3.66 | NCOR2 (nuclear receptor corepressor 2) | protein interactions | 9612 | 248 | 3 | 19454 | 50 |
SOX5,TNIK,NFIA |
2.586e-02 | -3.66 | parotid | COSMIC cancer mutations | parotid | 578 | 5 | 16828 | 49 |
MAML2,TNIK,PRKCA,RYR3,NTRK2 |
2.591e-02 | -3.65 | skin-upper_leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 49 |
PREX2 |
2.591e-02 | -3.65 | skin-chest-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-chest-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 49 |
PREX2 |
2.595e-02 | -3.65 | contractile muscle fiber | cellular component | GO:0043292 | 249 | 3 | 19108 | 49 |
RYR3,DST,NEBL |
2.597e-02 | -3.65 | HP | prosite domains | PS51089 | 8 | 1 | 12186 | 40 |
ABLIM1 |
2.599e-02 | -3.65 | enzyme-linked receptor protein signaling pathway | biological process | GO:0007167 | 626 | 5 | 18204 | 49 |
NRG3,NTRK2,NFIA,BMPR1B,SORBS1 |
2.599e-02 | -3.65 | intermediate filament cytoskeleton organization | biological process | GO:0045104 | 93 | 2 | 18204 | 49 |
DST,MACF1 |
2.607e-02 | -3.65 | Excitatory Neural Signalling Through 5-HTR 7 and Serotonin | SMPDB pathways | SMP0000311 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Nitric Oxide Signaling Pathway | SMPDB pathways | SMP0063777 | 9 | 1 | 1369 | 4 |
PRKCA |
2.607e-02 | -3.65 | Excitatory Neural Signalling Through 5-HTR 6 and Serotonin | SMPDB pathways | SMP0000312 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone | SMPDB pathways | SMP0000333 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Excitatory Neural Signalling Through 5-HTR 4 and Serotonin | SMPDB pathways | SMP0000309 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Intracellular Signalling Through Histamine H2 Receptor and Histamine | SMPDB pathways | SMP0000335 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.616e-02 | -3.64 | muscle contraction | biological process | GO:0006936 | 238 | 3 | 18204 | 49 |
DTNA,RYR3,ATP1A2 |
2.616e-02 | -3.64 | protein localization to cell periphery | biological process | GO:1990778 | 238 | 3 | 18204 | 49 |
DPP10,MACF1,TNIK |
2.618e-02 | -3.64 | axon development | biological process | GO:0061564 | 420 | 4 | 18204 | 49 |
GLI3,PTPRZ1,CTNNA2,BMPR1B |
2.621e-02 | -3.64 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 44 | 16828 | 49 |
RORA,GLI3,SLC4A4,GLIS3,RFX4,ZBTB20,TPD52L1,NRG3,FMN2,DPP10,CTNND2,PARD3B,SORBS1,GPC5,PAMR1,RYR3,MAML2,PRKCA,ATP1A2,ITPR2,NEBL,BMPR1B,CSGALNACT1,MACF1,ADCY2,NTRK2,CDH20,SPARCL1,NHSL1,DST,SLC1A3,SOX5,TNIK,NTM,PREX2,GPM6A,MGAT4C,TRPM3,NPAS3,NKAIN3,SLC1A2,FBXL7,LSAMP,PTPRZ1 |
2.622e-02 | -3.64 | neurotrophin binding | molecular function | GO:0043121 | 10 | 1 | 18094 | 48 |
NTRK2 |
2.622e-02 | -3.64 | phosphatidylinositol transfer activity | molecular function | GO:0008526 | 10 | 1 | 18094 | 48 |
PITPNC1 |
2.622e-02 | -3.64 | calcium-dependent protein kinase activity | molecular function | GO:0010857 | 10 | 1 | 18094 | 48 |
PRKCA |
2.631e-02 | -3.64 | DNAAF2 (dynein axonemal assembly factor 2) | protein interactions | 55172 | 98 | 2 | 19454 | 50 |
LSAMP,GPM6A |
2.631e-02 | -3.64 | FRS2 (fibroblast growth factor receptor substrate 2) | protein interactions | 10818 | 98 | 2 | 19454 | 50 |
SORBS1,NTRK2 |
2.645e-02 | -3.63 | dermatan sulfate biosynthesis | BIOCYC pathways | HUMAN_PWY-6571 | 12 | 1 | 902 | 2 |
CSGALNACT1 |
2.651e-02 | -3.63 | intermediate filament-based process | biological process | GO:0045103 | 94 | 2 | 18204 | 49 |
MACF1,DST |
2.654e-02 | -3.63 | upper_arm | COSMIC cancer mutations | upper_arm | 582 | 5 | 16828 | 49 |
ITPR2,PARD3B,PREX2,FMN2,SLC4A4 |
2.660e-02 | -3.63 | establishment of centrosome localization | biological process | GO:0051660 | 10 | 1 | 18204 | 49 |
PARD3B |
2.660e-02 | -3.63 | desmosome organization | biological process | GO:0002934 | 10 | 1 | 18204 | 49 |
PRKCA |
2.660e-02 | -3.63 | regulation of bone development | biological process | GO:1903010 | 10 | 1 | 18204 | 49 |
GLI3 |
2.660e-02 | -3.63 | retinal rod cell development | biological process | GO:0046548 | 10 | 1 | 18204 | 49 |
NTRK2 |
2.660e-02 | -3.63 | cAMP biosynthetic process | biological process | GO:0006171 | 10 | 1 | 18204 | 49 |
ADCY2 |
2.660e-02 | -3.63 | cellular response to brain-derived neurotrophic factor stimulus | biological process | GO:1990416 | 10 | 1 | 18204 | 49 |
NTRK2 |
2.660e-02 | -3.63 | trans-synaptic signaling, modulating synaptic transmission | biological process | GO:0099550 | 10 | 1 | 18204 | 49 |
NTRK2 |
2.660e-02 | -3.63 | substrate-independent telencephalic tangential migration | biological process | GO:0021826 | 10 | 1 | 18204 | 49 |
NRG3 |
2.660e-02 | -3.63 | spinal cord motor neuron cell fate specification | biological process | GO:0021520 | 10 | 1 | 18204 | 49 |
GLI3 |
2.660e-02 | -3.63 | regulation of mesenchymal stem cell differentiation | biological process | GO:2000739 | 10 | 1 | 18204 | 49 |
SOX5 |
2.660e-02 | -3.63 | positive regulation of lipopolysaccharide-mediated signaling pathway | biological process | GO:0031666 | 10 | 1 | 18204 | 49 |
PRKCA |
2.660e-02 | -3.63 | substrate-independent telencephalic tangential interneuron migration | biological process | GO:0021843 | 10 | 1 | 18204 | 49 |
NRG3 |
2.660e-02 | -3.63 | negative regulation of glial cell apoptotic process | biological process | GO:0034351 | 10 | 1 | 18204 | 49 |
PRKCA |
2.660e-02 | -3.63 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | biological process | GO:1903514 | 10 | 1 | 18204 | 49 |
RYR3 |
2.666e-02 | -3.62 | Ig_sub2 | interpro domains | IPR003598 | 239 | 3 | 18521 | 50 |
NTM,LSAMP,NTRK2 |
2.668e-02 | -3.62 | PAS_fold_3 | interpro domains | IPR013655 | 10 | 1 | 18521 | 50 |
NPAS3 |
2.668e-02 | -3.62 | HCO3_transpt_euk | interpro domains | IPR003020 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | HCO3_transpt-like_TM_dom | interpro domains | IPR011531 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | PTrfase/Anion_transptr | interpro domains | IPR016152 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.682e-02 | -3.62 | LIM | smart domains | SM00132 | 71 | 2 | 9717 | 35 |
NEBL,ABLIM1 |
2.701e-02 | -3.61 | STX6 (syntaxin 6) | protein interactions | 10228 | 444 | 4 | 19454 | 50 |
DTNA,DST,CSGALNACT1,MACF1 |
2.704e-02 | -3.61 | calcium ion transmembrane import into cytosol | biological process | GO:0097553 | 95 | 2 | 18204 | 49 |
RYR3,ITPR2 |
2.717e-02 | -3.61 | MYH9 (myosin heavy chain 9) | protein interactions | 4627 | 663 | 5 | 19454 | 50 |
MACF1,DST,ITPR2,ABLIM1,ZBTB20 |
2.720e-02 | -3.60 | PAS_3 | pfam domains | PF08447 | 10 | 1 | 17795 | 49 |
NPAS3 |
2.720e-02 | -3.60 | HCO3_cotransp | pfam domains | PF00955 | 10 | 1 | 17795 | 49 |
SLC4A4 |
2.731e-02 | -3.60 | SUFU (SUFU negative regulator of hedgehog signaling) | protein interactions | 51684 | 100 | 2 | 19454 | 50 |
GLIS3,GLI3 |
2.731e-02 | -3.60 | ATP4A (ATPase H+/K+ transporting subunit alpha) | protein interactions | 495 | 100 | 2 | 19454 | 50 |
GPM6A,ATP1A2 |
2.737e-02 | -3.60 | pancreas-other-adenoma | COSMIC cancer mutations | pancreas-other-adenoma | 224 | 3 | 16828 | 49 |
CTNND2,PRKCA,BMPR1B |
2.741e-02 | -3.60 | uveal_tract | COSMIC cancer mutations | uveal_tract | 587 | 5 | 16828 | 49 |
MACF1,TRPM3,CTNND2,PREX2,ADCY2 |
2.748e-02 | -3.59 | Post-translational modification: synthesis of GPI-anchored proteins | REACTOME pathways | R-HSA-163125 | 92 | 2 | 10285 | 29 |
NTM,LSAMP |
2.758e-02 | -3.59 | ErbB signaling pathway | KEGG pathways | ko04012 | 85 | 2 | 7161 | 22 |
PRKCA,NRG3 |
2.758e-02 | -3.59 | ErbB signaling pathway | KEGG pathways | hsa04012 | 85 | 2 | 7161 | 22 |
PRKCA,NRG3 |
2.769e-02 | -3.59 | NK-T_cell_lymphoma | COSMIC cancer mutations | NK-T_cell_lymphoma | 225 | 3 | 16828 | 49 |
MGAT4C,DTNA,RFX4 |
2.780e-02 | -3.58 | intracellular monoatomic cation homeostasis | biological process | GO:0030003 | 428 | 4 | 18204 | 49 |
SLC1A3,ATP1A2,SLC4A4,RYR3 |
2.785e-02 | -3.58 | Bicarbonate transporters | REACTOME pathways | R-HSA-425381 | 10 | 1 | 10285 | 29 |
SLC4A4 |
2.785e-02 | -3.58 | Acetylcholine regulates insulin secretion | REACTOME pathways | R-HSA-399997 | 10 | 1 | 10285 | 29 |
PRKCA |
2.785e-02 | -3.58 | PI3K events in ERBB4 signaling | REACTOME pathways | R-HSA-1250342 | 10 | 1 | 10285 | 29 |
NRG3 |
2.785e-02 | -3.58 | Adenylate cyclase activating pathway | REACTOME pathways | R-HSA-170660 | 10 | 1 | 10285 | 29 |
ADCY2 |
2.786e-02 | -3.58 | platelet dense tubular network | cellular component | GO:0031094 | 11 | 1 | 19108 | 49 |
ITPR2 |
2.786e-02 | -3.58 | perisynaptic extracellular matrix | cellular component | GO:0098966 | 11 | 1 | 19108 | 49 |
PTPRZ1 |
2.792e-02 | -3.58 | ITPKA (inositol-trisphosphate 3-kinase A) | protein interactions | 3706 | 11 | 1 | 19454 | 50 |
PRKCA |
2.792e-02 | -3.58 | Gtf2e2 (general transcription factor II E, polypeptide 2 (beta subunit)) | protein interactions | 68153 | 11 | 1 | 19454 | 50 |
NHSL1 |
2.792e-02 | -3.58 | Wipi2 (WD repeat domain, phosphoinositide interacting 2) | protein interactions | 74781 | 11 | 1 | 19454 | 50 |
MACF1 |
2.792e-02 | -3.58 | Cobll1 (Cobl-like 1) | protein interactions | 319876 | 11 | 1 | 19454 | 50 |
ABLIM1 |
2.792e-02 | -3.58 | AQP5 (aquaporin 5) | protein interactions | 362 | 11 | 1 | 19454 | 50 |
ATP1A2 |
2.792e-02 | -3.58 | Batf3 (basic leucine zipper transcription factor, ATF-like 3) | protein interactions | 381319 | 11 | 1 | 19454 | 50 |
MACF1 |
2.792e-02 | -3.58 | IRAG1 (inositol 1,4,5-triphosphate receptor associated 1) | protein interactions | 10335 | 11 | 1 | 19454 | 50 |
ITPR2 |
2.792e-02 | -3.58 | SYN3 (synapsin III) | protein interactions | 8224 | 11 | 1 | 19454 | 50 |
GPM6A |
2.792e-02 | -3.58 | TMEM53 (transmembrane protein 53) | protein interactions | 79639 | 11 | 1 | 19454 | 50 |
PRKCA |
2.802e-02 | -3.58 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | molecular function | GO:0000977 | 1385 | 8 | 18094 | 48 |
GLIS3,GLI3,ZBTB20,RORA,NFIA,NPAS3,RFX4,SOX5 |
2.810e-02 | -3.57 | positive regulation of JNK cascade | biological process | GO:0046330 | 97 | 2 | 18204 | 49 |
TPD52L1,TNIK |
2.810e-02 | -3.57 | nerve development | biological process | GO:0021675 | 97 | 2 | 18204 | 49 |
GLI3,SLC1A3 |
2.810e-02 | -3.57 | amino acid transmembrane transport | biological process | GO:0003333 | 97 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
2.832e-02 | -3.56 | human chr8q12.3 | chromosome location | human chr8q12.3 | 15 | 1 | 26134 | 50 |
NKAIN3 |
2.832e-02 | -3.56 | human chr10p12.31 | chromosome location | human chr10p12.31 | 15 | 1 | 26134 | 50 |
NEBL |
2.842e-02 | -3.56 | trans-synaptic signaling | biological process | GO:0099537 | 431 | 4 | 18204 | 49 |
DTNA,NTRK2,SLC1A2,SLC1A3 |
2.846e-02 | -3.56 | VHP | smart domains | SM00153 | 8 | 1 | 9717 | 35 |
ABLIM1 |
2.847e-02 | -3.56 | regulation of synapse organization | biological process | GO:0050807 | 246 | 3 | 18204 | 49 |
NTRK2,GPM6A,CTNNA2 |
2.865e-02 | -3.55 | HER-positive_carcinoma | COSMIC cancer mutations | HER-positive_carcinoma | 2025 | 11 | 16828 | 49 |
GLI3,PRKCA,NTRK2,MSI2,MAML2,RORA,ABLIM1,NRG3,PAMR1,GPC5,BMPR1B |
2.865e-02 | -3.55 | breast-carcinoma-HER-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-HER-positive_carcinoma | 2025 | 11 | 16828 | 49 |
MSI2,NRG3,MAML2,RORA,PRKCA,GLI3,NTRK2,PAMR1,ABLIM1,GPC5,BMPR1B |
2.866e-02 | -3.55 | Helical hairpin bin | gene3d domains | 1.10.287.570 | 10 | 1 | 14470 | 42 |
SLC4A4 |
2.875e-02 | -3.55 | skin-back-malignant_melanoma-nodular | COSMIC cancer mutations | skin-back-malignant_melanoma-nodular | 10 | 1 | 16828 | 49 |
PREX2 |
2.880e-02 | -3.55 | histone H3 kinase activity | molecular function | GO:0140996 | 11 | 1 | 18094 | 48 |
PRKCA |
2.880e-02 | -3.55 | sulfur amino acid transmembrane transporter activity | molecular function | GO:0000099 | 11 | 1 | 18094 | 48 |
SLC1A2 |
2.884e-02 | -3.55 | CSGALNACT2 (chondroitin sulfate N-acetylgalactosaminyltransferase 2) | protein interactions | 55454 | 103 | 2 | 19454 | 50 |
MGAT4C,CSGALNACT1 |
2.884e-02 | -3.55 | RAB6B (RAB6B, member RAS oncogene family) | protein interactions | 51560 | 103 | 2 | 19454 | 50 |
GPM6A,BMPR1B |
2.884e-02 | -3.55 | ID2 (inhibitor of DNA binding 2) | protein interactions | 3398 | 103 | 2 | 19454 | 50 |
MACF1,DST |
2.892e-02 | -3.54 | CH | prosite domains | PS50021 | 81 | 2 | 12186 | 40 |
MACF1,DST |
2.893e-02 | -3.54 | amino acid transmembrane transporter activity | molecular function | GO:0015171 | 100 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
2.893e-02 | -3.54 | Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin | SMPDB pathways | SMP0000338 | 10 | 1 | 1369 | 4 |
ADCY2 |
2.916e-02 | -3.54 | monoatomic ion channel activity | molecular function | GO:0005216 | 441 | 4 | 18094 | 48 |
GPM6A,ITPR2,TRPM3,RYR3 |
2.917e-02 | -3.53 | RFX_DBD | prosite domains | PS51526 | 9 | 1 | 12186 | 40 |
RFX4 |
2.922e-02 | -3.53 | cell fate commitment involved in pattern specification | biological process | GO:0060581 | 11 | 1 | 18204 | 49 |
GLI3 |
2.922e-02 | -3.53 | heparin biosynthetic process | biological process | GO:0030210 | 11 | 1 | 18204 | 49 |
CSGALNACT1 |
2.922e-02 | -3.53 | thymocyte apoptotic process | biological process | GO:0070242 | 11 | 1 | 18204 | 49 |
GLI3 |
2.922e-02 | -3.53 | establishment or maintenance of transmembrane electrochemical gradient | biological process | GO:0010248 | 11 | 1 | 18204 | 49 |
ATP1A2 |
2.922e-02 | -3.53 | glutamate secretion | biological process | GO:0014047 | 11 | 1 | 18204 | 49 |
NTRK2 |
2.922e-02 | -3.53 | ectodermal placode formation | biological process | GO:0060788 | 11 | 1 | 18204 | 49 |
NRG3 |
2.922e-02 | -3.53 | lactone metabolic process | biological process | GO:1901334 | 11 | 1 | 18204 | 49 |
ATP1A2 |
2.922e-02 | -3.53 | antral ovarian follicle growth | biological process | GO:0001547 | 11 | 1 | 18204 | 49 |
BMPR1B |
2.922e-02 | -3.53 | cellular response to caffeine | biological process | GO:0071313 | 11 | 1 | 18204 | 49 |
RYR3 |
2.922e-02 | -3.53 | L-ascorbic acid metabolic process | biological process | GO:0019852 | 11 | 1 | 18204 | 49 |
ATP1A2 |
2.922e-02 | -3.53 | ectodermal placode morphogenesis | biological process | GO:0071697 | 11 | 1 | 18204 | 49 |
NRG3 |
2.922e-02 | -3.53 | negative regulation of neuron migration | biological process | GO:2001223 | 11 | 1 | 18204 | 49 |
NRG3 |
2.922e-02 | -3.53 | ventral spinal cord interneuron fate commitment | biological process | GO:0060579 | 11 | 1 | 18204 | 49 |
GLI3 |
2.929e-02 | -3.53 | EF-hand_7 | pfam domains | PF13499 | 97 | 2 | 17795 | 49 |
MACF1,DST |
2.931e-02 | -3.53 | Tyr_kinase_rcpt_2_CS | interpro domains | IPR002011 | 11 | 1 | 18521 | 50 |
NTRK2 |
2.936e-02 | -3.53 | CDH5 (cadherin 5) | protein interactions | 1003 | 104 | 2 | 19454 | 50 |
CTNNA2,PRKCA |
2.941e-02 | -3.53 | GABAergic synapse | KEGG pathways | ko04727 | 88 | 2 | 7161 | 22 |
PRKCA,ADCY2 |
2.941e-02 | -3.53 | GABAergic synapse | KEGG pathways | hsa04727 | 88 | 2 | 7161 | 22 |
PRKCA,ADCY2 |
2.970e-02 | -3.52 | intracellular monoatomic ion homeostasis | biological process | GO:0006873 | 437 | 4 | 18204 | 49 |
ATP1A2,SLC1A3,RYR3,SLC4A4 |
2.979e-02 | -3.51 | active transmembrane transporter activity | molecular function | GO:0022804 | 444 | 4 | 18094 | 48 |
SLC1A3,ATP1A2,SLC4A4,SLC1A2 |
3.021e-02 | -3.50 | response to organic substance | biological process | GO:0010033 | 2498 | 12 | 18204 | 49 |
SORBS1,ADCY2,SLC1A2,ZBTB20,ATP1A2,ITPR2,NTRK2,PRKCA,RYR3,TNIK,RORA,SLC1A3 |
3.026e-02 | -3.50 | Pathways in cancer | KEGG pathways | hsa05200 | 395 | 4 | 7161 | 22 |
PRKCA,CTNNA2,ADCY2,GLI3 |
3.027e-02 | -3.50 | regulation of glucose metabolic process | biological process | GO:0010906 | 101 | 2 | 18204 | 49 |
SORBS1,RORA |
3.027e-02 | -3.50 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 3 | 18204 | 49 |
NTRK2,CTNNA2,GPM6A |
3.035e-02 | -3.49 | sodium:potassium-exchanging ATPase complex | cellular component | GO:0005890 | 12 | 1 | 19108 | 49 |
ATP1A2 |
3.035e-02 | -3.49 | synapse-associated extracellular matrix | cellular component | GO:0099535 | 12 | 1 | 19108 | 49 |
PTPRZ1 |
3.042e-02 | -3.49 | XK (X-linked Kx blood group antigen, Kell and VPS13A binding protein) | protein interactions | 7504 | 12 | 1 | 19454 | 50 |
PRKCA |
3.042e-02 | -3.49 | LMP-1 (latent membrane protein LMP-1) | protein interactions | 3783750 | 12 | 1 | 19454 | 50 |
TNIK |
3.042e-02 | -3.49 | ART4 (ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)) | protein interactions | 420 | 12 | 1 | 19454 | 50 |
GPM6A |
3.042e-02 | -3.49 | NTF4 (neurotrophin 4) | protein interactions | 4909 | 12 | 1 | 19454 | 50 |
NTRK2 |
3.042e-02 | -3.49 | CA4 (carbonic anhydrase 4) | protein interactions | 762 | 12 | 1 | 19454 | 50 |
SLC4A4 |
3.042e-02 | -3.49 | BAMBI (BMP and activin membrane bound inhibitor) | protein interactions | 25805 | 12 | 1 | 19454 | 50 |
BMPR1B |
3.042e-02 | -3.49 | Ctnnbl1 (catenin, beta like 1) | protein interactions | 66642 | 12 | 1 | 19454 | 50 |
PRKCA |
3.060e-02 | -3.49 | Type I hemidesmosome assembly | REACTOME pathways | R-HSA-446107 | 11 | 1 | 10285 | 29 |
DST |
3.082e-02 | -3.48 | alpha-beta T cell activation | biological process | GO:0046631 | 102 | 2 | 18204 | 49 |
GLI3,RORA |
3.083e-02 | -3.48 | response to stimulus | biological process | GO:0050896 | 7803 | 28 | 18204 | 49 |
GPM6A,ADCY2,SORBS1,CTNND2,TNIK,DTNA,CTNNA2,BMPR1B,ZBTB20,PRKCA,SOX5,NTRK2,FMN2,MACF1,NFIA,SPARCL1,SLC1A2,PREX2,DST,RYR3,PITPNC1,SLC1A3,NRG3,RORA,GLI3,ATP1A2,MAML2,ITPR2 |
3.087e-02 | -3.48 | eye | COSMIC cancer mutations | eye | 606 | 5 | 16828 | 49 |
PREX2,ADCY2,MACF1,CTNND2,TRPM3 |
3.100e-02 | -3.47 | RHOA (ras homolog family member A) | protein interactions | 387 | 1186 | 7 | 19454 | 50 |
MACF1,PREX2,ITPR2,PARD3B,CTNNA2,PRKCA,FMN2 |
3.101e-02 | -3.47 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 4 | 18204 | 49 |
MACF1,CTNNA2,NTRK2,TNIK |
3.107e-02 | -3.47 | MCAM (melanoma cell adhesion molecule) | protein interactions | 4162 | 464 | 4 | 19454 | 50 |
TNIK,PARD3B,CTNNA2,DST |
3.129e-02 | -3.46 | Morphine addiction | KEGG pathways | hsa05032 | 91 | 2 | 7161 | 22 |
ADCY2,PRKCA |
3.129e-02 | -3.46 | Morphine addiction | KEGG pathways | ko05032 | 91 | 2 | 7161 | 22 |
ADCY2,PRKCA |
3.138e-02 | -3.46 | regulation of neural precursor cell proliferation | biological process | GO:2000177 | 103 | 2 | 18204 | 49 |
GLI3,PTPRZ1 |
3.138e-02 | -3.46 | dipeptidyl-peptidase activity | molecular function | GO:0008239 | 12 | 1 | 18094 | 48 |
DPP10 |
3.138e-02 | -3.46 | adenylate cyclase binding | molecular function | GO:0008179 | 12 | 1 | 18094 | 48 |
ADCY2 |
3.138e-02 | -3.46 | inositol 1,4,5 trisphosphate binding | molecular function | GO:0070679 | 12 | 1 | 18094 | 48 |
ITPR2 |
3.147e-02 | -3.46 | DSG4 (desmoglein 4) | protein interactions | 147409 | 108 | 2 | 19454 | 50 |
SPARCL1,CSGALNACT1 |
3.147e-02 | -3.46 | FKBP1A (FKBP prolyl isomerase 1A) | protein interactions | 2280 | 108 | 2 | 19454 | 50 |
MSI2,RYR3 |
3.149e-02 | -3.46 | PFN1 (profilin 1) | protein interactions | 5216 | 466 | 4 | 19454 | 50 |
FMN2,NHSL1,ABLIM1,MACF1 |
3.151e-02 | -3.46 | protein complex oligomerization | biological process | GO:0051259 | 256 | 3 | 18204 | 49 |
RYR3,TRPM3,SLC1A2 |
3.158e-02 | -3.46 | skin-hand-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-hand-malignant_melanoma-acral_lentiginous | 11 | 1 | 16828 | 49 |
PREX2 |
3.158e-02 | -3.46 | skin-back-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-back-malignant_melanoma-superficial_spreading | 11 | 1 | 16828 | 49 |
PREX2 |
3.167e-02 | -3.45 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 8 | 16828 | 49 |
ADCY2,ZBTB20,PARD3B,GLI3,FMN2,DST,DPP10,PTPRZ1 |
3.177e-02 | -3.45 | Tgif disruption of Shh signaling | WikiPathways | WP3674 | 9 | 1 | 5310 | 19 |
GLI3 |
3.179e-02 | -3.45 | NAD+ Signalling and Aging | SMPDB pathways | SMP0084271 | 11 | 1 | 1369 | 4 |
RORA |
3.182e-02 | -3.45 | cell fate commitment | biological process | GO:0045165 | 257 | 3 | 18204 | 49 |
NFIA,SOX5,GLI3 |
3.184e-02 | -3.45 | auditory behavior | biological process | GO:0031223 | 12 | 1 | 18204 | 49 |
SLC1A3 |
3.184e-02 | -3.45 | nuclear membrane disassembly | biological process | GO:0051081 | 12 | 1 | 18204 | 49 |
PRKCA |
3.184e-02 | -3.45 | regulation of glial cell apoptotic process | biological process | GO:0034350 | 12 | 1 | 18204 | 49 |
PRKCA |
3.184e-02 | -3.45 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | biological process | GO:1902043 | 12 | 1 | 18204 | 49 |
BMPR1B |
3.184e-02 | -3.45 | dermatan sulfate proteoglycan metabolic process | biological process | GO:0050655 | 12 | 1 | 18204 | 49 |
CSGALNACT1 |
3.184e-02 | -3.45 | mammalian oogenesis stage | biological process | GO:0022605 | 12 | 1 | 18204 | 49 |
BMPR1B |
3.184e-02 | -3.45 | negative thymic T cell selection | biological process | GO:0045060 | 12 | 1 | 18204 | 49 |
GLI3 |
3.184e-02 | -3.45 | sulfur amino acid transport | biological process | GO:0000101 | 12 | 1 | 18204 | 49 |
SLC1A2 |
3.193e-02 | -3.44 | TGFB_receptor | interpro domains | IPR000333 | 12 | 1 | 18521 | 50 |
BMPR1B |
3.193e-02 | -3.44 | MAD_homology1_Dwarfin-type | interpro domains | IPR003619 | 12 | 1 | 18521 | 50 |
NFIA |
3.197e-02 | -3.44 | FOLN | smart domains | SM00274 | 9 | 1 | 9717 | 35 |
SPARCL1 |
3.200e-02 | -3.44 | PRR20A (proline rich 20A) | protein interactions | 122183 | 109 | 2 | 19454 | 50 |
TRPM3,SOX5 |
3.200e-02 | -3.44 | CLSTN1 (calsyntenin 1) | protein interactions | 22883 | 109 | 2 | 19454 | 50 |
MGAT4C,SLC1A3 |
3.204e-02 | -3.44 | human chr9q21.33 | chromosome location | human chr9q21.33 | 17 | 1 | 26134 | 50 |
NTRK2 |
3.207e-02 | -3.44 | biliary_tract-bile_duct-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-bile_duct-carcinoma-adenocarcinoma | 15095 | 48 | 16828 | 49 |
DTNA,SORBS1,GPC5,RYR3,PAMR1,PARD3B,MSI2,ABLIM1,SLC4A4,TPD52L1,NRG3,RFX4,GLIS3,ZBTB20,DPP10,CTNND2,FMN2,GLI3,RORA,MGAT4C,NPAS3,TRPM3,GPM6A,PREX2,NTM,LSAMP,PTPRZ1,FBXL7,SLC1A2,NTRK2,CDH20,ADCY2,SLC1A3,TNIK,SOX5,NHSL1,SPARCL1,DST,PITPNC1,NEBL,BMPR1B,MACF1,CSGALNACT1,PRKCA,MAML2,NFIA,ITPR2,ATP1A2 |
3.207e-02 | -3.44 | bile_duct | COSMIC cancer mutations | bile_duct | 15095 | 48 | 16828 | 49 |
NEBL,BMPR1B,CSGALNACT1,MACF1,PRKCA,MAML2,NFIA,ITPR2,ATP1A2,MGAT4C,TRPM3,NPAS3,NTM,PREX2,GPM6A,LSAMP,PTPRZ1,SLC1A2,FBXL7,NTRK2,CDH20,ADCY2,SLC1A3,SOX5,TNIK,SPARCL1,NHSL1,PITPNC1,DST,SLC4A4,GLIS3,RFX4,ZBTB20,TPD52L1,NRG3,DPP10,CTNND2,FMN2,GLI3,RORA,DTNA,SORBS1,GPC5,PAMR1,RYR3,PARD3B,MSI2,ABLIM1 |
3.227e-02 | -3.43 | NAKATPASE | prints domains | PR00121 | 9 | 1 | 5227 | 19 |
ATP1A2 |
3.251e-02 | -3.43 | response to interleukin-1 | biological process | GO:0070555 | 105 | 2 | 18204 | 49 |
RORA,PRKCA |
3.251e-02 | -3.43 | cellular response to alcohol | biological process | GO:0097306 | 105 | 2 | 18204 | 49 |
ITPR2,ADCY2 |
3.251e-02 | -3.43 | positive regulation of protein localization to membrane | biological process | GO:1905477 | 105 | 2 | 18204 | 49 |
SORBS1,DPP10 |
3.251e-02 | -3.43 | gland morphogenesis | biological process | GO:0022612 | 105 | 2 | 18204 | 49 |
NRG3,GLI3 |
3.254e-02 | -3.43 | LZTR1 (leucine zipper like post translational regulator 1) | protein interactions | 8216 | 110 | 2 | 19454 | 50 |
BMPR1B,PARD3B |
3.256e-02 | -3.42 | SNCA (synuclein alpha) | protein interactions | 6622 | 696 | 5 | 19454 | 50 |
NTRK2,MACF1,GPM6A,DST,TNIK |
3.256e-02 | -3.42 | MH1 | pfam domains | PF03165 | 12 | 1 | 17795 | 49 |
NFIA |
3.264e-02 | -3.42 | Visual phototransduction | REACTOME pathways | R-HSA-2187338 | 101 | 2 | 10285 | 29 |
GPC5,PRKCA |
3.264e-02 | -3.42 | Hedgehog 'off' state | REACTOME pathways | R-HSA-5610787 | 101 | 2 | 10285 | 29 |
ADCY2,GLI3 |
3.275e-02 | -3.42 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 5 | 18204 | 49 |
NTRK2,TNIK,MACF1,CTNNA2,GPM6A |
3.276e-02 | -3.42 | steroid binding | molecular function | GO:0005496 | 107 | 2 | 18094 | 48 |
RORA,ATP1A2 |
3.291e-02 | -3.41 | Pias1 (protein inhibitor of activated STAT 1) | protein interactions | 56469 | 13 | 1 | 19454 | 50 |
GLI3 |
3.291e-02 | -3.41 | IL23R (interleukin 23 receptor) | protein interactions | 149233 | 13 | 1 | 19454 | 50 |
PRKCA |
3.291e-02 | -3.41 | CEACAM16 (CEA cell adhesion molecule 16, tectorial membrane component) | protein interactions | 388551 | 13 | 1 | 19454 | 50 |
DST |
3.291e-02 | -3.41 | TBCC (tubulin folding cofactor C) | protein interactions | 6903 | 13 | 1 | 19454 | 50 |
NTM |
3.291e-02 | -3.41 | SPINK5 (serine peptidase inhibitor Kazal type 5) | protein interactions | 11005 | 13 | 1 | 19454 | 50 |
CSGALNACT1 |
3.291e-02 | -3.41 | PCDHA2 (protocadherin alpha 2) | protein interactions | 56146 | 13 | 1 | 19454 | 50 |
NFIA |
3.291e-02 | -3.41 | RAB3C (RAB3C, member RAS oncogene family) | protein interactions | 115827 | 13 | 1 | 19454 | 50 |
GPM6A |
3.291e-02 | -3.41 | KCNQ2 (potassium voltage-gated channel subfamily Q member 2) | protein interactions | 3785 | 13 | 1 | 19454 | 50 |
PRKCA |
3.300e-02 | -3.41 | dermatan sulfate biosynthesis | BIOCYC pathways | META_PWY-6571 | 15 | 1 | 902 | 2 |
CSGALNACT1 |
3.307e-02 | -3.41 | oogenesis | biological process | GO:0048477 | 106 | 2 | 18204 | 49 |
FMN2,BMPR1B |
3.330e-02 | -3.40 | Hedgehog signaling | KEGG pathways | hsa_M00678 | 11 | 1 | 7161 | 22 |
GLI3 |
3.330e-02 | -3.40 | Hedgehog signaling | KEGG pathways | M00678 | 11 | 1 | 7161 | 22 |
GLI3 |
3.333e-02 | -3.40 | Defective EXT1 causes exostoses 1, TRPS2 and CHDS | REACTOME pathways | R-HSA-3656253 | 12 | 1 | 10285 | 29 |
GPC5 |
3.333e-02 | -3.40 | Defective EXT2 causes exostoses 2 | REACTOME pathways | R-HSA-3656237 | 12 | 1 | 10285 | 29 |
GPC5 |
3.363e-02 | -3.39 | TBR1 (T-box brain transcription factor 1) | protein interactions | 10716 | 112 | 2 | 19454 | 50 |
SOX5,NFIA |
3.389e-02 | -3.38 | human chr18q21.33 | chromosome location | human chr18q21.33 | 18 | 1 | 26134 | 50 |
CDH20 |
3.389e-02 | -3.38 | human chr7q31.32 | chromosome location | human chr7q31.32 | 18 | 1 | 26134 | 50 |
PTPRZ1 |
3.395e-02 | -3.38 | monoatomic cation:bicarbonate symporter activity | molecular function | GO:0140410 | 13 | 1 | 18094 | 48 |
SLC4A4 |
3.395e-02 | -3.38 | transforming growth factor beta receptor activity | molecular function | GO:0005024 | 13 | 1 | 18094 | 48 |
BMPR1B |
3.395e-02 | -3.38 | potassium ion binding | molecular function | GO:0030955 | 13 | 1 | 18094 | 48 |
ATP1A2 |
3.396e-02 | -3.38 | regulation of nervous system development | biological process | GO:0051960 | 456 | 4 | 18204 | 49 |
NTRK2,PTPRZ1,GLI3,MACF1 |
3.408e-02 | -3.38 | organic anion transmembrane transporter activity | molecular function | GO:0008514 | 268 | 3 | 18094 | 48 |
SLC1A3,SLC4A4,SLC1A2 |
3.425e-02 | -3.37 | ZDHHC17 (zinc finger DHHC-type palmitoyltransferase 17) | protein interactions | 23390 | 277 | 3 | 19454 | 50 |
NEBL,GPM6A,SLC1A3 |
3.425e-02 | -3.37 | ACIN1 (apoptotic chromatin condensation inducer 1) | protein interactions | 22985 | 277 | 3 | 19454 | 50 |
PRKCA,NFIA,CSGALNACT1 |
3.429e-02 | -3.37 | Alpha-catenin/vinculin-like | gene3d domains | 1.20.120.230 | 12 | 1 | 14470 | 42 |
CTNNA2 |
3.432e-02 | -3.37 | PROTEIN_KINASE_ATP | prosite domains | PS00107 | 377 | 4 | 12186 | 40 |
PRKCA,TNIK,NTRK2,BMPR1B |
3.439e-02 | -3.37 | regulation of canonical Wnt signaling pathway | biological process | GO:0060828 | 265 | 3 | 18204 | 49 |
GLI3,GPC5,CTNND2 |
3.439e-02 | -3.37 | ear | COSMIC cancer mutations | ear | 624 | 5 | 16828 | 49 |
ZBTB20,SPARCL1,NPAS3,DPP10,MGAT4C |
3.440e-02 | -3.37 | skin-abdomen-malignant_melanoma-nodular | COSMIC cancer mutations | skin-abdomen-malignant_melanoma-nodular | 12 | 1 | 16828 | 49 |
PREX2 |
3.440e-02 | -3.37 | DNA-binding transcription factor activity | molecular function | GO:0003700 | 1441 | 8 | 18094 | 48 |
RFX4,NPAS3,SOX5,GLIS3,GLI3,ZBTB20,RORA,NFIA |
3.444e-02 | -3.37 | Stimuli-sensing channels | REACTOME pathways | R-HSA-2672351 | 104 | 2 | 10285 | 29 |
RYR3,TRPM3 |
3.444e-02 | -3.37 | cerebellar Purkinje cell differentiation | biological process | GO:0021702 | 13 | 1 | 18204 | 49 |
RORA |
3.444e-02 | -3.37 | negative regulation of cytosolic calcium ion concentration | biological process | GO:0051481 | 13 | 1 | 18204 | 49 |
ATP1A2 |
3.444e-02 | -3.37 | prepulse inhibition | biological process | GO:0060134 | 13 | 1 | 18204 | 49 |
CTNNA2 |
3.444e-02 | -3.37 | membrane disassembly | biological process | GO:0030397 | 13 | 1 | 18204 | 49 |
PRKCA |
3.444e-02 | -3.37 | ventral spinal cord interneuron differentiation | biological process | GO:0021514 | 13 | 1 | 18204 | 49 |
GLI3 |
3.444e-02 | -3.37 | regulation of respiratory gaseous exchange by nervous system process | biological process | GO:0002087 | 13 | 1 | 18204 | 49 |
ATP1A2 |
3.444e-02 | -3.37 | negative T cell selection | biological process | GO:0043383 | 13 | 1 | 18204 | 49 |
GLI3 |
3.444e-02 | -3.37 | glial cell fate commitment | biological process | GO:0021781 | 13 | 1 | 18204 | 49 |
NFIA |
3.444e-02 | -3.37 | ectodermal placode development | biological process | GO:0071696 | 13 | 1 | 18204 | 49 |
NRG3 |
3.444e-02 | -3.37 | T-helper 17 cell differentiation | biological process | GO:0072539 | 13 | 1 | 18204 | 49 |
RORA |
3.459e-02 | -3.36 | plasma membrane raft | cellular component | GO:0044853 | 114 | 2 | 19108 | 49 |
SORBS1,ATP1A2 |
3.459e-02 | -3.36 | small molecule binding | molecular function | GO:0036094 | 6197 | 23 | 18094 | 48 |
TNIK,ADCY2,SLC1A2,DTNA,CSGALNACT1,MACF1,DST,NTRK2,ABLIM1,RORA,RYR3,GLI3,ITPR2,ATP1A2,BMPR1B,SPARCL1,SLC1A3,PRKCA,ZBTB20,PITPNC1,MGAT4C,GLIS3,PAMR1 |
3.464e-02 | -3.36 | Lactose Intolerance | SMPDB pathways | SMP0000458 | 12 | 1 | 1369 | 4 |
ATP1A2 |
3.464e-02 | -3.36 | Lactose Degradation | SMPDB pathways | SMP0000457 | 12 | 1 | 1369 | 4 |
ATP1A2 |
3.466e-02 | -3.36 | synaptic signaling | biological process | GO:0099536 | 459 | 4 | 18204 | 49 |
NTRK2,SLC1A2,SLC1A3,DTNA |
3.474e-02 | -3.36 | ORF3b (ORF3b protein) | protein interactions | 1489670 | 114 | 2 | 19454 | 50 |
MACF1,ZBTB20 |
3.481e-02 | -3.36 | regulation of protein localization to plasma membrane | biological process | GO:1903076 | 109 | 2 | 18204 | 49 |
SORBS1,DPP10 |
3.487e-02 | -3.36 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | molecular function | GO:0000978 | 1180 | 7 | 18094 | 48 |
RFX4,SOX5,GLI3,GLIS3,ZBTB20,RORA,NFIA |
3.506e-02 | -3.35 | chemical homeostasis | biological process | GO:0048878 | 914 | 6 | 18204 | 49 |
ZBTB20,SLC4A4,ATP1A2,RYR3,RORA,SLC1A3 |
3.518e-02 | -3.35 | chondroitin sulfate biosynthesis | BIOCYC pathways | HUMAN_PWY-6569 | 16 | 1 | 902 | 2 |
CSGALNACT1 |
3.518e-02 | -3.35 | Phosphatidylinositol signaling system | KEGG pathways | hsa04070 | 97 | 2 | 7161 | 22 |
PRKCA,ITPR2 |
3.518e-02 | -3.35 | Phosphatidylinositol signaling system | KEGG pathways | ko04070 | 97 | 2 | 7161 | 22 |
ITPR2,PRKCA |
3.522e-02 | -3.35 | response to organonitrogen compound | biological process | GO:0010243 | 915 | 6 | 18204 | 49 |
SLC1A2,TNIK,ITPR2,SLC1A3,SORBS1,RYR3 |
3.527e-02 | -3.34 | VEGFR2 mediated cell proliferation | REACTOME pathways | R-HSA-5218921 | 258 | 3 | 10285 | 29 |
NRG3,ITPR2,PRKCA |
3.530e-02 | -3.34 | SMAD7 (SMAD family member 7) | protein interactions | 4092 | 115 | 2 | 19454 | 50 |
BMPR1B,SOX5 |
3.540e-02 | -3.34 | MB (myoglobin) | protein interactions | 4151 | 14 | 1 | 19454 | 50 |
MAML2 |
3.540e-02 | -3.34 | DACT2 (dishevelled binding antagonist of beta catenin 2) | protein interactions | 168002 | 14 | 1 | 19454 | 50 |
ZBTB20 |
3.540e-02 | -3.34 | Tecpr2 (tectonin beta-propeller repeat containing 2) | protein interactions | 104859 | 14 | 1 | 19454 | 50 |
DST |
3.540e-02 | -3.34 | Nedd4 (neural precursor cell expressed, developmentally down-regulated 4) | protein interactions | 17999 | 14 | 1 | 19454 | 50 |
GLIS3 |
3.540e-02 | -3.34 | Asap1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain1) | protein interactions | 13196 | 14 | 1 | 19454 | 50 |
MACF1 |
3.540e-02 | -3.34 | CHAT (choline O-acetyltransferase) | protein interactions | 1103 | 14 | 1 | 19454 | 50 |
PRKCA |
3.540e-02 | -3.34 | AZIN2 (antizyme inhibitor 2) | protein interactions | 113451 | 14 | 1 | 19454 | 50 |
TPD52L1 |
3.540e-02 | -3.34 | TAS2R7 (taste 2 receptor member 7) | protein interactions | 50837 | 14 | 1 | 19454 | 50 |
PRKCA |
3.540e-02 | -3.34 | BOD1L2 (biorientation of chromosomes in cell division 1 like 2) | protein interactions | 284257 | 14 | 1 | 19454 | 50 |
FMN2 |
3.540e-02 | -3.34 | PLXNA4 (plexin A4) | protein interactions | 91584 | 14 | 1 | 19454 | 50 |
GPM6A |
3.540e-02 | -3.34 | RHEBL1 (RHEB like 1) | protein interactions | 121268 | 14 | 1 | 19454 | 50 |
BMPR1B |
3.540e-02 | -3.34 | SLC1A2 (solute carrier family 1 member 2) | protein interactions | 6506 | 14 | 1 | 19454 | 50 |
SLC1A2 |
3.553e-02 | -3.34 | RECEPTOR_TYR_KIN_II | prosite domains | PS00239 | 11 | 1 | 12186 | 40 |
NTRK2 |
3.573e-02 | -3.33 | positive regulation of cellular metabolic process | biological process | GO:0031325 | 3164 | 14 | 18204 | 49 |
RORA,TNIK,GLI3,MAML2,NTRK2,SLC4A4,BMPR1B,ZBTB20,NPAS3,GLIS3,TPD52L1,RFX4,NFIA,SORBS1 |
3.574e-02 | -3.33 | human chr6q24.1 | chromosome location | human chr6q24.1 | 19 | 1 | 26134 | 50 |
NHSL1 |
3.574e-02 | -3.33 | human chr5p15.2 | chromosome location | human chr5p15.2 | 19 | 1 | 26134 | 50 |
CTNND2 |
3.574e-02 | -3.33 | human chr11q25 | chromosome location | human chr11q25 | 19 | 1 | 26134 | 50 |
NTM |
3.575e-02 | -3.33 | large_cell_carcinoma | COSMIC cancer mutations | large_cell_carcinoma | 849 | 6 | 16828 | 49 |
PRKCA,NTRK2,TNIK,PTPRZ1,DPP10,BMPR1B |
3.575e-02 | -3.33 | lung-carcinoma-large_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-large_cell_carcinoma | 849 | 6 | 16828 | 49 |
BMPR1B,DPP10,PTPRZ1,TNIK,NTRK2,PRKCA |
3.577e-02 | -3.33 | SH3DOMAIN | prints domains | PR00452 | 83 | 2 | 5227 | 19 |
SORBS1,NEBL |
3.579e-02 | -3.33 | HCO3TRNSPORT | prints domains | PR01231 | 10 | 1 | 5227 | 19 |
SLC4A4 |
3.585e-02 | -3.33 | Estrogen signaling pathway | KEGG pathways | hsa04915 | 98 | 2 | 7161 | 22 |
ADCY2,ITPR2 |
3.585e-02 | -3.33 | Estrogen signaling pathway | KEGG pathways | ko04915 | 98 | 2 | 7161 | 22 |
ADCY2,ITPR2 |
3.586e-02 | -3.33 | SKIL (SKI like proto-oncogene) | protein interactions | 6498 | 116 | 2 | 19454 | 50 |
MACF1,SPARCL1 |
3.593e-02 | -3.33 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 5 | 18204 | 49 |
NTRK2,TNIK,CTNNA2,GPM6A,MACF1 |
3.604e-02 | -3.32 | rhythmic process | biological process | GO:0048511 | 270 | 3 | 18204 | 49 |
BMPR1B,RORA,NTRK2 |
3.606e-02 | -3.32 | ERBB2 Activates PTK6 Signaling | REACTOME pathways | R-HSA-8847993 | 13 | 1 | 10285 | 29 |
NRG3 |
3.606e-02 | -3.32 | NOTCH2 intracellular domain regulates transcription | REACTOME pathways | R-HSA-2197563 | 13 | 1 | 10285 | 29 |
MAML2 |
3.606e-02 | -3.32 | CLEC7A (Dectin-1) induces NFAT activation | REACTOME pathways | R-HSA-5607763 | 13 | 1 | 10285 | 29 |
ITPR2 |
3.606e-02 | -3.32 | Notch-HLH transcription pathway | REACTOME pathways | R-HSA-350054 | 13 | 1 | 10285 | 29 |
MAML2 |
3.612e-02 | -3.32 | kidney-carcinoma-chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 49 |
PRKCA,TNIK,BMPR1B,NTRK2 |
3.612e-02 | -3.32 | chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 49 |
PRKCA,TNIK,BMPR1B,NTRK2 |
3.612e-02 | -3.32 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 25 | 16828 | 49 |
DPP10,CTNND2,MACF1,FMN2,NEBL,ZBTB20,NRG3,ITPR2,PRKCA,GLI3,RORA,GPC5,PTPRZ1,PAMR1,RYR3,MGAT4C,TRPM3,NPAS3,PREX2,SORBS1,SOX5,NTRK2,PARD3B,CDH20,ADCY2 |
3.647e-02 | -3.31 | phosphorus metabolic process | biological process | GO:0006793 | 1707 | 9 | 18204 | 49 |
PTPRZ1,TNIK,RORA,CSGALNACT1,PRKCA,NTRK2,ATP1A2,ADCY2,BMPR1B |
3.652e-02 | -3.31 | microtubule minus-end binding | molecular function | GO:0051011 | 14 | 1 | 18094 | 48 |
MACF1 |
3.670e-02 | -3.31 | phosphatidylinositol binding | molecular function | GO:0035091 | 276 | 3 | 18094 | 48 |
ITPR2,PARD3B,PITPNC1 |
3.699e-02 | -3.30 | DNM1 (dynamin 1) | protein interactions | 1759 | 118 | 2 | 19454 | 50 |
GPM6A,PRKCA |
3.699e-02 | -3.30 | TTC3 (tetratricopeptide repeat domain 3) | protein interactions | 7267 | 118 | 2 | 19454 | 50 |
SPARCL1,DST |
3.699e-02 | -3.30 | VSIG8 (V-set and immunoglobulin domain containing 8) | protein interactions | 391123 | 118 | 2 | 19454 | 50 |
CSGALNACT1,SPARCL1 |
3.704e-02 | -3.30 | layer formation in cerebral cortex | biological process | GO:0021819 | 14 | 1 | 18204 | 49 |
GLI3 |
3.704e-02 | -3.30 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 49 |
RYR3 |
3.704e-02 | -3.30 | radial glial cell differentiation | biological process | GO:0060019 | 14 | 1 | 18204 | 49 |
GLI3 |
3.704e-02 | -3.30 | relaxation of cardiac muscle | biological process | GO:0055119 | 14 | 1 | 18204 | 49 |
ATP1A2 |
3.704e-02 | -3.30 | mechanosensory behavior | biological process | GO:0007638 | 14 | 1 | 18204 | 49 |
SLC1A3 |
3.704e-02 | -3.30 | response to forskolin | biological process | GO:1904321 | 14 | 1 | 18204 | 49 |
ADCY2 |
3.704e-02 | -3.30 | negative regulation of sodium ion transmembrane transporter activity | biological process | GO:2000650 | 14 | 1 | 18204 | 49 |
ATP1A2 |
3.704e-02 | -3.30 | cellular response to ethanol | biological process | GO:0071361 | 14 | 1 | 18204 | 49 |
ITPR2 |
3.704e-02 | -3.30 | glutathione biosynthetic process | biological process | GO:0006750 | 14 | 1 | 18204 | 49 |
SLC1A2 |
3.704e-02 | -3.30 | cellular response to forskolin | biological process | GO:1904322 | 14 | 1 | 18204 | 49 |
ADCY2 |
3.709e-02 | -3.29 | cellular homeostasis | biological process | GO:0019725 | 689 | 5 | 18204 | 49 |
SLC1A3,ATP1A2,SLC4A4,ZBTB20,RYR3 |
3.721e-02 | -3.29 | skin-scalp-malignant_melanoma-nodular | COSMIC cancer mutations | skin-scalp-malignant_melanoma-nodular | 13 | 1 | 16828 | 49 |
PREX2 |
3.721e-02 | -3.29 | skin-shoulder-malignant_melanoma-nodular | COSMIC cancer mutations | skin-shoulder-malignant_melanoma-nodular | 13 | 1 | 16828 | 49 |
PREX2 |
3.749e-02 | -3.28 | Trehalose Degradation | SMPDB pathways | SMP0000467 | 13 | 1 | 1369 | 4 |
ATP1A2 |
3.749e-02 | -3.28 | Succinate Signalling During Inflammation | SMPDB pathways | SMP0084634 | 13 | 1 | 1369 | 4 |
PRKCA |
3.750e-02 | -3.28 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 2 | 16828 | 49 |
GPC5,NRG3 |
3.754e-02 | -3.28 | basal plasma membrane | cellular component | GO:0009925 | 288 | 3 | 19108 | 49 |
SLC1A3,SLC4A4,DST |
3.754e-02 | -3.28 | cellular response to organic substance | biological process | GO:0071310 | 1716 | 9 | 18204 | 49 |
SLC1A2,ITPR2,ATP1A2,ADCY2,ZBTB20,SORBS1,SLC1A3,RORA,RYR3 |
3.756e-02 | -3.28 | ITGB4 (integrin subunit beta 4) | protein interactions | 3691 | 119 | 2 | 19454 | 50 |
DST,PRKCA |
3.780e-02 | -3.28 | axolemma | cellular component | GO:0030673 | 15 | 1 | 19108 | 49 |
SLC1A2 |
3.788e-02 | -3.27 | XIRP1 (xin actin binding repeat containing 1) | protein interactions | 165904 | 15 | 1 | 19454 | 50 |
NEBL |
3.788e-02 | -3.27 | FN3K (fructosamine 3 kinase) | protein interactions | 64122 | 15 | 1 | 19454 | 50 |
PRKCA |
3.788e-02 | -3.27 | IGSF1 (immunoglobulin superfamily member 1) | protein interactions | 3547 | 15 | 1 | 19454 | 50 |
BMPR1B |
3.788e-02 | -3.27 | TIAM2 (TIAM Rac1 associated GEF 2) | protein interactions | 26230 | 15 | 1 | 19454 | 50 |
TNIK |
3.788e-02 | -3.27 | TESPA1 (thymocyte expressed, positive selection associated 1) | protein interactions | 9840 | 15 | 1 | 19454 | 50 |
ITPR2 |
3.788e-02 | -3.27 | GRM7 (glutamate metabotropic receptor 7) | protein interactions | 2917 | 15 | 1 | 19454 | 50 |
PRKCA |
3.788e-02 | -3.27 | TAFA5 (TAFA chemokine like family member 5) | protein interactions | 25817 | 15 | 1 | 19454 | 50 |
NEBL |
3.788e-02 | -3.27 | ADRA1B (adrenoceptor alpha 1B) | protein interactions | 147 | 15 | 1 | 19454 | 50 |
PRKCA |
3.788e-02 | -3.27 | PCSK1N (proprotein convertase subtilisin/kexin type 1 inhibitor) | protein interactions | 27344 | 15 | 1 | 19454 | 50 |
MGAT4C |
3.788e-02 | -3.27 | OGG1 (8-oxoguanine DNA glycosylase) | protein interactions | 4968 | 15 | 1 | 19454 | 50 |
PRKCA |
3.788e-02 | -3.27 | ENTPD5 (ectonucleoside triphosphate diphosphohydrolase 5 (inactive)) | protein interactions | 957 | 15 | 1 | 19454 | 50 |
PRKCA |
3.788e-02 | -3.27 | Melanogenesis | KEGG pathways | hsa04916 | 101 | 2 | 7161 | 22 |
PRKCA,ADCY2 |
3.788e-02 | -3.27 | Melanogenesis | KEGG pathways | ko04916 | 101 | 2 | 7161 | 22 |
ADCY2,PRKCA |
3.806e-02 | -3.27 | positive regulation of MAPK cascade | biological process | GO:0043410 | 473 | 4 | 18204 | 49 |
PRKCA,TPD52L1,NTRK2,TNIK |
3.808e-02 | -3.27 | learning or memory | biological process | GO:0007611 | 276 | 3 | 18204 | 49 |
ATP1A2,NTRK2,PTPRZ1 |
3.810e-02 | -3.27 | CEP128 (centrosomal protein 128) | protein interactions | 145508 | 289 | 3 | 19454 | 50 |
NEBL,ABLIM1,SORBS1 |
3.814e-02 | -3.27 | cis-regulatory region sequence-specific DNA binding | molecular function | GO:0000987 | 1203 | 7 | 18094 | 48 |
ZBTB20,GLIS3,GLI3,NFIA,RORA,RFX4,SOX5 |
3.843e-02 | -3.26 | BCOR (BCL6 corepressor) | protein interactions | 54880 | 290 | 3 | 19454 | 50 |
SOX5,GLI3,NFIA |
3.851e-02 | -3.26 | stomach-carcinoma | COSMIC cancer mutations | stomach-carcinoma | 439 | 4 | 16828 | 49 |
TNIK,PRKCA,NTRK2,BMPR1B |
3.857e-02 | -3.26 | Glucagon signaling pathway | KEGG pathways | ko04922 | 102 | 2 | 7161 | 22 |
ADCY2,ITPR2 |
3.857e-02 | -3.26 | Glucagon signaling pathway | KEGG pathways | hsa04922 | 102 | 2 | 7161 | 22 |
ITPR2,ADCY2 |
3.868e-02 | -3.25 | positive regulation of phosphorus metabolic process | biological process | GO:0010562 | 697 | 5 | 18204 | 49 |
SLC4A4,ZBTB20,TNIK,NTRK2,TPD52L1 |
3.868e-02 | -3.25 | positive regulation of phosphate metabolic process | biological process | GO:0045937 | 697 | 5 | 18204 | 49 |
SLC4A4,ZBTB20,NTRK2,TNIK,TPD52L1 |
3.878e-02 | -3.25 | actin filament organization | biological process | GO:0007015 | 278 | 3 | 18204 | 49 |
FMN2,NEBL,SORBS1 |
3.878e-02 | -3.25 | DCC mediated attractive signaling | REACTOME pathways | R-HSA-418885 | 14 | 1 | 10285 | 29 |
ABLIM1 |
3.878e-02 | -3.25 | SHC1 events in ERBB4 signaling | REACTOME pathways | R-HSA-1250347 | 14 | 1 | 10285 | 29 |
NRG3 |
3.880e-02 | -3.25 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 9 | 16828 | 49 |
ATP1A2,DST,GPC5,LSAMP,MACF1,SOX5,PTPRZ1,RORA,SLC4A4 |
3.881e-02 | -3.25 | bone-humerus-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-humerus-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 107 | 2 | 16828 | 49 |
PARD3B,NEBL |
3.900e-02 | -3.24 | germ_cell_tumour | COSMIC cancer mutations | germ_cell_tumour | 867 | 6 | 16828 | 49 |
PREX2,NTRK2,BMPR1B,TNIK,PRKCA,MACF1 |
3.908e-02 | -3.24 | phosphatidylglycerol binding | molecular function | GO:1901611 | 15 | 1 | 18094 | 48 |
PITPNC1 |
3.908e-02 | -3.24 | filamin binding | molecular function | GO:0031005 | 15 | 1 | 18094 | 48 |
NEBL |
3.908e-02 | -3.24 | tropomyosin binding | molecular function | GO:0005523 | 15 | 1 | 18094 | 48 |
NEBL |
3.914e-02 | -3.24 | skin-leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-leg-malignant_melanoma-nodular | 258 | 3 | 16828 | 49 |
SLC4A4,FMN2,PTPRZ1 |
3.930e-02 | -3.24 | BRK1 (BRICK1 subunit of SCAR/WAVE actin nucleating complex) | protein interactions | 55845 | 122 | 2 | 19454 | 50 |
DTNA,NHSL1 |
3.935e-02 | -3.24 | perinuclear region of cytoplasm | cellular component | GO:0048471 | 735 | 5 | 19108 | 49 |
NTRK2,FMN2,TPD52L1,PRKCA,SLC1A3 |
3.943e-02 | -3.23 | human chr10q23.1 | chromosome location | human chr10q23.1 | 21 | 1 | 26134 | 50 |
NRG3 |
3.943e-02 | -3.23 | human chr13q31.3 | chromosome location | human chr13q31.3 | 21 | 1 | 26134 | 50 |
GPC5 |
3.947e-02 | -3.23 | testis-germ_cell_tumour-seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-seminoma | 648 | 5 | 16828 | 49 |
TNIK,PRKCA,BMPR1B,NTRK2,PREX2 |
3.948e-02 | -3.23 | glycoprotein biosynthetic process | biological process | GO:0009101 | 280 | 3 | 18204 | 49 |
MGAT4C,BMPR1B,CSGALNACT1 |
3.953e-02 | -3.23 | chondroitin sulfate biosynthesis | BIOCYC pathways | META_PWY-6569 | 18 | 1 | 902 | 2 |
CSGALNACT1 |
3.964e-02 | -3.23 | system process | biological process | GO:0003008 | 2015 | 10 | 18204 | 49 |
SLC4A4,CTNNA2,DTNA,ABLIM1,SLC1A2,NTRK2,ATP1A2,RYR3,SLC1A3,PTPRZ1 |
3.964e-02 | -3.23 | positive regulation of glycogen biosynthetic process | biological process | GO:0045725 | 15 | 1 | 18204 | 49 |
SORBS1 |
3.964e-02 | -3.23 | synapse maturation | biological process | GO:0060074 | 15 | 1 | 18204 | 49 |
NFIA |
3.964e-02 | -3.23 | negative regulation of sodium ion transmembrane transport | biological process | GO:1902306 | 15 | 1 | 18204 | 49 |
ATP1A2 |
3.964e-02 | -3.23 | response to caffeine | biological process | GO:0031000 | 15 | 1 | 18204 | 49 |
RYR3 |
3.964e-02 | -3.23 | protein homotrimerization | biological process | GO:0070207 | 15 | 1 | 18204 | 49 |
SLC1A2 |
3.964e-02 | -3.23 | dorsal/ventral neural tube patterning | biological process | GO:0021904 | 15 | 1 | 18204 | 49 |
GLI3 |
3.964e-02 | -3.23 | intracellular potassium ion homeostasis | biological process | GO:0030007 | 15 | 1 | 18204 | 49 |
ATP1A2 |
3.964e-02 | -3.23 | exit from mitosis | biological process | GO:0010458 | 15 | 1 | 18204 | 49 |
NFIA |
3.964e-02 | -3.23 | peripheral nervous system neuron development | biological process | GO:0048935 | 15 | 1 | 18204 | 49 |
NTRK2 |
3.964e-02 | -3.23 | neuroblast division | biological process | GO:0055057 | 15 | 1 | 18204 | 49 |
SOX5 |
3.964e-02 | -3.23 | cerebellar Purkinje cell layer formation | biological process | GO:0021694 | 15 | 1 | 18204 | 49 |
RORA |
3.964e-02 | -3.23 | regulation of neuron projection arborization | biological process | GO:0150011 | 15 | 1 | 18204 | 49 |
MACF1 |
3.964e-02 | -3.23 | sarcoplasmic reticulum calcium ion transport | biological process | GO:0070296 | 15 | 1 | 18204 | 49 |
RYR3 |
3.964e-02 | -3.23 | peripheral nervous system neuron differentiation | biological process | GO:0048934 | 15 | 1 | 18204 | 49 |
NTRK2 |
3.975e-02 | -3.23 | ATPase_P-typ_cation-transptr_C | interpro domains | IPR006068 | 15 | 1 | 18521 | 50 |
ATP1A2 |
3.975e-02 | -3.23 | FH2_Formin | interpro domains | IPR015425 | 15 | 1 | 18521 | 50 |
FMN2 |
3.975e-02 | -3.23 | FH2_Formin_sf | interpro domains | IPR042201 | 15 | 1 | 18521 | 50 |
FMN2 |
3.975e-02 | -3.23 | CNH_dom | interpro domains | IPR001180 | 15 | 1 | 18521 | 50 |
TNIK |
3.988e-02 | -3.22 | UBA5 (ubiquitin like modifier activating enzyme 5) | protein interactions | 79876 | 123 | 2 | 19454 | 50 |
DST,PRKCA |
4.008e-02 | -3.22 | transcription cis-regulatory region binding | molecular function | GO:0000976 | 1485 | 8 | 18094 | 48 |
NFIA,RORA,ZBTB20,GLIS3,GLI3,SOX5,RFX4,NPAS3 |
4.020e-02 | -3.21 | MAPRE1 (microtubule associated protein RP/EB family member 1) | protein interactions | 22919 | 504 | 4 | 19454 | 50 |
ABLIM1,PRKCA,MACF1,DST |
4.020e-02 | -3.21 | synapse assembly | biological process | GO:0007416 | 118 | 2 | 18204 | 49 |
NRG3,GPM6A |
4.023e-02 | -3.21 | Prot_kinase_dom | interpro domains | IPR000719 | 480 | 4 | 18521 | 50 |
TNIK,BMPR1B,PRKCA,NTRK2 |
4.027e-02 | -3.21 | postsynaptic density, intracellular component | cellular component | GO:0099092 | 16 | 1 | 19108 | 49 |
TNIK |
4.035e-02 | -3.21 | transcription regulatory region nucleic acid binding | molecular function | GO:0001067 | 1487 | 8 | 18094 | 48 |
ZBTB20,GLI3,GLIS3,NFIA,RORA,RFX4,NPAS3,SOX5 |
4.035e-02 | -3.21 | NRGN (neurogranin) | protein interactions | 4900 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | RHO (rhodopsin) | protein interactions | 6010 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | CASTOR2 (cytosolic arginine sensor for mTORC1 subunit 2) | protein interactions | 729438 | 16 | 1 | 19454 | 50 |
DST |
4.035e-02 | -3.21 | TPD52L3 (TPD52 like 3) | protein interactions | 89882 | 16 | 1 | 19454 | 50 |
TPD52L1 |
4.035e-02 | -3.21 | Sumo3 (small ubiquitin-like modifier 3) | protein interactions | 20610 | 16 | 1 | 19454 | 50 |
ITPR2 |
4.035e-02 | -3.21 | GALNT13 (polypeptide N-acetylgalactosaminyltransferase 13) | protein interactions | 114805 | 16 | 1 | 19454 | 50 |
TNIK |
4.035e-02 | -3.21 | FNDC8 (fibronectin type III domain containing 8) | protein interactions | 54752 | 16 | 1 | 19454 | 50 |
SPARCL1 |
4.035e-02 | -3.21 | CDH12 (cadherin 12) | protein interactions | 1010 | 16 | 1 | 19454 | 50 |
CTNNA2 |
4.035e-02 | -3.21 | GABRR1 (gamma-aminobutyric acid type A receptor subunit rho1) | protein interactions | 2569 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | SAPCD1 (suppressor APC domain containing 1) | protein interactions | 401251 | 16 | 1 | 19454 | 50 |
CTNNA2 |
4.035e-02 | -3.21 | TWIST2 (twist family bHLH transcription factor 2) | protein interactions | 117581 | 16 | 1 | 19454 | 50 |
ZBTB20 |
4.035e-02 | -3.21 | Prkcz (protein kinase C, zeta) | protein interactions | 18762 | 16 | 1 | 19454 | 50 |
DST |
4.035e-02 | -3.21 | GABRB3 (gamma-aminobutyric acid type A receptor subunit beta3) | protein interactions | 2562 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | CNTNAP2 (contactin associated protein 2) | protein interactions | 26047 | 16 | 1 | 19454 | 50 |
MACF1 |
4.035e-02 | -3.21 | AMMECR1L (AMMECR1 like) | protein interactions | 83607 | 16 | 1 | 19454 | 50 |
MACF1 |
4.035e-02 | -3.21 | WWC3 (WWC family member 3) | protein interactions | 55841 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | SLC6A9 (solute carrier family 6 member 9) | protein interactions | 6536 | 16 | 1 | 19454 | 50 |
PRKCA |
4.053e-02 | -3.21 | CNH | pfam domains | PF00780 | 15 | 1 | 17795 | 49 |
TNIK |
4.053e-02 | -3.21 | Cation_ATPase_C | pfam domains | PF00689 | 15 | 1 | 17795 | 49 |
ATP1A2 |
4.053e-02 | -3.21 | FH2 | pfam domains | PF02181 | 15 | 1 | 17795 | 49 |
FMN2 |
4.054e-02 | -3.21 | Wnt signaling pathway | biological process | GO:0016055 | 283 | 3 | 18204 | 49 |
MACF1,CTNND2,TNIK |
4.092e-02 | -3.20 | regulation of signaling | biological process | GO:0023051 | 3534 | 15 | 18204 | 49 |
SORBS1,PREX2,MACF1,TPD52L1,BMPR1B,NTRK2,ATP1A2,GLI3,PRKCA,CTNND2,GPC5,NRG3,TNIK,RORA,SLC1A3 |
4.106e-02 | -3.19 | STXBP1 (syntaxin binding protein 1) | protein interactions | 6812 | 125 | 2 | 19454 | 50 |
GPM6A,PRKCA |
4.106e-02 | -3.19 | SOCS6 (suppressor of cytokine signaling 6) | protein interactions | 9306 | 125 | 2 | 19454 | 50 |
BMPR1B,DST |
4.112e-02 | -3.19 | regulation of transmembrane transport | biological process | GO:0034762 | 485 | 4 | 18204 | 49 |
ATP1A2,SLC1A2,SORBS1,DPP10 |
4.117e-02 | -3.19 | secondary active transmembrane transporter activity | molecular function | GO:0015291 | 289 | 3 | 18094 | 48 |
SLC1A3,SLC4A4,SLC1A2 |
4.118e-02 | -3.19 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 10 | 16828 | 49 |
PTPRZ1,RYR3,FMN2,PITPNC1,FBXL7,NTRK2,CDH20,NEBL,PREX2,ADCY2 |
4.131e-02 | -3.19 | extremity | COSMIC cancer mutations | extremity | 1876 | 10 | 16828 | 49 |
CDH20,NTRK2,ADCY2,PREX2,NEBL,PTPRZ1,RYR3,PITPNC1,FBXL7,FMN2 |
4.150e-02 | -3.18 | Depolymerisation of the Nuclear Lamina | REACTOME pathways | R-HSA-4419969 | 15 | 1 | 10285 | 29 |
PRKCA |
4.150e-02 | -3.18 | WNT5A-dependent internalization of FZD4 | REACTOME pathways | R-HSA-5099900 | 15 | 1 | 10285 | 29 |
PRKCA |
4.150e-02 | -3.18 | Adenylate cyclase inhibitory pathway | REACTOME pathways | R-HSA-170670 | 15 | 1 | 10285 | 29 |
ADCY2 |
4.150e-02 | -3.18 | ERBB2 Regulates Cell Motility | REACTOME pathways | R-HSA-6785631 | 15 | 1 | 10285 | 29 |
NRG3 |
4.150e-02 | -3.18 | N-Glycan antennae elongation | REACTOME pathways | R-HSA-975577 | 15 | 1 | 10285 | 29 |
MGAT4C |
4.150e-02 | -3.18 | Inhibition of adenylate cyclase pathway | REACTOME pathways | R-HSA-997269 | 15 | 1 | 10285 | 29 |
ADCY2 |
4.156e-02 | -3.18 | regulation of cell communication | biological process | GO:0010646 | 3541 | 15 | 18204 | 49 |
CTNND2,GPC5,SLC1A3,NRG3,TNIK,RORA,BMPR1B,GLI3,PRKCA,NTRK2,ATP1A2,MACF1,TPD52L1,SORBS1,PREX2 |
4.163e-02 | -3.18 | adenylate cyclase activity | molecular function | GO:0004016 | 16 | 1 | 18094 | 48 |
ADCY2 |
4.163e-02 | -3.18 | diacylglycerol-dependent serine/threonine kinase activity | molecular function | GO:0004697 | 16 | 1 | 18094 | 48 |
PRKCA |
4.163e-02 | -3.18 | oxysterol binding | molecular function | GO:0008142 | 16 | 1 | 18094 | 48 |
RORA |
4.166e-02 | -3.18 | SYP (synaptophysin) | protein interactions | 6855 | 126 | 2 | 19454 | 50 |
PITPNC1,GPM6A |
4.198e-02 | -3.17 | ossification | biological process | GO:0001503 | 287 | 3 | 18204 | 49 |
GLI3,BMPR1B,CSGALNACT1 |
4.215e-02 | -3.17 | MFAP5-mediated ovarian cancer cell motility and invasiveness | WikiPathways | WP3301 | 12 | 1 | 5310 | 19 |
RYR3 |
4.215e-02 | -3.17 | Bone Morphogenic Protein (BMP) Signalling and Regulation | WikiPathways | WP1425 | 12 | 1 | 5310 | 19 |
BMPR1B |
4.223e-02 | -3.16 | spinal cord dorsal/ventral patterning | biological process | GO:0021513 | 16 | 1 | 18204 | 49 |
GLI3 |
4.223e-02 | -3.16 | nonribosomal peptide biosynthetic process | biological process | GO:0019184 | 16 | 1 | 18204 | 49 |
SLC1A2 |
4.223e-02 | -3.16 | regulation of amino acid import across plasma membrane | biological process | GO:0010958 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.223e-02 | -3.16 | non-proteinogenic amino acid biosynthetic process | biological process | GO:0170043 | 16 | 1 | 18204 | 49 |
SLC1A3 |
4.223e-02 | -3.16 | locomotory exploration behavior | biological process | GO:0035641 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.223e-02 | -3.16 | positive regulation of macrophage differentiation | biological process | GO:0045651 | 16 | 1 | 18204 | 49 |
PRKCA |
4.223e-02 | -3.16 | regulation of amino acid transmembrane transport | biological process | GO:1903789 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.223e-02 | -3.16 | nose development | biological process | GO:0043584 | 16 | 1 | 18204 | 49 |
GLI3 |
4.223e-02 | -3.16 | asymmetric cell division | biological process | GO:0008356 | 16 | 1 | 18204 | 49 |
SOX5 |
4.223e-02 | -3.16 | regulation of respiratory system process | biological process | GO:0044065 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.240e-02 | -3.16 | DWA | smart domains | SM00523 | 12 | 1 | 9717 | 35 |
NFIA |
4.267e-02 | -3.15 | neuron projection terminus | cellular component | GO:0044306 | 128 | 2 | 19108 | 49 |
SLC1A2,NTRK2 |
4.269e-02 | -3.15 | Formin, FH2 domain | gene3d domains | 1.20.58.2220 | 15 | 1 | 14470 | 42 |
FMN2 |
4.282e-02 | -3.15 | RASL12 (RAS like family 12) | protein interactions | 51285 | 17 | 1 | 19454 | 50 |
BMPR1B |
4.282e-02 | -3.15 | Sqstm1 (sequestosome 1) | protein interactions | 18412 | 17 | 1 | 19454 | 50 |
BMPR1B |
4.282e-02 | -3.15 | CYP3A4 (cytochrome P450 family 3 subfamily A member 4) | protein interactions | 1576 | 17 | 1 | 19454 | 50 |
PRKCA |
4.282e-02 | -3.15 | LIPT1 (lipoyltransferase 1) | protein interactions | 51601 | 17 | 1 | 19454 | 50 |
PRKCA |
4.282e-02 | -3.15 | MSANTD2 (Myb/SANT DNA binding domain containing 2) | protein interactions | 79684 | 17 | 1 | 19454 | 50 |
SOX5 |
4.282e-02 | -3.15 | SEPSECS (Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase) | protein interactions | 51091 | 17 | 1 | 19454 | 50 |
ABLIM1 |
4.282e-02 | -3.15 | PDE7A (phosphodiesterase 7A) | protein interactions | 5150 | 17 | 1 | 19454 | 50 |
PRKCA |
4.282e-02 | -3.15 | NOTCH4 (notch receptor 4) | protein interactions | 4855 | 17 | 1 | 19454 | 50 |
MAML2 |
4.282e-02 | -3.15 | PAX4 (paired box 4) | protein interactions | 5078 | 17 | 1 | 19454 | 50 |
NTM |
4.282e-02 | -3.15 | DPP6 (dipeptidyl peptidase like 6) | protein interactions | 1804 | 17 | 1 | 19454 | 50 |
GPM6A |
4.282e-02 | -3.15 | TAGAP (T cell activation RhoGTPase activating protein) | protein interactions | 117289 | 17 | 1 | 19454 | 50 |
DTNA |
4.282e-02 | -3.15 | TNNT2 (troponin T2, cardiac type) | protein interactions | 7139 | 17 | 1 | 19454 | 50 |
PRKCA |
4.282e-02 | -3.15 | Shcbp1 (Shc SH2-domain binding protein 1) | protein interactions | 20419 | 17 | 1 | 19454 | 50 |
GPC5 |
4.286e-02 | -3.15 | ATF7IP (activating transcription factor 7 interacting protein) | protein interactions | 55729 | 128 | 2 | 19454 | 50 |
MACF1,SOX5 |
4.286e-02 | -3.15 | PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta) | protein interactions | 5577 | 128 | 2 | 19454 | 50 |
GPM6A,PRKCA |
4.311e-02 | -3.14 | human chr5p15.31 | chromosome location | human chr5p15.31 | 23 | 1 | 26134 | 50 |
ADCY2 |
4.329e-02 | -3.14 | ovary-carcinoma-mucinous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-mucinous_carcinoma | 456 | 4 | 16828 | 49 |
BMPR1B,NTRK2,TNIK,PRKCA |
4.334e-02 | -3.14 | ovary-carcinoma-clear_cell_carcinoma | COSMIC cancer mutations | ovary-carcinoma-clear_cell_carcinoma | 665 | 5 | 16828 | 49 |
BMPR1B,NTRK2,PRKCA,TNIK,SPARCL1 |
4.346e-02 | -3.14 | CHD7 (chromodomain helicase DNA binding protein 7) | protein interactions | 55636 | 129 | 2 | 19454 | 50 |
SOX5,ZBTB20 |
4.350e-02 | -3.13 | cellular response to growth factor stimulus | biological process | GO:0071363 | 494 | 4 | 18204 | 49 |
BMPR1B,NFIA,NTRK2,SOX5 |
4.350e-02 | -3.13 | modulation of chemical synaptic transmission | biological process | GO:0050804 | 494 | 4 | 18204 | 49 |
SLC1A3,ATP1A2,NTRK2,NRG3 |
4.362e-02 | -3.13 | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 891 | 6 | 16828 | 49 |
SPARCL1,ATP1A2,PTPRZ1,ABLIM1,ITPR2,NPAS3 |
4.366e-02 | -3.13 | channel activity | molecular function | GO:0015267 | 502 | 4 | 18094 | 48 |
RYR3,TRPM3,ITPR2,GPM6A |
4.377e-02 | -3.13 | regulation of trans-synaptic signaling | biological process | GO:0099177 | 495 | 4 | 18204 | 49 |
SLC1A3,NRG3,ATP1A2,NTRK2 |
4.381e-02 | -3.13 | response to hypoxia | biological process | GO:0001666 | 292 | 3 | 18204 | 49 |
FMN2,ITPR2,RORA |
4.388e-02 | -3.13 | mucinous_carcinoma | COSMIC cancer mutations | mucinous_carcinoma | 458 | 4 | 16828 | 49 |
NTRK2,BMPR1B,PRKCA,TNIK |
4.392e-02 | -3.13 | passive transmembrane transporter activity | molecular function | GO:0022803 | 503 | 4 | 18094 | 48 |
GPM6A,ITPR2,TRPM3,RYR3 |
4.397e-02 | -3.12 | positive regulation of lipid metabolic process | biological process | GO:0045834 | 124 | 2 | 18204 | 49 |
ZBTB20,SORBS1 |
4.397e-02 | -3.12 | action potential | biological process | GO:0001508 | 124 | 2 | 18204 | 49 |
ATP1A2,NTRK2 |
4.400e-02 | -3.12 | basal part of cell | cellular component | GO:0045178 | 307 | 3 | 19108 | 49 |
DST,SLC4A4,SLC1A3 |
4.417e-02 | -3.12 | transmembrane receptor protein phosphatase activity | molecular function | GO:0019198 | 17 | 1 | 18094 | 48 |
PTPRZ1 |
4.417e-02 | -3.12 | transmembrane receptor protein tyrosine phosphatase activity | molecular function | GO:0005001 | 17 | 1 | 18094 | 48 |
PTPRZ1 |
4.420e-02 | -3.12 | PI3K events in ERBB2 signaling | REACTOME pathways | R-HSA-1963642 | 16 | 1 | 10285 | 29 |
NRG3 |
4.420e-02 | -3.12 | Regulation of KIT signaling | REACTOME pathways | R-HSA-1433559 | 16 | 1 | 10285 | 29 |
PRKCA |
4.420e-02 | -3.12 | PKA activation | REACTOME pathways | R-HSA-163615 | 16 | 1 | 10285 | 29 |
ADCY2 |
4.420e-02 | -3.12 | GRB2 events in ERBB2 signaling | REACTOME pathways | R-HSA-1963640 | 16 | 1 | 10285 | 29 |
NRG3 |
4.428e-02 | -3.12 | clear_cell_carcinoma | COSMIC cancer mutations | clear_cell_carcinoma | 669 | 5 | 16828 | 49 |
SPARCL1,BMPR1B,NTRK2,TNIK,PRKCA |
4.446e-02 | -3.11 | G Protein Signaling Pathways | WikiPathways | WP35 | 95 | 2 | 5310 | 19 |
ADCY2,PRKCA |
4.448e-02 | -3.11 | PDZ | pfam domains | PF00595 | 122 | 2 | 17795 | 49 |
PREX2,PARD3B |
4.461e-02 | -3.11 | actomyosin structure organization | biological process | GO:0031032 | 125 | 2 | 18204 | 49 |
SORBS1,NEBL |
4.461e-02 | -3.11 | mammary gland development | biological process | GO:0030879 | 125 | 2 | 18204 | 49 |
NRG3,GLI3 |
4.461e-02 | -3.11 | cerebral cortex development | biological process | GO:0021987 | 125 | 2 | 18204 | 49 |
NTRK2,GLI3 |
4.467e-02 | -3.11 | regulation of cellular process | biological process | GO:0050794 | 11468 | 37 | 18204 | 49 |
GPM6A,PTPRZ1,TPD52L1,GLIS3,MSI2,SORBS1,ADCY2,GPC5,CTNND2,TNIK,DPP10,DTNA,CTNNA2,ZBTB20,BMPR1B,SOX5,PRKCA,FMN2,NTRK2,MACF1,RFX4,NPAS3,NFIA,SPARCL1,PREX2,SLC1A2,DST,PITPNC1,RYR3,SLC1A3,NRG3,RORA,SLC4A4,GLI3,ITPR2,ATP1A2,MAML2 |
4.468e-02 | -3.11 | TRPS1 (transcriptional repressor GATA binding 1) | protein interactions | 7227 | 131 | 2 | 19454 | 50 |
NFIA,SOX5 |
4.468e-02 | -3.11 | ZNF609 (zinc finger protein 609) | protein interactions | 23060 | 131 | 2 | 19454 | 50 |
SOX5,NFIA |
4.468e-02 | -3.11 | NCOA2 (nuclear receptor coactivator 2) | protein interactions | 10499 | 131 | 2 | 19454 | 50 |
RORA,NFIA |
4.481e-02 | -3.11 | cGMP metabolic process | biological process | GO:0046068 | 17 | 1 | 18204 | 49 |
RORA |
4.481e-02 | -3.11 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 49 |
SLC1A2 |
4.481e-02 | -3.11 | specification of animal organ identity | biological process | GO:0010092 | 17 | 1 | 18204 | 49 |
GLI3 |
4.481e-02 | -3.11 | retinal rod cell differentiation | biological process | GO:0060221 | 17 | 1 | 18204 | 49 |
NTRK2 |
4.481e-02 | -3.11 | T-helper 17 type immune response | biological process | GO:0072538 | 17 | 1 | 18204 | 49 |
RORA |
4.481e-02 | -3.11 | microvillus assembly | biological process | GO:0030033 | 17 | 1 | 18204 | 49 |
TNIK |
4.481e-02 | -3.11 | cellular response to ATP | biological process | GO:0071318 | 17 | 1 | 18204 | 49 |
RYR3 |
4.481e-02 | -3.11 | membrane depolarization during cardiac muscle cell action potential | biological process | GO:0086012 | 17 | 1 | 18204 | 49 |
ATP1A2 |
4.481e-02 | -3.11 | cell migration in hindbrain | biological process | GO:0021535 | 17 | 1 | 18204 | 49 |
CTNNA2 |
4.481e-02 | -3.11 | heparin metabolic process | biological process | GO:0030202 | 17 | 1 | 18204 | 49 |
CSGALNACT1 |
4.481e-02 | -3.11 | embryonic digestive tract morphogenesis | biological process | GO:0048557 | 17 | 1 | 18204 | 49 |
GLI3 |
4.481e-02 | -3.11 | cell communication by electrical coupling involved in cardiac conduction | biological process | GO:0086064 | 17 | 1 | 18204 | 49 |
ATP1A2 |
4.481e-02 | -3.11 | positive regulation of glycogen metabolic process | biological process | GO:0070875 | 17 | 1 | 18204 | 49 |
SORBS1 |
4.481e-02 | -3.11 | viral genome replication | biological process | GO:0019079 | 17 | 1 | 18204 | 49 |
NFIA |
4.481e-02 | -3.11 | ureter development | biological process | GO:0072189 | 17 | 1 | 18204 | 49 |
NFIA |
4.493e-02 | -3.10 | A/G_cyclase_CS | interpro domains | IPR018297 | 17 | 1 | 18521 | 50 |
ADCY2 |
4.493e-02 | -3.10 | CA_dom | interpro domains | IPR001148 | 17 | 1 | 18521 | 50 |
PTPRZ1 |
4.493e-02 | -3.10 | CA_dom_sf | interpro domains | IPR036398 | 17 | 1 | 18521 | 50 |
PTPRZ1 |
4.507e-02 | -3.10 | ductal_carcinoma | COSMIC cancer mutations | ductal_carcinoma | 15798 | 49 | 16828 | 49 |
GPM6A,PREX2,NTM,NPAS3,TRPM3,MGAT4C,FBXL7,SLC1A2,NKAIN3,PTPRZ1,LSAMP,ADCY2,CDH20,NTRK2,DST,PITPNC1,NHSL1,SPARCL1,TNIK,SOX5,SLC1A3,NEBL,MACF1,CSGALNACT1,BMPR1B,NFIA,MAML2,PRKCA,ATP1A2,ITPR2,SORBS1,DTNA,RYR3,PAMR1,GPC5,MSI2,PARD3B,ABLIM1,TPD52L1,NRG3,ZBTB20,RFX4,GLIS3,SLC4A4,FMN2,CTNND2,DPP10,RORA,GLI3 |
4.525e-02 | -3.10 | limbic system development | biological process | GO:0021761 | 126 | 2 | 18204 | 49 |
ATP1A2,GLI3 |
4.529e-02 | -3.09 | TTC29 (tetratricopeptide repeat domain 29) | protein interactions | 83894 | 18 | 1 | 19454 | 50 |
MACF1 |
4.529e-02 | -3.09 | NKIRAS1 (NFKB inhibitor interacting Ras like 1) | protein interactions | 28512 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.529e-02 | -3.09 | SELL (selectin L) | protein interactions | 6402 | 18 | 1 | 19454 | 50 |
PRKCA |
4.529e-02 | -3.09 | KLHL1 (kelch like family member 1) | protein interactions | 57626 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.529e-02 | -3.09 | OPCML (opioid binding protein/cell adhesion molecule like) | protein interactions | 4978 | 18 | 1 | 19454 | 50 |
NTM |
4.529e-02 | -3.09 | Cnot2 (CCR4-NOT transcription complex, subunit 2) | protein interactions | 72068 | 18 | 1 | 19454 | 50 |
MACF1 |
4.529e-02 | -3.09 | Tgfbr1 (transforming growth factor, beta receptor I) | protein interactions | 21812 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.529e-02 | -3.09 | ACAP1 (ArfGAP with coiled-coil, ankyrin repeat and PH domains 1) | protein interactions | 9744 | 18 | 1 | 19454 | 50 |
NEBL |
4.558e-02 | -3.09 | Cell-type Dependent Selectivity of CCK2R Signaling | WikiPathways | WP3679 | 13 | 1 | 5310 | 19 |
RYR3 |
4.565e-02 | -3.09 | ovary-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | ovary-carcinoma-endometrioid_carcinoma | 464 | 4 | 16828 | 49 |
TNIK,PRKCA,NTRK2,BMPR1B |
4.569e-02 | -3.09 | carboxylic acid transport | biological process | GO:0046942 | 297 | 3 | 18204 | 49 |
SLC1A3,NTRK2,SLC1A2 |
4.569e-02 | -3.09 | muscle system process | biological process | GO:0003012 | 297 | 3 | 18204 | 49 |
DTNA,RYR3,ATP1A2 |
4.569e-02 | -3.09 | Serotonergic synapse | KEGG pathways | hsa04726 | 112 | 2 | 7161 | 22 |
PRKCA,ITPR2 |
4.573e-02 | -3.08 | carbohydrate derivative metabolic process | biological process | GO:1901135 | 975 | 6 | 18204 | 49 |
ATP1A2,RORA,MGAT4C,CSGALNACT1,BMPR1B,ADCY2 |
4.581e-02 | -3.08 | Carb_anhydrase | pfam domains | PF00194 | 17 | 1 | 17795 | 49 |
PTPRZ1 |
4.581e-02 | -3.08 | ZZ | pfam domains | PF00569 | 17 | 1 | 17795 | 49 |
DTNA |
4.590e-02 | -3.08 | response to amino acid | biological process | GO:0043200 | 127 | 2 | 18204 | 49 |
NTRK2,SLC1A2 |
4.590e-02 | -3.08 | cell-cell junction assembly | biological process | GO:0007043 | 127 | 2 | 18204 | 49 |
CDH20,PRKCA |
4.597e-02 | -3.08 | protein phosphorylation | biological process | GO:0006468 | 503 | 4 | 18204 | 49 |
PRKCA,NTRK2,TNIK,BMPR1B |
4.604e-02 | -3.08 | SLC-mediated transmembrane transport | REACTOME pathways | R-HSA-425407 | 287 | 3 | 10285 | 29 |
SLC4A4,SLC1A2,SLC1A3 |
4.606e-02 | -3.08 | extraskeletal | COSMIC cancer mutations | extraskeletal | 903 | 6 | 16828 | 49 |
NPAS3,ITPR2,ABLIM1,PTPRZ1,ATP1A2,SPARCL1 |
4.607e-02 | -3.08 | organic acid transport | biological process | GO:0015849 | 298 | 3 | 18204 | 49 |
NTRK2,SLC1A2,SLC1A3 |
4.641e-02 | -3.07 | positive regulation of transcription by RNA polymerase II | biological process | GO:0045944 | 1237 | 7 | 18204 | 49 |
GLI3,MAML2,NFIA,BMPR1B,RORA,GLIS3,RFX4 |
4.652e-02 | -3.07 | monoatomic cation homeostasis | biological process | GO:0055080 | 505 | 4 | 18204 | 49 |
SLC4A4,RYR3,SLC1A3,ATP1A2 |
4.653e-02 | -3.07 | NUFIP1 (nuclear FMR1 interacting protein 1) | protein interactions | 26747 | 134 | 2 | 19454 | 50 |
GPM6A,NTM |
4.671e-02 | -3.06 | transmembrane receptor protein tyrosine kinase activator activity | molecular function | GO:0030297 | 18 | 1 | 18094 | 48 |
NRG3 |
4.671e-02 | -3.06 | phosphatidylcholine transporter activity | molecular function | GO:0008525 | 18 | 1 | 18094 | 48 |
PITPNC1 |
4.690e-02 | -3.06 | PKA-mediated phosphorylation of CREB | REACTOME pathways | R-HSA-111931 | 17 | 1 | 10285 | 29 |
ADCY2 |
4.690e-02 | -3.06 | Trafficking of GluR2-containing AMPA receptors | REACTOME pathways | R-HSA-416993 | 17 | 1 | 10285 | 29 |
PRKCA |
4.690e-02 | -3.06 | PKA activation in glucagon signalling | REACTOME pathways | R-HSA-164378 | 17 | 1 | 10285 | 29 |
ADCY2 |
4.690e-02 | -3.06 | Elevation of cytosolic Ca2+ levels | REACTOME pathways | R-HSA-139853 | 17 | 1 | 10285 | 29 |
ITPR2 |
4.716e-02 | -3.05 | FOXP1 (forkhead box P1) | protein interactions | 27086 | 135 | 2 | 19454 | 50 |
SOX5,NFIA |
4.716e-02 | -3.05 | MTNR1B (melatonin receptor 1B) | protein interactions | 4544 | 135 | 2 | 19454 | 50 |
DST,MACF1 |
4.718e-02 | -3.05 | Leukocyte transendothelial migration | KEGG pathways | hsa04670 | 114 | 2 | 7161 | 22 |
CTNNA2,PRKCA |
4.718e-02 | -3.05 | Leukocyte transendothelial migration | KEGG pathways | ko04670 | 114 | 2 | 7161 | 22 |
CTNNA2,PRKCA |
4.720e-02 | -3.05 | response to organophosphorus | biological process | GO:0046683 | 129 | 2 | 18204 | 49 |
ITPR2,RYR3 |
4.722e-02 | -3.05 | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | 15813 | 49 | 16828 | 49 |
MAML2,NFIA,PRKCA,ATP1A2,ITPR2,NEBL,BMPR1B,MACF1,CSGALNACT1,ADCY2,NTRK2,CDH20,NHSL1,SPARCL1,DST,PITPNC1,SLC1A3,TNIK,SOX5,PREX2,GPM6A,NTM,MGAT4C,NPAS3,TRPM3,NKAIN3,FBXL7,SLC1A2,LSAMP,PTPRZ1,RORA,GLI3,SLC4A4,TPD52L1,NRG3,GLIS3,RFX4,ZBTB20,FMN2,DPP10,CTNND2,MSI2,PARD3B,ABLIM1,SORBS1,DTNA,GPC5,RYR3,PAMR1 |
4.737e-02 | -3.05 | circulatory system process | biological process | GO:0003013 | 508 | 4 | 18204 | 49 |
ATP1A2,SLC1A2,SLC1A3,SLC4A4 |
4.737e-02 | -3.05 | Glycosaminoglycan metabolism | REACTOME pathways | R-HSA-1630316 | 124 | 2 | 10285 | 29 |
GPC5,CSGALNACT1 |
4.738e-02 | -3.05 | cardiac myofibril assembly | biological process | GO:0055003 | 18 | 1 | 18204 | 49 |
NEBL |
4.738e-02 | -3.05 | negative regulation of anoikis | biological process | GO:2000811 | 18 | 1 | 18204 | 49 |
NTRK2 |
4.738e-02 | -3.05 | maintenance of cell polarity | biological process | GO:0030011 | 18 | 1 | 18204 | 49 |
DST |
4.738e-02 | -3.05 | spinal cord patterning | biological process | GO:0021511 | 18 | 1 | 18204 | 49 |
GLI3 |
4.738e-02 | -3.05 | dendritic spine morphogenesis | biological process | GO:0060997 | 18 | 1 | 18204 | 49 |
CTNND2 |
4.738e-02 | -3.05 | positive regulation of circadian rhythm | biological process | GO:0042753 | 18 | 1 | 18204 | 49 |
RORA |
4.738e-02 | -3.05 | negative regulation of sodium ion transport | biological process | GO:0010766 | 18 | 1 | 18204 | 49 |
ATP1A2 |
4.749e-02 | -3.05 | positive regulation of cell communication | biological process | GO:0010647 | 1792 | 9 | 18204 | 49 |
SLC1A3,TPD52L1,TNIK,GPC5,MACF1,PRKCA,NTRK2,SORBS1,BMPR1B |
4.752e-02 | -3.05 | Leu-rich_rpt_Cys-con_subtyp | interpro domains | IPR006553 | 18 | 1 | 18521 | 50 |
FBXL7 |
4.752e-02 | -3.05 | ATPase_P-typ_cation-transptr_N | interpro domains | IPR004014 | 18 | 1 | 18521 | 50 |
ATP1A2 |
4.752e-02 | -3.05 | Nucleotide_cyclase | interpro domains | IPR029787 | 18 | 1 | 18521 | 50 |
ADCY2 |
4.752e-02 | -3.05 | A/G_cyclase | interpro domains | IPR001054 | 18 | 1 | 18521 | 50 |
ADCY2 |
4.761e-02 | -3.04 | postsynaptic density | cellular component | GO:0014069 | 317 | 3 | 19108 | 49 |
TNIK,NTRK2,CTNND2 |
4.764e-02 | -3.04 | astrocyte projection | cellular component | GO:0097449 | 19 | 1 | 19108 | 49 |
SLC1A2 |
4.764e-02 | -3.04 | postsynaptic specialization, intracellular component | cellular component | GO:0099091 | 19 | 1 | 19108 | 49 |
TNIK |
4.764e-02 | -3.04 | cation-transporting ATPase complex | cellular component | GO:0090533 | 19 | 1 | 19108 | 49 |
ATP1A2 |
4.764e-02 | -3.04 | parallel fiber to Purkinje cell synapse | cellular component | GO:0098688 | 19 | 1 | 19108 | 49 |
GPM6A |
4.768e-02 | -3.04 | primary_central_nervous_system_lymphoma | COSMIC cancer mutations | primary_central_nervous_system_lymphoma | 683 | 5 | 16828 | 49 |
MACF1,PARD3B,NRG3,DST,ZBTB20 |
4.768e-02 | -3.04 | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | 683 | 5 | 16828 | 49 |
MACF1,PARD3B,NRG3,DST,ZBTB20 |
4.769e-02 | -3.04 | SMURF1 (SMAD specific E3 ubiquitin protein ligase 1) | protein interactions | 57154 | 533 | 4 | 19454 | 50 |
FMN2,TNIK,BMPR1B,PRKCA |
4.774e-02 | -3.04 | GCHFR (GTP cyclohydrolase I feedback regulator) | protein interactions | 2644 | 19 | 1 | 19454 | 50 |
NEBL |
4.774e-02 | -3.04 | OSM (oncostatin M) | protein interactions | 5008 | 19 | 1 | 19454 | 50 |
TRPM3 |
4.774e-02 | -3.04 | SPZ1 (spermatogenic leucine zipper 1) | protein interactions | 84654 | 19 | 1 | 19454 | 50 |
DTNA |
4.774e-02 | -3.04 | C3orf62 (chromosome 3 open reading frame 62) | protein interactions | 375341 | 19 | 1 | 19454 | 50 |
ATP1A2 |
4.774e-02 | -3.04 | TNR (tenascin R) | protein interactions | 7143 | 19 | 1 | 19454 | 50 |
PTPRZ1 |
4.774e-02 | -3.04 | RRAD (RRAD, Ras related glycolysis inhibitor and calcium channel regulator) | protein interactions | 6236 | 19 | 1 | 19454 | 50 |
PRKCA |
4.774e-02 | -3.04 | RIT2 (Ras like without CAAX 2) | protein interactions | 6014 | 19 | 1 | 19454 | 50 |
DTNA |
4.774e-02 | -3.04 | INKA1 (inka box actin regulator 1) | protein interactions | 389119 | 19 | 1 | 19454 | 50 |
ZBTB20 |
4.774e-02 | -3.04 | PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like) | protein interactions | 84457 | 19 | 1 | 19454 | 50 |
GPM6A |
4.774e-02 | -3.04 | TRPV6 (transient receptor potential cation channel subfamily V member 6) | protein interactions | 55503 | 19 | 1 | 19454 | 50 |
PRKCA |
4.774e-02 | -3.04 | JSRP1 (junctional sarcoplasmic reticulum protein 1) | protein interactions | 126306 | 19 | 1 | 19454 | 50 |
PRKCA |
4.774e-02 | -3.04 | CNTNAP4 (contactin associated protein family member 4) | protein interactions | 85445 | 19 | 1 | 19454 | 50 |
MACF1 |
4.777e-02 | -3.04 | positive regulation of signaling | biological process | GO:0023056 | 1794 | 9 | 18204 | 49 |
BMPR1B,SORBS1,NTRK2,PRKCA,GPC5,MACF1,TNIK,TPD52L1,SLC1A3 |
4.793e-02 | -3.04 | skin-back-malignant_melanoma | COSMIC cancer mutations | skin-back-malignant_melanoma | 280 | 3 | 16828 | 49 |
ATP1A2,PREX2,TNIK |
4.809e-02 | -3.03 | N-glycan biosynthesis, complex type | KEGG pathways | M00075 | 16 | 1 | 7161 | 22 |
MGAT4C |
4.809e-02 | -3.03 | cAMP signaling | KEGG pathways | hsa_M00695 | 16 | 1 | 7161 | 22 |
ADCY2 |
4.809e-02 | -3.03 | cAMP signaling | KEGG pathways | M00695 | 16 | 1 | 7161 | 22 |
ADCY2 |
4.809e-02 | -3.03 | N-glycan biosynthesis, complex type | KEGG pathways | hsa_M00075 | 16 | 1 | 7161 | 22 |
MGAT4C |
4.815e-02 | -3.03 | FH2 | prosite domains | PS51444 | 15 | 1 | 12186 | 40 |
FMN2 |
4.815e-02 | -3.03 | CNH | prosite domains | PS50219 | 15 | 1 | 12186 | 40 |
TNIK |
4.822e-02 | -3.03 | mitotic cell cycle process | biological process | GO:1903047 | 511 | 4 | 18204 | 49 |
NFIA,FBXL7,PRKCA,TPD52L1 |
4.824e-02 | -3.03 | Alpha carbonic anhydrase | gene3d domains | 3.10.200.10 | 17 | 1 | 14470 | 42 |
PTPRZ1 |
4.842e-02 | -3.03 | TBL1X (transducin beta like 1 X-linked) | protein interactions | 6907 | 137 | 2 | 19454 | 50 |
SOX5,NFIA |
4.843e-02 | -3.03 | Ras signaling in the CD4+ TCR pathway | Pathway Interaction DB | tcrraspathway | 11 | 1 | 2226 | 10 |
PRKCA |
4.843e-02 | -3.03 | oligoastrocytoma_Grade_II | COSMIC cancer mutations | oligoastrocytoma_Grade_II | 121 | 2 | 16828 | 49 |
CDH20,DTNA |
4.844e-02 | -3.03 | Cation_ATPase_N | pfam domains | PF00690 | 18 | 1 | 17795 | 49 |
ATP1A2 |
4.844e-02 | -3.03 | Guanylate_cyc | pfam domains | PF00211 | 18 | 1 | 17795 | 49 |
ADCY2 |
4.852e-02 | -3.03 | carboxylic acid transmembrane transport | biological process | GO:1905039 | 131 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
4.859e-02 | -3.02 | human chr18q12.1 | chromosome location | human chr18q12.1 | 26 | 1 | 26134 | 50 |
DTNA |
4.867e-02 | -3.02 | Thyroid hormone signaling pathway | KEGG pathways | hsa04919 | 116 | 2 | 7161 | 22 |
ATP1A2,PRKCA |
4.900e-02 | -3.02 | ERK Pathway in Huntington's Disease | WikiPathways | WP3853 | 14 | 1 | 5310 | 19 |
NTRK2 |
4.905e-02 | -3.01 | EXOC1 (exocyst complex component 1) | protein interactions | 55763 | 138 | 2 | 19454 | 50 |
MACF1,DST |
4.905e-02 | -3.01 | NFIB (nuclear factor I B) | protein interactions | 4781 | 138 | 2 | 19454 | 50 |
SOX5,NFIA |
4.911e-02 | -3.01 | sequence-specific double-stranded DNA binding | molecular function | GO:1990837 | 1547 | 8 | 18094 | 48 |
SOX5,NPAS3,RFX4,NFIA,RORA,ZBTB20,GLI3,GLIS3 |
4.916e-02 | -3.01 | response to decreased oxygen levels | biological process | GO:0036293 | 306 | 3 | 18204 | 49 |
FMN2,ITPR2,RORA |
4.924e-02 | -3.01 | alkali metal ion binding | molecular function | GO:0031420 | 19 | 1 | 18094 | 48 |
ATP1A2 |
4.924e-02 | -3.01 | transmembrane receptor protein serine/threonine kinase activity | molecular function | GO:0004675 | 19 | 1 | 18094 | 48 |
BMPR1B |
4.930e-02 | -3.01 | CNH | smart domains | SM00036 | 14 | 1 | 9717 | 35 |
TNIK |
4.937e-02 | -3.01 | monoatomic ion homeostasis | biological process | GO:0050801 | 515 | 4 | 18204 | 49 |
RYR3,SLC4A4,ATP1A2,SLC1A3 |
4.966e-02 | -3.00 | cell division | biological process | GO:0051301 | 516 | 4 | 18204 | 49 |
PARD3B,FMN2,SOX5,FBXL7 |
4.968e-02 | -3.00 | SPCS2 (signal peptidase complex subunit 2) | protein interactions | 9789 | 139 | 2 | 19454 | 50 |
MGAT4C,GPC5 |
4.983e-02 | -3.00 | PK_Tyr_Ser-Thr | pfam domains | PF07714 | 130 | 2 | 17795 | 49 |
NTRK2,BMPR1B |
4.987e-02 | -3.00 | ligand-gated monoatomic cation channel activity | molecular function | GO:0099094 | 135 | 2 | 18094 | 48 |
RYR3,ITPR2 |
4.995e-02 | -3.00 | microvillus organization | biological process | GO:0032528 | 19 | 1 | 18204 | 49 |
TNIK |
4.995e-02 | -3.00 | positive regulation of bone resorption | biological process | GO:0045780 | 19 | 1 | 18204 | 49 |
PRKCA |
4.995e-02 | -3.00 | vocalization behavior | biological process | GO:0071625 | 19 | 1 | 18204 | 49 |
GLI3 |
4.995e-02 | -3.00 | craniofacial suture morphogenesis | biological process | GO:0097094 | 19 | 1 | 18204 | 49 |
GLI3 |
4.995e-02 | -3.00 | chondroitin sulfate biosynthetic process | biological process | GO:0030206 | 19 | 1 | 18204 | 49 |
CSGALNACT1 |
4.995e-02 | -3.00 | response to potassium ion | biological process | GO:0035864 | 19 | 1 | 18204 | 49 |
ATP1A2 |
4.995e-02 | -3.00 | cerebellar Purkinje cell layer morphogenesis | biological process | GO:0021692 | 19 | 1 | 18204 | 49 |
RORA |
4.995e-02 | -3.00 | regulation of neurotransmitter uptake | biological process | GO:0051580 | 19 | 1 | 18204 | 49 |
ATP1A2 |